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1.1 Abstract 
 
Background CKD disproportionately affects older patients, and survival in older renal patients is 
known to be poor. Older renal patients also report high symptom burden and poor quality of life.  
Distress has been described as “the negative emotional experience of the individual” (National 
Comprehensive Cancer Network, 2010). It is a deliberately broad term, recognising that the causes 
of distress can be manifold.  
Roth et al (1998) developed a simple tool, the Distress Thermometer (DT), to identify distress 
associated with unmet need in cancer patients. The aim was to enable staff, who may often 
concentrate solely on physical health issues, to consider and discuss with patients their psychological 
and social needs. It has been used in many diverse settings, however it has not yet been validated 
for use in renal patients. 
Objective of this thesis To explore the phenomenon of distress in renal patients 
Study 1 We compared the Distress Thermometer to four other screening tools in frequent use in 
renal patients: the Hospital Anxiety and Depression Scale (HADS), the Beck Depression Inventory II 
(BDI-II), the Memorial Symptom Assessment Scale (MSAS-SF), and the SF-36 quality of life 
assessment tool. Receiver Operator Characteristic analysis was used to compare the DT with the 
HADS and BDI-II, and sensitivity and specificity were calculated. We found high levels of agreement 
between the Distress Thermometer and the HADS and BDI-II depression screening tools (AUC 0.76 
and 0.87 respectively), correlation between high DT scores and high symptom burden on the MSAS-
SF, and an inverse correlation between all subscales of the SF-36, in particular the Energy and 
Emotional Wellbeing subscales, suggesting that distress worsens with worsening quality of life. 
Median time to complete the DT was 4 minutes, and only 1/285 participants found it objectionable.  
Study 2 We compared DT scores of patients on haemodialysis with DT scores of patients with 
CKD4/5. Haemodialysis patients had significantly higher DT scores than CKD4/5 patients, even 
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following adjustment for age, gender and comorbidities (median DT score 4 for haemodialysis 
patients and 2 for CKD4/5 patients, p < 0.001). Younger age, female gender and previous diagnosis of 
depression were also associated with higher levels of distress.  
Study 3 We obtained records for 316 CKD4/5 patients aged <70 with ≥3 DTs and KPSs in their 
patient record. 23 started haemodialysis during the study period. Linear regression was used to 
analyse DT score, KPS and other factors of interest at baseline. Multi-level regression was used to 
analyse changes in DT and KPS score over time. Visual Graphical Analysis (VGA) was used to 
assess the trajectories of patients who started dialysis in the study period. 
For each 10% loss of functional performance on the KPS, DT score fell by 0.47 (p<0.001). The 
relationship between change in DT scores over time and factors such as gender, eGFR and age, was 
not statistically significant. We identified four common trajectories of distress around the time of 
initiation of dialysis. For a minority of participants their DT scores were unaffected by starting 
dialysis. The majority however saw a rise in their DT scores around the time of start on 
haemodialysis. For some participants this returned to pre-dialysis distress levels within six months, 
but for others their distress levels remained high.  
Study 4 Using an interpretative phenomenology approach, we interviewed participants about their 
experiences of distress. Distress appeared to be a near-universal response to the transition onto 
dialysis, and a broad range of definitions of distress were used by our participants. In particular, 
delays and lack of individual care led to feelings of alienation of patients from the dialysis team. 
Discussion Distress is common in renal patients, and haemodialysis patients appear to experience 
higher levels of distress than CKD4/5 patients, even following adjustment for other factors. Time of 
initiation of dialysis seems to be a time of particular distress, and resources should be focused on 
easing this transition. Individualised care is particularly welcomed by patients.  
It would seem that the word “distress” does not unambiguously refer to any one concept, 
experience, or phenomenon, but rather is a cluster of related terms, with meaning generated 
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idiosyncratically by each individual. The advantage of the Distress Thermometer is that it is designed 
to work with whatever definition of distress each patient deploys, without challenging them on that 
definition.  
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4 Background  
4.1 The Ageing Renal Patient 
In the 1970s and 80s the lack of dialysis provision in the UK was a national scandal. Less than 25% of 
patients referred for dialysis in the UK were accepted onto a programme (less than half the rate of 
Sweden), and this was strongly correlated with the distance the patient lived from the nearest renal 
unit (a true postcode lottery)1-4. To combat this shortage, there was an expansion in the number of 
renal units in the UK towards the end of the 1980s, and the development of the “hub and spoke” 
satellite dialysis units that are common today5-8. 
  
 
There has also been a significant expansion in the number of frail older patients diagnosed with 
advanced CKD over the past thirty years9. Indeed, the burden of CKD disproportionately affects older 
patients. Despite this, the majority of older patients die with CKD (due to other comorbidities), not 
from it10-14.   
Figure 4.1 RRT incidence rates 1980-2012, UK renal registry 16th annual report, 
2013 
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These elderly patients have high levels of co-morbidity, and as a consequence the face of renal 
medicine is changing – there is an increasing need to focus on traditionally geriatric areas of 
expertise such as falls prevention and rehabilitation, and shift in focus onto improving patient well-
being rather than longevity. This will involve guiding patients towards treatment options which will 
maintain their independence and quality of life. 
It has become clear that dialysis is not the best option for everyone. The concept of “Maximal 
Conservative Management” was introduced in some units around 15 years ago (notably, the Royal 
Free Hospital was one of the first)15,16 and is now an established treatment choice in the majority of 
renal units in the UK. It provides symptom control, non-dialytic correction of electrolyte and fluid 
imbalances, anaemia management, and end of life care. The emphasis is on maintaining quality of 
life for the patient and their families (described as “rational care, not rationing care”17).  
Unfortunately it is difficult for nephrologists to advise patients whether to choose dialysis or 
conservative management. There is not currently enough evidence to allow accurate prediction of 
who will do well on dialysis and who will not. Some older patients do extremely well on dialysis. For 
others, particularly those patients with multiple co-morbidities or at the extremes of old age, 
survival is similar on conservative management as it would have been on dialysis17-19. It is also not 
clear which patients will feel better on dialysis and who will not. The evidence to date suggests that 
patient’s self-reported quality of life may worsen on dialysis while those patients who have chosen 
conservative management do not see a significant decline17. Currently some patients who would 
probably have an increased survival on dialysis choose to sacrifice longevity for a better quality of 
life20. For most patients this remains a very personal decision. 
Over the last ten years the research picture has changed considerably. Recent small scale and 
qualitative studies have changed the perception of older patients’ experience of end-stage kidney 
disease and have legitimised conservative management as the fourth option for ESRF along with 
haemodialysis, peritoneal dialysis and transplantation. The challenges now faced include expanding 
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the evidence base in this area with larger epidemiological studies. Many of these patients have 
multiple comorbidities and are housebound, and many die before they reach end-stage renal failure, 
so any longitudinal studies which undertake to follow patients from CKD to ESRF must recruit large 
numbers of patients in order to have sufficient patients starting dialysis. Many of the tools used in 
this area are unwieldy and difficult for frail older patients, some of whom have cognitive or visual 
impairments, to complete.  
 
4.2 Older patients with Chronic Kidney Disease in the UK 
CKD disproportionately affects older patients (Figure 4.2, Figure 4.3)9,10,21,22. Since 2006 UK primary 
care providers have maintained CKD disease registers as part of Quality and Outcomes Framework 
(QOF)23, and more patients are now diagnosed and referred to nephrology clinics from primary 
care24. There is debate about whether this higher incidence of reduced eGFR in older patients 
represents normal ageing or a disease process25. There has been shown to be an age-related 
reduction in effective renal plasma flow (ERPF) and increase in renovascular resistance in even 
healthy older patients26. These changes in renal haemodynamic autoregulation lead to an increased 
risk for acute kidney injury (AKI) from relatively small insults. Many older patients also develop a 
reduced glomerular filtration rate and have fewer nephrons than younger patients, although this 
may be related to underlying macrovascular disease as up to a third of normotensive older patients 
maintain a normal GFR27,28.  
In addition, the most common method of diagnosing CKD in the UK is by estimating GFR from serum 
creatinine. There are potential problems with this, as serum creatinine is related to muscle mass 
which may decline in older patients leading to an overestimation of glomerular filtration rate. The 
MDRD equation is the most commonly used equation in NHS labs. The newer CKD-Epi equation29, 
although currently less commonly used, is thought to be more accurate at higher glomerular 
filtration rates. However both equations have recently been validated in older patients30. Newer 
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biomarkers (such as cystatin C) which are not related to muscle mass may give a more accurate 
estimation of GFR in sarcopenic patients, but are expensive, not currently widely available, and may 
have their own drawbacks (for example, cystatin C may be elevated in inflammation31 and may also 
be affected by factors such as smoking history, gender and age independent of kidney function32).   
Finally, a large proportion of CKD in the UK is associated with hypertensive/renovascular disease, 
diabetic nephropathy, or obstructive uropathy (due to prostatic disease or bladder dysfunction), all 
of which disproportionately affect older patients. The most recent UK renal registry report found 
that the median age of incident RRT patients was 64.6yrs9. A still greater number of older patients 
with CKD will never progress to end-stage renal failure10 (Figure 4.4) but many of these will still have 
the symptoms and decreased life expectancy associated with CKD. 
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Figure 4.2 Incidence of CKD 1-5 in the UK (Roderick et al, 2011)22 
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Figure 4.3 Number of incident dialysis patients in 2012, by age group and initial dialys is 
modality (UK renal registry 16th annual report, 2013)9 
Figure 4.4 Proportion of patients with CKD V receiving RRT compared with those who do not, 
by age group (Moon et al, ANZDATA registry report, 2011)10 
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4.3 Survival in older patients with CKD 
Survival in older renal patients is known to be poor.  UK renal registry data shows that new starters 
on dialysis who are aged over 75 have a 30% mortality rate within the first year, and more than half 
will be dead within two years (Figure 4.5)9. Five year survival is less than 20%, worse than many 
cancers (Figure 4.6)33. Many nephrologists may find it difficult to be explicit with patients about this. 
 
It could be argued that the excess mortality in older incident dialysis patients is in part due to older 
patients with multi-organ failure being started on dialysis inappropriately, for example because they 
are too frail to be accepted by the intensive care unit. However when patients who died within 90 
days of starting dialysis are excluded, the survival rate for patients aged 65-74 only improves by 5%, 
and the survival rate for patients aged 85 and older does not improve at all (Figure 4.7). 
 
The UK Renal Registry does not currently collect data on patients who choose conservative 
management or who have stable CKD5, however a number of smaller studies have compared 
outcomes for these patients6,17-19,34-39.  Taken as a whole, patients who choose to dialyse do generally 
live longer that those who choose MCM, although it does vary quite significantly from study to 
study, depending on definition of MCM (Figure 4.8). However, they also spend much more time in 
hospital (including outpatient dialysis appointments) (Figure 4.9)18 and frequently report that they 
are so exhausted after a dialysis session that they cannot even manage to prepare a meal.40,41 
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Figure 4.5 Survival of incident patients (unadjusted) 1997-2011 cohort (without censoring 
at transplantation), UK renal registry 16th annual report 20139 
Figure 4.6 Relative 5 year survival of dialysis patients compared with cancer patients. 
Nordio et al, AJKD 200933 
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Figure 4.7 Unadjusted survival of incident RRT patients by age group, 2011 cohort. 
UK renal registry 16th annual report 20139 
Figure 4.8 Review of median survival of elderly ESRD patients reported in the 
literature. Carson et al, CJASN 200918 
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Figure 4.10 Time to recovery following dialysis sessions. Source: Caplin et al, NDT 2011 41 
Figure 4.9 Relative survival of HD patients and MCM patients. Carson et al, 
CJASN 200918 
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When we consider those patients with high levels of comorbidity however, the picture is somewhat 
bleaker. As Murtagh et al showed, the survival benefit of dialysis for patients aged >75 disappears in 
those patients with high comorbidity19 (defined as Davies comorbidity score >2). 
 
 
 
 
Figure 4.11 Relative survival of patients on MCM and HD pathways, stratified by low comorbidity 
(top graph) and high comorbidity (bottom graph). Source: Murtagh et al , NDT 200719 
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This is consistent with other studies, such as Davies42, and the Rein renal registry43, both of whom 
showed that survival in ESRF is greatly reduced in the presence of either diabetes or cardiovascular 
disease. Cohen44 showed worse survival in haemodialysis patients with low albumin, peripheral 
vascular disease, dementia, and a negative answer to the “surprise question” (“Would you be 
surprised if your patient died in the next six months?”). Interestingly, the “surprise question” alone 
has high discriminating power when asked of nephrologists and senior dialysis nurses44-46. This 
suggests that failing dialysis patients are actually well-recognised within the dialysis unit. The 
concern is that in many units, this recognition does not automatically prompt intervention and is not 
discussed with the patient or their family47-49. Regular screening for failing dialysis patients, the use 
of Advance Care Planning (ACP) tools, and the creation of “cause for concern” registers in some 
units, aim to address these issues50-60. 
Survival calculators now exist which can improve the advice we give to older patients about their life 
expectancy on dialysis. For example, the Cohen survival calculator (based on the CJASN paper 
above44) is available as a web-based calculator (http://touchcalc.com/calculators/sq) and a 
smartphone app. However these predictions must always be individualised for each patient, and 
there is a margin of uncertainty in any prediction. 
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4.4 Comorbidity and quality of life in older CKD and dialysis patients 
 Comorbidity 
Older renal patients have been shown to have high levels of comorbidity44,61-63 and excess mortality 
from both cardiovascular and cerebrovascular disease as well as cancer9,33,43,64-71. A forty year old 
patient on dialysis has the same annual cardiovascular mortality rate as an eighty year old in the 
general population and 80% of US haemodialysis patients have some form of cardiac disease 
(including coronary artery disease, valvular disease, and heart failure)72.  
There are several potential reasons for this. Firstly, the cardiovascular disease may predate or even 
have caused the renal disease (in the case of cholesterol embolisation following PCI, or severe 
congestive cardiac failure).  Both diseases may be caused by the same underlying condition (for 
example in patients with diabetic nephropathy, diabetes may be the cause of both the 
cardiovascular disease and the renal disease). It is possible that renal insufficiency is in itself an 
independent risk factor for cardiovascular disease. CKD may also simply be a surrogate marker for 
the presence and severity of an underlying pathogenic atherosclerotic process71.  
There is an association between vitamin D deficiency and renal mineral bone disease, and increased 
cardiovascular risk73,74. It is suggested that altered vitamin D metabolism and secondary 
hyperparathyroidism may be independent risk factors for cardiovascular disease, by activating the 
renin-angiotensin system and by increasing vascular calcification.  
When established cardiovascular disease has developed, patients with ESRF do less well than 
patients with normal renal function75. Partly this is because acute coronary events are recognised 
less promptly in dialysis patients (who are more likely to present atypically75,76, with pulmonary 
oedema but no chest pain, and less likely to present with dynamic ECG changes). Anecdotally there 
is widespread confusion about the role of troponin assays in renal patients with suspected acute 
coronary syndrome, even amongst cardiologists. These patients are also offered less treatment than 
patients in the general population (less likely to be offered lower PCI/CABG, perhaps due to concerns 
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about giving contrast, or concerns about poorer surgical outcomes)72,76. Randomised controlled trials 
(RCTs) often specifically exclude renal patients, and so management is often based on “common 
sense”, or by treating renal patients exactly the same as patients with normal renal function77.  
Unfortunately, there have been several instances where RCTs were later carried out and the 
evidence did not in fact support either of those approaches72. The phrase “reverse 
epidemiology”65,70,78 is used to describe the fact that conventional risk factors of cardiovascular 
disease and mortality in the general population such as body mass, serum cholesterol, and blood 
pressure are also found to relate to outcome in maintenance dialysis patients, but in the inverse 
direction. For example being overweight is associated with an increased cardiovascular mortality risk 
in the general population, but is associated with a reduced annual cardiovascular mortality risk in 
haemodialysis patients65,70. 
The high rate of death from cancer is also likely to be multifactorial – some patients will have a 
history of immunosuppression either due to their underlying renal disease or previous renal 
transplants, giving a higher incidence of cancer overall. Many chemotherapeutic drugs cannot be 
given to patients with renal impairment due to the risk of toxicity33, so patients do not have access 
to the full range of treatment options which are available to those with normal renal function. Renal 
patients may also have less functional reserve79, and be more likely to develop sepsis (preventing 
further cycles of chemotherapy). 
 
 Symptoms 
Renal patients report high symptom burden, whether they are CKD patients80, dialysis patients81, or 
transplant patients82. Indeed, it has been noted that “patients with stage 5 CKD have considerable 
symptom control needs, similar to advanced cancer populations”80. 
Individual symptoms may fluctuate day by day (Dineen, unpublished data). Fatigue is a major 
symptom, along with itch and loss of appetite40,49,80,81,83-92. Again, there are numerous reasons for 
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this. Uraemia itself causes many symptoms such as fatigue, itch and loss of appetite. Renal anaemia 
may also contribute to loss of energy, shortness of breath, and to other symptoms such as angina.  
Patients report high levels of pain93-96, but this often goes untreated. This may partly be due to 
reluctance in medical professionals to prescribe painkillers. NSAIDs are nephrotoxic (although this is 
less of a concern in patients who no longer have any residual renal function) and may cause GI 
bleeding (a significant problem in renal patients, who are already at increased bleeding risk due to 
platelet dysfunction, and who may already be on other anti-platelet drugs as secondary prevention 
in macrovascular disease).  Opioid painkillers and other agents such as gabapentin may accumulate 
in severe renal failure, although these can usually be given safely if the dose is reduced or dosing 
interval is increased. Finally, renal patients may not be offered interventions for their pain (knee 
replacement, cardiac surgery) due to their increased risk of complications. 
There is also a relationship between symptom burden and both depression and poor functional 
status81,89,91-95, which will be discussed further in subsequent sections. 
 
 Performance status 
CKD and dialysis patients have high rates of dependency. In the US, 11% of new-starters on 
haemodialysis aged over 70 are in a nursing home97, and these patients have very poor outcomes98-
102.  
Kurella Tamura et al101 found that physical function declined rapidly in the three months before 
initiation of haemodialysis, which might be expected due to increasing uraemia. However, contrary 
to expectation physical function did not appear to recover following initiation of dialysis, and 
patients remained significantly functionally impaired. Jassal et al103 found that 30% of new starters 
on dialysis became more functionally dependent within the first six months of being on 
haemodialysis, including those patients who had previously lived independently. Although functional 
status did not worsen after the first six months, it did not improve either. In contrast, Murtagh104 
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found that patients managed conservatively maintained functional status until the last month of life. 
There is the possibility of lead-time bias here – patients were included in the study when eGFR was 
<15mls/min (ie long before dialysis would usually be initiated) and eGFR at point of death was not 
recorded, so it is quite possible that “last month of life” is equivalent to (or even earlier than) “time 
at which patient would have started dialysis if they had not been managed conservatively”. 
A later study by Cook and Jassal105 found that in a cohort of 168 prevalent haemodialysis patients 
aged over 65 years, only 5% were independent in all ADLs and IADLs, and 53% were dependent in at 
least one of the six basic ADLs. Almost half were unable to wash without assistance. Only a quarter 
could rise from a chair without using their arms, and less than a third had normal balance. Over 30% 
had fallen at least once in the previous year. Functional status is somewhat better in peritoneal 
dialysis patients106, but this may be due to patient selection (if assisted PD is not available, only 
patients with relatively good functional status will be offered PD).  
There are several possible reasons for the high levels of dependency seen in CKD patients. Firstly, as 
previously discussed, these patients have high rates of comorbidity42,107-110 including high rates of 
diabetes and macrovascular disease, which may cause physical dependency. Secondly, chronic 
kidney disease itself often causes metabolic disturbances associated with fatigue and weakness, 
such as acidaemia, anaemia, peripheral oedema and pulmonary oedema. 
There have been several suggestions about how to reverse this functional decline. Correction of 
acidaemia has been associated with improved muscle strength111. However it is not yet known 
whether this translates to a meaningful improvement in functional status – more studies need to be 
carried out in this area. Correction of anaemia has not been shown to reverse functional 
decline112,113. The effectiveness of rehabilitation is hotly debated – some researchers have found it to 
be effective114-118, while others have not found any benefit119. This is probably due to differences in 
patient selection120-124, for example patients with cognitive impairment are much less likely to 
achieve rehabilitation goals. 
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 Frailty  
Frailty, defined by Clegg et al as a cumulative decline in multiple physiological systems and 
impairment of homeostasis leading to increased vulnerability to external stressors125, is a key area of 
great interest in current geriatric research, and is seen as one of the “Geriatric Giants” (along with 
falls, dementia and incontinence). It is a concept which has long been widely understood as a marker 
of decreased physiological reserve and increased mortality by clinicians. However, although most 
geriatricians “would know it if they saw it”, there is still no firm consensus on the use of tools to 
diagnose or screen for it. 
There are two main models of frailty – the Rockwood Frailty Index, which views frailty as an 
accumulation of deficits, with patients moving along a continuum from non-frail to frail126, and the 
Fried Frailty Phenotype, which sees frailty as a syndrome which is either present or absent127, based 
on presence of  three or more of the following criteria: unintentional weight loss, self-reported 
exhaustion, weakness, slow walking speed, and low physical activity. In both models, this cumulative 
decline depletes homoeostatic reserves until minor stressor events trigger disproportionate changes 
in health status (for example, a minor urinary tract infection may lead to delirium and bedfastness in 
a frail patient, while the same illness would have minimal effect on a robust patient of the same 
age). 
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Figure 4.12 The cycle of frailty. Principles of Geriatric Medicine and Gerontology, 4th Ed. 
McGraw-Hill 1999128. 
 
A high proportion of renal patients are frail. Indeed, some studies have shown that over 78% of 
dialysis patients aged over 70 would meet the Fried frailty criteria79,129,130 , compared with 6.9% of 
Fried’s original cohort of older patients with normal renal function131. There are a number of 
possible reasons for the extremely high proportion of frail dialysis patients - in a later study, Fried 
found an association between protein-energy wasting and both impaired renal function and chronic 
inflammation132. This may be exacerbated by poor intake due to uraemia and dietary restrictions. 
High levels of comorbidities, frequent infections and regular hospital admissions in this population 
will also predispose to frailty. This has a number of implications for nephrologists – should we screen 
for frailty, if it is so prevalent? And how should we intervene when we find it?133 
The most evidence-based intervention for frailty is the comprehensive geriatric assessment (CGA), 
defined as “a multidimensional interdisciplinary diagnostic process focused on determining a frail 
older person’s medical, psychological and functional capability in order to develop a coordinated and 
integrated plan for treatment and long term follow up”134. The resources are not currently in place 
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to allow a comprehensive geriatric assessment for 80% of our prevalent dialysis patients, but pilot 
studies by Jassal and others which offered CGA to older new starters on dialysis have shown 
promising early results116,118,135. Another option might be the wider use of “Cause for Concern” 
screening tools to identify the failing dialysis patient and to intervene early. 
 
 Falls/fractures 
Older dialysis patients frequently fall136-138, when they do fall they are at increased risk of 
fractures139-143, and they are more likely to have poor outcomes than similar-aged patients with 
normal renal function143-146. Cook and Jassal found that over 30% of dialysis patients aged over 65 
had fallen at least once in the previous year, and only 20% of patients had normal timed functional 
mobility scores105. Post-dialysis hypotension, underlying cerebrovascular and cardiovascular disease, 
polypharmacy, autonomic dysfunction and peripheral neuropathy (due to co-existing diabetes and 
deposition of B2 microglobulin) are just some of the potential causes of these falls. There is an 
association between vitamin D deficiency, somatic muscular weakness and falls risk in both renal 
patients and the general population74,137,147,148. Many patients have amputations149-152. Many patients 
also have visual153 or cognitive problems154, and trying to climb off and onto the bed for dialysis and 
then to negotiate a busy, noisy dialysis unit can be a disorientating experience for many older 
patients. In addition, patients with cognitive problems have higher rates of falls when their attention 
is distracted80,81, and dialysis units are generally rather distracting places. 
Awareness of some of these problems can lead to risk reduction143 – for example, regular 
medication reviews, omitting antihypertensives on the morning of dialysis to prevent hypotension, 
removing trip hazards in the dialysis unit and offering assistance with transfers, and early screening 
and referral to physiotherapy or occupational therapy for walking aids and grab rails. Simple 
screening tools such as the sit-to-stand test and the timed up-and-go are effective at predicting falls 
risk155, and can easily be carried out in clinic or on the dialysis unit. 
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 Depression and Quality of life 
Depression is widespread in renal patients – there is wide inter-study variation depending on the 
diagnostic criteria used, but it is generally accepted that between 20-30% of dialysis patients are 
depressed156. This should not be surprising, as studies in non-renal illness have found 
correspondingly high levels of depression in similarly functionally dependent patients157. Depression 
in dialysis patients is associated with higher morbidity and mortality156,158-165, higher functional 
dependence83,166,167, and worse quality of life83,166. Depressed renal patients are more likely to be 
malnourished168, more likely to be non-adherent to dietary and fluid restrictions169-174, and more 
likely to complain of somatic symptoms40,83,91,170,175-177, although the direction of causality is not clear. 
They are also more likely to withdraw from dialysis156,178, although it may be that both the 
depression and withdrawal from dialysis are caused by disease severity, rather than that patients 
withdraw solely due to depression. Most renal units in the UK now have a renal psychologist or 
counselling service, however depression remains under-recognised179. This may in part be patient-
led – Wuerth found that many patients refused evaluation for depression and were non-adherent to 
antidepressant medication therapy, perhaps due to the stigma which still remains around mental 
illness180. 
Unsurprisingly, given the high levels of functional dependency, depression and symptom burden in 
many renal patients, quality of life has been found to be generally poor83,96,181-185, particularly for 
those patients on dialysis.  Da Silva Gane17 found that quality of life worsens after dialysis start, 
particularly in haemodialysis patients. In contrast, patients managed conservatively maintained their 
quality of life.  Interestingly, Moser186 found that older patients were likely to have better self-
reported quality of life than younger patients despite having more functional impairment, due to 
their lower expectations. This is supported by other studies suggesting that good family and social 
support, socioeconomic factors, an external locus of control, good psychological coping strategies 
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and higher levels of disease acceptance were all associated with higher self-reported health-related 
quality of life, while disease intrusiveness was associated with lower quality of life187-198.  
 
Cognitive function 
An estimated 30-70% of haemodialysis patients have been shown to have some degree of cognitive 
impairment154,199-203, and incidence of new cognitive impairment has been associated with both 
severity of chronic kidney disease200,204,205 and with both rate of decline of renal function and 
albuminuria206. This is probably due to a combination of comorbidity (presence of diabetes, vascular 
disease and hypertension are all independent risk factors207,208) and factors unique to chronic kidney 
disease, such as the presence of uraemia.  
Cognitive function is worse during dialysis sessions209, presumably due to reduced cerebral 
perfusion, and best either just before or the day after a dialysis session. It does not seem to improve 
with more frequent haemodialysis210, and there is conflicting evidence regarding improvement 
following transplantation211-213, suggesting that some of this damage may be permanent. 
Visuospatial and executive functions are disproportionately affected in these patients207,214,215, and 
NHANES III found slower learning speeds and impaired visual concentration even in otherwise 
healthy, younger CKD patients (aged 20-59), compared with standardised populations216. This has 
obvious implications for pre-dialysis counselling and patient education programmes, as well as with 
treatment compliance. Importantly, these deficits may not be immediately obvious to clinicians in 
the way that loss of short-term memory or orientation might be, and will also not be detected using 
short screening tools such as the Abbreviated Mental Test (AMT), which is widely used to screen for 
dementia in patients acutely admitted to NHS hospitals. 
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The presence of cognitive impairment has been linked with an increased risk of hospitalisation217 and 
death202 in this population, and there are probably several reasons for this. Firstly, the presence of 
comorbidities such as diabetes and vascular disease will predispose patients to both cognitive 
impairment and higher rates of hospitalisation and death. However difficulties in taking medications 
or following dietary or fluid restrictions due to impaired executive function may also play a role. 
Lastly, it is important to understand that for many older patients, there is an overlap between 
depression and dementia218-220. Depression may give rise to pseudo-dementia, where low mood 
causes poor motivation and the appearance of cognitive impairment. Equally, many patients with 
dementia do become depressed. It can be very difficult to distinguish between the two, even with 
very careful history-taking. In patients who do exhibit signs of depression, cognitive function should 
be re-assessed following treatment of the depression before a diagnosis of dementia is made. 
 
4.5 Choosing the right modality and Advance Care Planning 
Traditionally, renal replacement therapy has always been seen as the logical end-point for CKD, and 
since the late 1990s the Low Clearance Clinic model221-226 has been used to provide pre-dialysis 
patients with information about the renal replacement therapy options available to them. 
Conservative (non-dialytic) management was not seen as part of the nephrologist’s remit, and 
patients who were not suitable for (or not willing to have) dialysis were discharged back to the 
community (or indeed never referred in the first place)16,62,227. This meant that these patients missed 
out on specialist symptom management (such as anaemia management, correction of acidosis, and 
specialist dietary advice). 
Over the past 10-15yrs, evidence that high-risk patients (those who are older, with multiple co-
morbidities, dementia or vascular disease) have very poor survival9,33,44,108,130,228,229, and survive as 
long (or maybe even longer) without dialysis17,19,35,230, has changed this picture. Conservative 
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management is now widely seen as a valid alternative to dialysis in renal centres in the UK16,34,38,231, 
providing specialist renal palliative care (there are often links with local community palliative care 
services232).  
The challenge is now to ensure that the information that we give to older patients is accurate and 
appropriate to them. Davison233-236 demonstrated that patients do actually want to know about their 
prognosis, and need to be able to plan ahead. Our preconceptions about patients’ quality of life may 
also be inaccurate or paternalistic - Rachel Morton237,238 found that patients and carers prioritised 
convenience and dialysis-free days, and indeed patients would be willing to give up 23 months of life 
in order to travel more. These preferences should be discussed with patients while they are well, so 
that we can focus our care on the areas that matter most to them as part of the Advance Care 
Planning process51,222,234,239,240. 
Equally important, when the leading cause of death among dialysis patients in the US is withdrawal 
from dialysis130, we need to start conversations about future options with failing dialysis patients 
early. The Surprise Question (“Would you be surprised if this patient died in the next 6 or 12 
months?”), particularly when asked of senior clinical staff in the dialysis unit, is robust at identifying 
short-term mortality risk in these patients44-46,241. Frailty screening has also been 
discussed129,228,242,243. The tool used to identify these patients is probably less important than the fact 
that discussions are taking place and that the patient has the opportunity to make their wishes 
known, even if that does not lead to a formal Advance Care Plan 51-53,56,57,59,60,244. 
  
4.6 Patient reported outcome measures and experience measures in CKD 
Given that hard outcomes such as survival seem to be so similar between many dialysis and 
conservatively-managed patients, many researchers have turned their attention to more subjective 
outcomes such as quality of life, pain, and symptoms. Patient-reported outcome measures are 
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widely used both clinically and in health-related quality of life research, and provide an insight into 
the way patients perceive their own health and the impact that a treatment or disease has on their 
life.  
There is also a new focus in the NHS on “improving the areas that matter most to patients” in the 
light of recent inquiries into the standard of NHS care. The Government White Paper, “Equity and 
excellence: Liberating the NHS”245 envisaged an increase in the scope and coverage of Patient-
reported outcome measures (PROMs):  
“Information generated by patients themselves will be critical to this process, and will include much 
wider use of effective tools like Patient Reported Outcome Measures (PROMs), patient experience 
data, and real-time feedback. At present, PROMs, other outcome measures, patient experience 
surveys and national clinical audit are not used widely enough. We will expand their validity, 
collection and use. The Department will extend national clinical audit to support clinicians across a 
much wider range of treatments and conditions, and it will extend PROMs across the NHS wherever 
practicable.”  
It is important to distinguish between patient-reported outcome measures (PROMs), which measure 
outcomes, and patient-reported experience measures (PREMs), which look at the overall patient 
experience. Patient-reported experience measures have arisen from patient satisfaction surveys and 
feedback forms, but unlike these tools PREMs focus on what actually happened to the patient rather 
than their feelings about it. For example, “how long did you wait for transport (in minutes)”, rather 
than “are you satisfied with the amount of time you waited for transport”. This both gives a focus for 
improvement for service managers, and prevents the ceiling effect, where all respondents are “fairly 
satisfied”.  
The use of patient-reported experience measures (PREMs) is not novel in the US, where Medicare 
and Kaiser Permanente facilities among others have used annual reports such as the Hospital 
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Consumer Assessment of Healthcare Providers and Systems (HCAHPS) to drive service improvement 
for many years.  
At its most basic, this includes the use of the “Friends and Family” test (whether patients or staff 
would advise their friends and family to be treated at their local hospital). The UK Renal Registry is 
currently working on adopting some of these measures to assess quality of dialysis care in the UK. 
There are many different patient-reported outcome tools available. Some are specifically validated 
in renal patients, others are used descriptively (often in a wide range of diseases) and there is 
therefore no gold standard to validate against. I have described the most commonly used self-report 
tools below, with their main advantages and disadvantages. 
 
 Symptoms 
Several symptoms scores are established for use in renal patients. Probably the most widely-used in 
the UK are the Memorial Symptom Assessment Score (MSAS), and its renal-specific version the 
MSAS-SF (Renal). The MSAS was designed to be used in a wide range of different patient groups, and 
is therefore quite broad. It comprises 32 physical and psychological symptoms, assessed by severity, 
which then gives an overall score and three subscores (physical, psychological, global distress). The 
MSAS-SF (Renal) was developed by Murtagh80 in 2007. It consists of the 32-item MSAS-SF with seven 
additional symptoms which have been found to be common in CKD patients: joint and bone pain; 
muscle cramps; dry skin; muscle soreness; headaches; chest pain and restless legs. This renal-specific 
score may be more sensitive at detecting symptoms in renal patients, however it is at the cost of 
being somewhat longer. 
The Edmonton Symptom Assessment System (ESAS) was validated for both cross-sectional and 
longitudinal use in renal patients by Davison et al in 200687,88. It was validated against the Kidney 
Disease Quality of Life short-form scale (KDQOL-SF), which is not itself a measure of symptom 
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burden (see below). The ESAS is a visual analogue scale assessing the prevalence and severity of 10 
symptoms (pain, tiredness, depression, anxiety, drowsiness, nausea, loss of appetite, well-being and 
shortness of breath, plus “other” of patient’s choosing). It has the advantage of being free to use, 
relatively short (1 page) and broad (combining both somatic and psychological symptoms). 
Conversely, it is not particularly detailed and may miss less common symptoms. 
The Dialysis Symptom Index92 is a 30-point patient-reported symptom assessment score devised 
specifically to assess symptoms which are common in dialysis patients. Scores >9 are usually seen as 
significant in a research context. The main drawback it its length, which makes it impractical for 
frequent use. However it is free to use, very comprehensive, and as it was created using dialysis 
patient focus groups, it is considered to be particularly well-suited for use in renal patients. 
The Modified Transplant Symptom Occurrence and Symptom Distress Scale82 was specifically 
designed to assess symptoms associated with transplant immunosuppression (as these symptoms 
may affect adherence). It does not have utility in the general renal population. 
 
 Depression 
The most common depression screening tools used in renal patients are the Hospital Anxiety and 
Depression Scale (HADS)246,247, and the Beck Depression Index II (BDI-II). Other scales, such as the 
Geriatric Depression Scale, have also been used in renal patients248-250 but have more limited 
application (older patients only). All are validated in renal patients248,249,251. 
The HADS, first devised by Zigmond and Snaith in 1983246, is a 14-item multiple-choice self-report 
inventory based on how the subject has felt over the past week.  Each item is scored 0-3, giving a 
total score 0-21 for depression, 0-21 for anxiety, and 0-42 overall. This scale was designed to screen 
for depression and anxiety in hospital patients without being affected by the presence of physical 
symptoms which may be related to the underlying illness rather than depression. Validated by 
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several groups for use in renal patients, using psychological interview as gold-standard, a score of 12 
is said to represent “caseness” in renal patients251. 
The original BDI was devised in 1961 by Beck. It was extremely novel for its time; patients' verbatim 
descriptions of symptoms were collated, and these were used to structure a scale which could 
reflect the intensity or severity symptoms. The BDI was revised in 1996 to reflect the changes in the 
DSM-IV diagnostic criteria of depression252. The BDI-II is a 21-item multiple choice self-report 
questionnaire; each item is scored 0-3, giving a total score of 0-63. In the general population, the 
following cut-offs are used: 0–13: minimal depression; 14–19: mild depression; 20–28; moderate 
depression; and 29–63: severe depression. Higher total scores indicate more severe depressive 
symptoms. In renal patients, there is no accepted cut off to indicate “caseness”, as previous 
validation studies have demonstrated cut offs between 10-15 depending on the gold standard 
used248,251,253. For the purposed of this project, we used a cut-off of 13 which was obtained from the 
Loosman study which simultaneously validated both the BDI-II and the HADS in renal patients, so 
that the cut offs used for both tools were validated against the same gold standard (psychological 
interview).  
The main drawback to the BDI-II is its cost – it is under copyright and must be licensed for use. In 
addition, as it is based on the APA’s DSM IV diagnostic criteria for major depression, it includes 
somatic symptoms such as sleep and appetite disturbance, which may be due to the underlying 
renal failure rather than depression per se. 
The Geriatric Depression Scale (Short form) is a 15-item self-report assessment to identify 
depression in older patients. Devised by Yesavage in 1982254, this was intended to be as simple as 
possible (yes/no answers instead of multiple choice) as it was felt that older patients became 
confused when faced with too many choices. The questions were carefully worded to avoid causing 
alarm or making patients defensive. There was also an effort to avoid focusing on somatic symptoms 
(as these would often be present in non-depressed older patients). It is scored from 0-15, and it is 
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felt that scores over 5 represent “caseness”. The tool is freely available from the Stanford University 
website. It has been validated in older renal patients, using the BDI-II as gold standard248. 
 
 Quality of life  
Quality of life is a nebulous term which encompasses both objective functional and psychosocial 
status, and subjective patient satisfaction with life. Accordingly, there are many quality of life scales 
in existence, and the emphasis of each varies depending on what it was initially designed to assess. 
The choice of which quality of life score to use will therefore depend very much on the aims of the 
research project. 
The SF-36 emerged from the Medical Outcome Study (MOS) by the Rand Corporation. A commercial 
version is now available, with the same questions but slight differences in scoring compared to the 
original (which is available free of charge on the RAND website). There are specific sub-domains for 
physical functioning (ADLs), role limitations due to physical health, role limitations due to emotional 
health, fatigue, emotional well-being, social role functioning, bodily pain, and general health 
perception. This is a very thorough questionnaire, but is rather long (36 questions) and therefore 
often has a high non-completion rate, particularly in older patients. It also emphasises ability to work 
and carry out physical tasks (as it was designed to assess quality-adjusted life years), which may not 
discriminate well between different levels of disability in chronically ill or older patients.  
The Kidney Disease Quality of Life Scale (KDQOL) is another free RAND tool, based on the SF-36. 
There are two versions (long and short form). The short form consists of the first 12 questions in the  
SF-36, with additional questions about the intrusiveness of the kidney disease, and the presence or 
absence of renal-specific symptoms. The long form also contains questions about patient satisfaction 
with the renal service. This is therefore very well-suited for use in dialysis populations, but not 
always appropriate for CKD/transplant patients. Like the SF-36 it is fairly long, and this may lead to 
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higher non-completion rates. However there is less emphasis on working and on physical function 
that in the original SF-36. 
By contrast, the EQ-5D (formerly Euroqol) survey has only 5 multiple-choice questions (mobility, self-
care, usual activities, pain, depression) and a visual analogue scale (the patient records how good 
their health is today, out of 100). It is very quick and easy to complete. However it is not very 
detailed, and is also under copyright. 
The Palliative Care Outcome Scale (POS)255,256 was designed by the Palliative Care Core Audit Project 
Advisory Group at the Cicely Saunders Institute in London. It consists of 10 questions about pain, 
patient and family anxiety, adequacy of information, self-worth and personal affairs, and asks the 
patient to list their current main concern. It was designed specifically to fill the gap in outcome 
measures suitable for use in a palliative care setting, and as such is excellent for assessing how well 
the concerns of seriously ill and dying patients are being addressed, and how that is impacting on 
their subjective quality of life. It is a very different measure to the SF-36 and EQ-5D, with entirely 
divergent standards for judging quality of life, and as such should be used in quite different settings.  
 
 Comorbidity Indices  
The Khan Index109 was devised in 1993, based on the two-year survival of 375 patients with ESRF. 
Based on a combination of age and a number of comorbid conditions, patients are stratified into 
low, medium and high mortality groups. The drawback for our research is that all patients aged over 
80 are automatically allocated to the high mortality group, leading to a “ceiling effect”257. 
The Davies Score42 specifically excludes age, as it was designed to be used with age as an 
independent covariate. Points are given for a wide range of comorbidities, arguably making it a 
rather “blunt tool”257 as many patients will score highly. 
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The Charlson Comorbidity Index (CCI)258 was originally designed to predict ten-year survival for a 
patient with a range of comorbid conditions such as renal failure, ischaemic heart disease, HIV, etc. 
It therefore includes age as a variable. Each comorbid condition present is given a score which is 
weighted between 1-6 depending on its likely effect on mortality. For example, dementia is given a 
score of 1, while metastatic cancer has a score of 6. An extra point is given for each decade of life 
over age 40. It is worth considering that all of our patients will already have “renal failure” as a 
comorbidity, and as such will generally have life expectancies much shorter than 10 years. However 
a study comparing the ability of the Khan, Davies and Charlson scores to predict two-year mortality 
in ESRF patients found that the Charlson score has slightly better prognostic power than the other 
two scores (the Davies score when combined with age had similar predictive power, as one might 
expect)259. 
 
 Functional Status 
Numerous tools exist to quantify functional status, or physical functioning. These have been 
developed by different professions to measure different outcomes, and are therefore not 
necessarily equivalent. For example, the Karnofsky Performance Scale (KPS)260 was initially designed 
for inpatient palliative care use. It ranks physical function from 100% (no symptoms) to 0% (dead). 
The KPS has been modified recently to reflect modern palliative care practice261, with a focus on 
home-based care (Australia-modified KPS), and it is this version which we use in our study. 
Other researchers have used the Barthel Index, which was initially designed by a physiotherapist to 
assess physical dependence in long-term inpatients262. It is used widely to measure ability to perform 
activities of daily living (ADLs) in a standardised, reproducible way, particularly in rehab settings (in 
order to track improvement in ADL functioning)263. It is rated from observation and has two items 
scored 0-1, six items scored 0-2, and two items scored 0-3, giving a total score from 0-20 (higher 
scores are more independent). 
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The Katz ADL Scale264 is widely used in the US. This consists of a yes/no scale for the following 6-
items: feeding; transferring; washing; dressing; toileting; continence. It is useful as a simple and 
standardised descriptor of dependence, however it is not detailed enough to measure small 
incremental improvements in functional status, such as in rehabilitation settings.  
In contrast to basic ADLs, which are required for basic self-care, Instrumental ADLs (IADLs) are more 
complex activities required to live independently, such as shopping, housekeeping, managing 
money, food preparation, managing medications, using the telephone, using transportation. There 
are scales such as the Lawton IADL scale265, an 8-item scale where each item is scored 0-4. 
Amusingly, in the original 1969 scale men were not scored on food preparation or housekeeping 
domains as they were not expected to be able to manage these things unaided. Current advice is to 
assess both genders on all domains. There is no clear consensus on which activities comprise IADLs – 
whether or not the individual patient is impaired will depend very much on what they personally 
need to be able to manage in order to live independently. Some other scales rely on patient 
interview (Frenchay Activity Index, Hamrin Activity Index266), however full Occupational Therapy 
assessment remains the gold standard. 
 
 Cognitive Function 
Cognitive function is also an extremely complex domain to assess. Patients may be extremely 
cognitively impaired but still perform well in some areas on standardised screening. For example, in 
frontotemporal lobe dementia impulse control and executive function are significantly affected, but 
patients may remember facts extremely well. The gold standard assessment of cognitive function is 
a face to face interview with an old age psychiatrist or psychologist with a battery of cognitive 
function tests267, but multiple shorter screening tools exist. It is important to note that these 
screening tools will not give a cause for the cognitive impairment, and in older renal patients this 
may be due to many causes154, not limited to: uraemia; dementia (of which there are many causes); 
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delirium (which can persist for many months following the original insult); and of course depression. 
A collateral history from carers or family may also be extremely helpful. 
The environment in which the assessment is carried out can make a significant difference to 
performance (loud, distracting or badly lit environments should be avoided)268, and it is also worth 
remembering that many causes of cognitive function show diurnal variation. The patient should not 
be assessed when they are tired, have just woken from sleep or around mealtimes. They should also 
be assessed in a calm and emotionally non-threatening manner, letting the patient set the pace. 
The Mini Mental State Exam (MMSE)269 is one of the best-known screening tools. It was introduced 
by Folstein in 1975, and is very popular because it assesses a wide range of cognitive domains 
(orientation to time and place, short- and long-term memory, executive function, visuospatial ability, 
arithmetic, language). It consists of a wide variety of questions (naming items, drawing interlocking 
shapes, recalling items), takes about 10 minutes to administer, and is scored from 0-30 with scores 
between 19-24 considered mild impairment, between 10-18 considered moderate impairment, and 
below 9 considered severe. Performance on the MMSE is adversely influenced by education, age, 
language, and verbal ability. The MMSE also is criticized for taking too long to administer and score, 
and is also now (controversially) under copyright which has led to it falling out of favour with 
researchers in recent years270. 
The Sweet 16271 assessment was introduced to avoid the copyright issues surrounding the MMSE. It 
is a 16-item assessment and unlike the MMSE it is not adversely influenced by age, language, and 
education. It takes about half as much time to administer and score as the MMSE. However later in 
2011, Psychological Assessment Resources (PAR), the MMSE copyright holders, forced Sweet 16 to 
be withdrawn claiming copyright infringement due to similarities between the two assessments270. 
The Montreal Cognitive Assessment (MoCA)272 has been suggested as a replacement. Like the 
MMSE it is a 30-item assessment which takes about 10minutes to complete and covers a wide range 
of domains. Scores below 27 indicate cognitive impairment. It has a greater emphasis than the 
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MMSE on executive function and attention. It is also more sensitive at detecting mild cognitive 
impairment than the MMSE, although less able to discriminate between moderate and severe 
dementia273,274. It is freely available on the internet and can be used in educational and clinical 
settings without permission, although the author requests that written permission is sought before 
it is used in research. 
The Hodkinson Abbreviated Mental Test (AMT)275,276 is a brief 10-point screening tool which is 
widely used to screen for impaired cognitive function, particularly in hospital inpatient settings. It is 
very quick, but tests only memory and orientation. As it is so short, it is not sensitive enough to track 
change in cognitive function over time for the purposes of most research studies. 
Numerous other tools exist which examine specific facets of cognitive function, such as executive 
function, or visuospatial awareness. 
 
 Distress 
Distress has been described as “the negative emotional experience of the individual” 277. It is often 
assessed using patient interviews. It is a deliberately broad term - the concept of distress is intended 
to be more inclusive and less stigmatizing for patients than terms such as depression or poor quality 
of life. It recognises that the causes of distress can be manifold, from practical problems to 
symptoms.  
In 1998 Roth et al278 described a simple tool, the Distress Thermometer (DT), to identify distress 
associated with unmet need in cancer patients.  It consists of a visual analogue scale (where 0= no 
distress and 10= severe distress) with prompts for possible practical, social, emotional and physical 
problems which may cause distress. The patient ticks any of these which may apply to them. The aim 
was to enable staff, who may often concentrate on physical health issues, to consider and discuss 
with patients their psychological and social needs.  
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DT scores have been shown to correlate with depression, low quality of life and high symptom 
burden in other studies279-281.  The majority of published work on the Distress Thermometer has 
involved cancer patients282-284, however several studies report its particular value in older 
patients282,284-287, and those with other chronic diseases. Indeed, it has recently been adopted as part 
of the Gold Standards Framework (GSF) for Care Homes288,289, a UK government-funded quality 
assurance programme to facilitate provision of quality care for residents nearing the end of life. The 
Distress Thermometer has also previously been evaluated in CKD patients as a tool to improve the 
recognition and management of patients’ distress290. However it has not yet been formally validated 
in renal patients.   
 
 Minimum Data Set 
All patients in Medicare-funded nursing homes in the US must complete this wide-ranging 
assessment annually. It examines functional status, cognitive function, psychosocial wellbeing, as 
well as comorbidities and medication histories. As such, it is widely used by US researchers as it is a 
large, pre-existing dataset. 
 
4.7 The concept of “Distress” 
There is a large body of research on distress in diseases such as cancer. However, the concept of 
distress is rarely unpacked. Much of this research presupposes that distress as a concept requires no 
further explanation.  
Several definitions of distress do exist within the US cancer literature. The NCCN, in their “Distress 
Management” practice guidelines291, define distress as: “A multifactorial unpleasant emotional 
experience of a psychological (cognitive, behavioural, emotional), social, and/or spiritual nature that 
may interfere with the ability to cope effectively with cancer, its physical symptoms, and its 
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treatment. Distress extends along a continuum, ranging from common normal feelings of 
vulnerability, sadness, and fears to problems that can become disabling, such as depression, anxiety, 
panic, social isolation, and existential and spiritual crisis” (p7). In the Clinical Journal of Oncology 
Nursing, Vitek et al292 state that “Rather than a single physical or emotional symptom, distress can 
be multifactorial in aetiology and may represent physical, social, and emotional components” 
(p413). 
In contrast to these broad definitions, many of the studies which use the distress thermometer to 
assess prevalence of distress in cancer patients make the assumption that distress is the same thing 
as depression or anxiety, using tests for depression as their comparator, and even using the terms 
interchangeably279,284.  
Steinberg et al287 did investigate the relative importance of physical and psychological factors 
responsible for distress in lung cancer patients. They found that DT scores were highly correlated 
with depression and nervousness scores on the Edmonton Symptom Assessment Scale, and once 
these subscales were excluded there was little relation between DT scores and other ESAS subscales. 
The UK Gold Standards Framework for Nursing Homes288, which recommends using the DT as a 
screening tool for elderly care home residents, also conflates distress and depression. Stone et al293 
also review distress in older people, however they focus on the impact of living alone on distress. 
They use the GHQ-12, a self-report tool generally accepted to include three distinct constructs of 
'Anxiety', 'Social dysfunction' and 'Loss of confidence'294, to measure their concept of distress. 
In renal literature, Ramer et al295 focused on the prevalence of stressful life events in dialysis 
patients. This paper was novel in that it identified many different sources of distress for dialysis 
patients – only 50% of participants reported stressful life events related to their own health, with 
other common sources of stress including personal relationships and financial worries. However the 
impact of these stressful life events on the patients was not evaluated. 
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Gilbar et al296 carried out structured interviews with haemodialysis patients to assess whether 
different coping styles affected psychological distress. They assessed distress using the Brief 
Symptom Inventory (BSI), which measures the severity of psychiatric symptoms. Although they do 
not define distress themselves, one may derive the implication that distress is a psychiatric 
phenomenon. In contrast, Chiou’s Physical Symptom Distress Scale297 is a self-report tool which 
assesses distress in dialysis patients by measuring physical symptom intensity, ignoring sources of 
psychological distress altogether. 
Interestingly Gamondi et al298 conflated the concept of distress with that of physical pain – distress 
being the response to experiencing pain. There are many similarities between the concepts of 
distress and pain, but I would argue strongly that they are not synonymous. 
 
4.8 Why was this project needed? 
CKD is a burden for older patients. It is associated with high mortality, high symptom burden, and 
poor quality of life. It is not clear whether we always pick up on patients’ concerns, or intervene – for 
example depression is under-diagnosed in this group. This may be because patients don’t tell us, or 
because we don’t ask them. 
It is also not always clear if our interventions (such as social worker referral, medication change or 
even starting dialysis) actually make any difference to how the patient feels. There have been 
several longitudinal studies to date which have assessed how functional status101 and quality of life17 
change after initiation of dialysis. But these have been observational studies rather than intervention 
studies. 
One problem with assessing patient wellbeing is that it is difficult to screen for all of the different 
factors which may cause distress within a fifteen-minute consultation. Patients, particularly older 
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ones, may also be conscious of “not bothering the doctor” and thus not mention their problems 
unless directly asked.  
We introduced the Distress Thermometer, an ultrashort screening tool for psychological distress, 
into routine practice in our nephrology clinic, and pilot work reported that staff and patients found it 
helpful in focussing the conversation on the patient’s concerns rather than the doctor’s. 
However, we encountered many questions about the Distress Thermometer (What is distress? Is this 
the same as depression? What is this actually measuring?). We also had questions ourselves (Does 
distress rise when patients start dialysis? Which patients are at higher risk of distress?). This project 
aimed to answer those questions.  
In order for the Distress Thermometer to be accepted for widespread use within the renal 
community, it was necessary to clarify what exactly it measures – depression, high symptom burden, 
or something else? We also needed to be confident that the Distress Thermometer is reliable at 
measuring distress, and that results are reproducible. Our first study attempts to answer these 
questions. 
In addition, it is not clear whether some subgroups (such as older patients, or those on 
haemodialysis compared with CKD4/5 patients) are more distressed than others, or whether factors 
such as anaemia or multiple comorbidities are associated with distress. The second study aims to 
address these issues. 
The third study aims to provide more information about the trajectory of distress scores when either 
choosing haemodialysis or choosing not to dialyse. Does distress rise around the time of initiation of 
haemodialysis, and if so does it return to baseline over the succeeding six months? Are there patient 
factors (age, gender, comorbidity) which affect this? Previous work by other groups has examined 
trajectories of functional status in patients who have chosen not to dialyse23, and trajectories of 
quality of life compared with survival in patients choosing to dialyse compared with those choosing 
conservative management27. 
Psychosocial Distress in Older Patients with Advanced Chronic Kidney Disease 
 
Page 54 of 277 
 
Finally, we carried out a series of nineteen interviews with a broad range of dialysis and CKD4/5 
patients. We explored their definition of and experience of distress, and how they had managed 
distressing experiences in their lives. We discussed their original diagnosis with CKD, the impact that 
their illness had had on their life and family, and what in terms of education and support would have 
reduced their illness-related distress.  
 
4.9 Rationale for mixed methods approach 
Traditionally there are two opposing research paradigms: the quantitative and the qualitative. The 
quantitative approach, or scientific method, measures data and attempts to prove or disprove 
hypotheses. It is excellent at providing a big-picture view of large groups of patients, and at 
answering yes/no or “countable” questions. 
Qualitative work is able to explore phenomena in a depth which would not be possible to achieve 
with a standardised questionnaire, and allows for a multiplicity of narratives. Instead of large sample 
sizes and statistical tests, the design and conduct of the study, the internal and external validity of 
the findings, and their positioning within the existing literature are used to assess the quality of the 
work299. However the small sample sizes and lack of “objectivity” may make it difficult for 
quantitative researchers to accept the findings of qualitative research. 
The ”Mixed Methods” approach combines both quantitative and qualitative elements, in order to 
give a greater breath of understanding than could be achieved by either approach alone. In 1959 
Campbell and Fiske300 introduced the concept of “Triangulation”, suggesting that by studying a 
phenomenon using multiple methods, one could be more certain that one’s findings were not due to 
methodological artefact, in the same way that reproducibility is so important in quantitative studies. 
Greene et al301 reviewed a sample of 57 mixed methods studies, and identified four other purposes 
in carrying out mixed methods research (in addition to triangulation): complementarity, where 
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qualitative and quantitative methods are used to measure overlapping but different facets of a 
phenomenon; development, where the results obtained by one method inform the design of the 
other; initiation seeks to find paradoxes and reframe questions using new knowledge from the other 
method; and expansion seeks to increase the range of the research question by using different 
methods. 
There are several different approaches to carrying out a mixed methods study302. The study may be 
quantitative-based with a minor qualitative aspect, qualitative-based with a minor quantitative 
aspect, or fully mixed. The synthesis of data may take place during data analysis, in the data-
collection stage, or there may be full mixing of methodological worldviews and language. And the 
impetus for using a mixed methods approach may be driven by the research question itself, or by 
the researcher’s methodological preferences. 
There has been criticism of mixed method approaches from both sides of the paradigm wars. The 
paradigmatic differences inherent in mixed method research has led to accusations of lack of 
methodological rigor, and of fundamental incompatibility of the two paradigms. However the field 
has evolved, and there are now established frameworks for designing and evaluating mixed methods 
research303,304. 
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5 Aims and objectives of the thesis 
This thesis explores the phenomenon of distress in renal patients.  What do patients mean when 
they talk of “distress?” Can we identify risk factors for distress? Does dialysis initiation cause 
distress, and if so is this potentially modifiable? We focus in particular on the use of the Distress 
Thermometer in renal populations – is it useful as a screening tool? What is it measuring? 
 
The aims are: 
1. To assess the construct validity of the Distress Thermometer by comparing agreement between DT 
scores and scores on other frequently-used depression and symptom scores, and to identify a 
threshold for “caseness” above which intervention should be considered. 
 
2. To investigate potential risk factors associated with increased DT scores in both CKD4/5 and 
haemodialysis patients. 
 
 
3. To assess the relationship between change in functional status and change in distress over time, in 
particular around time of dialysis initiation. 
 
4. To explore patient definitions of distress, investigate patient-perceived causes of distress in CKD4/5 
and dialysis patients, and to ask patients what we as healthcare professionals currently do, and what 
could we do differently, to mitigate this distress? 
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6 Validation of the Distress Thermometer in a UK Renal Population 
6.1 Introduction 
 Aims of this study 
1. To assess time taken to complete the DT, and to assess its acceptability to respondents 
2. To assess construct validity of the DT by comparing agreement between DT scores and scores on 
other frequently-used depression and symptom scores 
3. To identify a cut-off threshold for the Distress Thermometer (a score above which patients are likely 
to be a “case” on the BDI-II and HADS questionnaires), which may be used by clinicians or future 
researchers 
4. To assess reliability of DT scores on repeat testing  
 
 Hypotheses 
1. The DT may be completed quickly (<10mins) by UK renal patients, and is deemed acceptable by 
>75% of respondents. 
2. The DT has moderate correlation with the Beck Depression Inventory II (BDI-II), Hospital Anxiety and 
Depression Scale (HADS), Memorial Symptom Assessment Score (Short Form) (MSAS-SF) and SF36 
scores. 
3. The cut-off DT score in renal patients is no different to that of non-renal patients in previous studies. 
4. There is intra-respondent stability in DT scores over a two-month period, with ICC>0.60 (“good” 
reliability) 
 
 Outcomes of interest 
DT, HADS, BDI-II, MSAS-SF and SF-36 scores 
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 Study Design  
We assessed construct validity of the DT by comparing agreement between DT scores and scores on 
a variety of symptom, depression and quality of life tools.   
We then carried out a method comparison study to establish whether what DT score corresponded 
with ‘caseness’ for the BDI-II and HADS scores. We assessed intra-respondent stability of the DT by 
comparing the change in relationship between DT scores and scores on the BDI-II and HADS over a 
two-month period. 
A smaller questionnaire study to gauge time taken to complete and acceptability of the Distress 
Thermometer was also carried out. 
 
6.2 Methods 
6.3 2.2 Methods 
 Research Ethics Committee Approval 
Research ethics committee approval was obtained from Newcastle & North Tyneside 2 Research 
Ethics Committee (REC reference 13/NE/0087, see appendix for approval letter). The study was also 
included in the NIHR CRN Portfolio. 
 Study group 
6.3.2.1 Study Setting 
This was a two-centre study. The Royal Free NHS Foundation Trust in north London is an 840-bed 
acute hospital trust with a large tertiary renal department providing CKD, haemodialysis, peritoneal 
dialysis and transplant services to north central London across both the main hospital and five 
satellite units. It has 1500 CKD4/5 patients who attend regular outpatient clinics, and approximately 
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450 prevalent haemodialysis patients. It serves an ethnically diverse community, encompassing both 
very wealthy and very deprived boroughs. 
In contrast, the Lister Hospital is a 730-bed district general hospital providing acute services for the 
rural and suburban counties of Hertfordshire and south Bedfordshire. Its renal department provides 
CKD, haemodialysis and peritoneal dialysis services across the main site and four satellite units, but 
does not have an acute transplant service. It has approximately 1000 CKD4/5 patients, and 450 
haemodialysis patients. It serves a majority white British population which is predominantly middle-
class, although there are pockets of deprivation. 
 
6.3.2.2 Study Population 
All patients attending Lister Hospital and Royal Free Hospital nephrology outpatient low clearance 
clinics (CKD 4/5) and outpatient haemodialysis units were screened for eligibility for the study. 
Unfortunately due to the small size of these hospitals’ peritoneal dialysis cohorts, a separate PD arm 
would not have been able to recruit enough patients to be adequately powered, and there is 
evidence that PD patients and HD patients are sufficiently heterogenous17 that a combined RRT arm 
would have been methodologically unsound. 
 
6.3.2.3 Inclusion Criteria 
Attending either Lister or Royal Free Hospital low clearance clinic or haemodialysis unit. 
Aged >18 yrs.  
No upper age limit. 
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6.3.2.4 Exclusion Criteria 
Inability to consent 
Unable to understand or complete Distress Thermometer (DT) 
Unable to comprehend written English (BDI, HADS, MSAS and SF-36 are written tools; translation 
into other languages is a lengthy process requiring multiple cross-checks if validity is to be 
maintained in the new language305). 
 
 Sample size calculation  
There were three main problems when carrying out a sample size calculation – firstly, there is no 
existing data on the sensitivity or specificity of the Distress Thermometer for detecting depression in 
renal patients as it has not previously been used in this patient group. Secondly, the prevalence of 
depression in this group of patients has been calculated as anywhere between 15-35%, making the 
coefficient (k) of cases to controls in a random sample anywhere between 1.86 - 5.67. Finally 
calculation of sample sizes for Receiver Operator Curve (ROC) studies is complex306-308, and is rarely 
done248,251,253,309. This means that there were few prior studies to use as models. 
The Hanley and McNeil sample size calculation formula310, in conjunction with the worked examples 
provided by Hajian-Tilaki’s review paper306, was used to calculate sample size. From a review of the 
literature, this method appears to be extremely well-respected306,308 and the original paper has over 
15000 citations on PubMed. 
First the VF, or variance function, was calculated using the highest and lowest likely values of k 
shown above: 
𝑉𝐹 =  (0.0099 × 𝑒−𝐴×𝐴/2) × [(5 × 𝐴2 + 8) + (𝐴2 + 8)/𝑘] 
Where A is the parameter from the binomial distribution, calculated below: 
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𝐴 = 𝜑−1(𝐴𝑈𝐶) × 1.414 
= (0.95−1 × 0.80) × 1.414 
= 1.191 
Where 𝜑−1 represents the inverse of the cumulative normal distribution function. An estimated AUC 
of 0.80 was chosen, as previous studies have shown similar or higher AUCs when evaluating 
depression scores in renal patients248,249,251,253, and DT scores in non-renal patients280,283,286: 
So 𝑉𝐹 = (0.0099 × 𝑒−1.191×1.191/2) × [(5 × 1.1912 + 8) + (1.1912 + 8)/𝑘] 
When k = 1.86, VF = 0.064 
When k = 5.67, VF = 0.021 
Then the number of “cases” required was calculated, as shown below: 
  𝑁 =
[𝑍𝛼
2
2×𝑉𝐹]
𝐿2
   
 
Where N= number of cases, 𝑍𝛼/2 is 1.96 for a 95% confidence interval, VF is the variance function, 
and L is the desired half-width of the confidence interval, in this case 0.05. This gives the number of 
cases needed as:  
𝑁 = (1.962 × 𝑉𝐹) ÷ 0.052 
𝑁 = 3.84 × 𝑉𝐹 ÷ 0.0025 
 
When k = 1.86, 𝑁 =
(3.84×0.064)
0.0025
=  99  
When k = 5.67, 𝑁 =  
(3.84×0.021)
0.0025
 =  33 
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(rounded up to nearest whole number as one cannot be a partial “case”) 
The total sample size can be calculated as follows: 
𝑁 × (1 + 𝑘) 
When k = 1.86, 𝑁 = 284 
When k = 5.67, 𝑁 = 220 
Therefore 220-284 participants would be needed, depending on the prevalence of depression in this 
population. 
 Recruitment  
6.3.4.1 Research Team 
The research team at the Royal Free comprised Helen Alston (HA); Aine Burns (AB), my supervisor 
and lead consultant for Low Clearance, who was study Primary Investigator (PI); and the Royal Free’s 
team of renal research nurses.   
The research team at the Lister comprised a renal counsellor with extensive research experience in 
dialysis quality of life (who was Site Lead); a renal consultant; and a renal social worker.  
All members of both research teams were up to date with Good Clinical Practice (GCP) and NHS 
Information Governance training. 
 
6.3.4.2 Low Clearance Clinics 
Potentially eligible patients were identified by a member of the research team from outpatient clinic 
lists using the electronic patient record. The patient information sheet and a covering letter were 
sent to all eligible patients with their clinic appointment letters. Patients were then approached in 
the clinic waiting room on arrival for their routine appointment, and asked if they were interested in 
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taking part. Inclusion and exclusion criteria were re-confirmed with the patient. English language 
skills and cognitive skills were informally assessed by the researcher during the recruitment process, 
as these exclusion criteria were not always well-documented on the electronic patient record. 
If they expressed interest, they were provided with written information about the study, and given 
up to fifteen minutes to consider the study and to ask questions. Those who were happy to proceed 
were asked to provide written consent. If more time was requested, they were approached again at 
their next appointment (usually one month later). There was also a contact telephone number on 
the patient information sheet if they, or any of their family or friends, had any questions for the 
research team. Patients who refused to take part in the study were not approached again. 
 
6.3.4.3 Haemodialysis Patients 
Potentially eligible patients were identified by a member of the research team from the dialysis 
schedule, and were discussed with the patient’s named nurse to confirm that the patient met the 
inclusion and exclusion criteria for the study (named nurses generally know their patients extremely 
well and would be aware of any cognitive impairment or insufficient English language skills even 
when these were not documented on the electronic patient record).  
All eligible patients were given a patient information sheet and a brief explanation of the study by 
one of the researcher team at their routine dialysis session, with the opportunity to ask questions. 
They were then given a week to consider whether or not they would like to take part. There was also 
a contact telephone number on the patient information sheet if they, or any of their family or 
friends, had any questions for the research team.  
A researcher approached them at a subsequent dialysis session one week later to confirm whether 
or not they would like to take part, and to answer any further questions. If patients wished to take 
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part in the study, they were asked to provide written consent. Patients who refused were not 
approached again. 
 
 Data 
6.3.5.1 Reference standards 
The reference standards for the study were three widely used screening questionnaires standardised 
for use with physically ill patients, all of which have been previously validated in renal patients:  
 HADS - 14-item measure that gives scores for ‘possible’ and ‘probable’ anxiety and depression. 
When a global score was used, a case for ‘emotional distress’ was defined as >12 in renal patients251. 
 Beck Depression Inventory II – a depression tool containing 21 questions, each answer being scored 
on a scale value of 0 to 3. A cut-off of >13 was used to detect “caseness” in renal patients. Higher 
total scores indicate more severe depressive symptoms. 
 Memorial Symptom Assessment Scale (Short Form) - symptom assessment scale which measures 
frequency and distress of 32 highly prevalent symptoms 
 SF-36 – a quality of life tool consisting of 8 scaled scores: vitality, physical functioning, bodily pain, 
general health perceptions, physical role functioning, emotional functioning, social functioning, and 
mental health. 
Copies of these reference questionnaires may be found in Appendix B. 
A short acceptability questionnaire was also administered. This consisted of three closed questions 
(the time taken to complete the DT, if participants were upset by completing it and if they consider 
any changes are needed to its format or content) and an open question for further comments. 
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6.3.5.2 Data Collection 
In order to assess sensitivity to change over time, all 5 tools were administered together on three 
occasions: three consecutive clinic visits (baseline, 4-6 and 8-10 weeks) for low clearance patients, 
and at start of three dialysis sessions (each a month apart, on same day of week to avoid changes in 
patient distress due to differences in volume status/uraemia) for dialysis patients.  
It is known that performance on neuropsychiatric tests may fluctuate before, during and after 
dialysis, with best performance in cognitive tests achieved 24hrs after a dialysis session311-313 (this is 
thought to be due to a combination of low uraemic toxins in the blood following dialysis, and 
recovery from the cerebral hypoperfusion which frequently occurs during dialysis sessions). It is 
possible that symptoms and low mood may also fluctuate in a similar manner. It is also possible that 
distress levels may be different during dialysis sessions than at other times of the week (distress may 
be higher, because the participant does not find dialysis enjoyable. Or it may be lower, if the 
participant has troublesome symptoms related to fluid overload which they know the dialysis 
session will improve). We therefore aimed to complete the reference questionnaires at the same 
time for each patient, in order to minimise this variability.  
 
6.3.5.3 Data handling and record keeping 
Names, hospital numbers, dates of birth and genders of patients, along with responses to the 
questionnaires, were collected from patients in accordance with the patient consent form, patient 
information sheet and the study protocol. 
The data was collected electronically for statistical analysis using Excel 2010 (Microsoft) and the 
statistical package STATA/IC 12.1 (StataCorp LP). University College London acted as the data 
controller for the study. 
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I processed, stored and disposed of the patient demographic information and questionnaire results 
in accordance with the Data Protection Act 1998, and with NHS data protection guidelines. Royal 
Free patient data was stored centrally at the Centre for Nephrology: the hard copies of 
questionnaires were stored in a locked filing cabinet with access controlled by me, and the database 
was stored on password-protected UCL computers in a secure office (requiring swipecard access), 
and on an NHS-issued encrypted USB stick (for transfer between NHS sites only).  
Hard copies of Lister patient questionnaires were stored in a locked filing cupboard in the Lister 
renal research department, and electronic data transferred to me via encrypted NHS.net email. The 
patient data was not transferred to any party except those identified in this protocol and was not 
processed and/or transferred other than in accordance with the patients’ consent.  At the end of the 
study, the patient questionnaires and consent forms were sent for local NHS archiving. 
 
 Statistical methods 
6.3.6.1 Receiver Operating Characteristic Curves 
A Receiver Operating Characteristic (ROC) curve shows the diagnostic ability of a test as the 
discrimination threshold is varied (ie as the score for “caseness” changes)314. The points on the curve 
are created by plotting the sensitivity against the false positive rate (1-specificity) for each different 
threshold level.  
The curve begins at 0,0 the diagnostic threshold at which all subjects test negative for the disease, 
and ends at 1,1 the threshold at which all subjects test positive. The straight diagonal line connecting 
these two points represents a dummy test with no ability to distinguish between cases and non-
cases (ie random chance). The further the ROC curve lies away from this diagonal (ie the greater the 
area under the curve (AUC) is), the greater the diagnostic accuracy of the test under evaluation. 
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6.3.6.2 Regression analysis 
In simple linear regression we regress the outcome of interest onto a single explanatory variable 
(exposure). This regression provides us with a constant (intercept of the line of best fit, ie the 
expected observed value when the exposure = 0), and a value for the slope. This can be expressed by 
the equation y = a + bx where “y” is the observed outcome, “a” is the constant, “b” is the slope, and 
“x” is the exposure. 
Multivariable regression can adjust for many variables at the same time, accounting for different 
types of outcome and independent variables. We can then test which of several potential models 
best fits the observed data using the likelihood ratio test (the likelihood of any value of a parameter 
compared to the likelihood for the most likely value, ie the maximum likelihood). The advantage to 
the likelihood ratio test is that a null hypothesis for a parameter can then be tested. 
 
6.3.6.3 Multi-level modelling 
Classical statistical techniques and regression models both share the assumption that individual 
observations are statistically independent of each other. In other words, there is no correlation 
between individuals.  
However, when we consider repeated measures on the same individual (such as repeated DT scores 
over time), this assumption is not valid. We would expect scores from the same person to be more 
similar than scores from different people, ie there would be correlation between them. This is 
known as clustering of data (clustering may also be seen when individuals are recruited from the 
same clinic or family, or share other characteristics which make the correlation of observations 
within the cluster greater than the correlation between clusters). 
To take account of this clustering, specific statistical methods must be used (use of classical methods 
will produce confidence intervals that are too narrow and P-values that are too small). In this study I 
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have used fixed and random effects models (also called mixed models, or multi-level models), but 
other methods such as Generalised Estimating Equations (GEE) and Robust Standard Errors may also 
be used. The proportion of correlation between individual observations within a cluster (the Intra-
Cluster Correlation Coefficient, ICC) can also be calculated.  
Multi-level models consist of fixed effects and random effects. When constructing multi-level 
models, we can specify whether the intercept in the model should be fixed or allowed to vary at the 
cluster level (fixed slope, random intercept model) or whether both the slope and intercept should 
be allowed to vary (random slope, random intercept model). Likelihood ratio testing is then used to 
confirm which model best fits the data. 
 
6.3.6.4 Statistical approach used in this study 
Descriptive analysis 
Data were analysed using STATA/IC 12.1 (StataCorp LP). Histograms were plotted to show the 
distribution of scores for the DT and each of the reference questionnaires and their subscales. 
Summary statistics such as mean and median scores were calculated.  
 
Construct Validity 
The DT was non-normally distributed, so correlation between the DT and the reference 
questionnaires was assessed using Spearman’s Rank Correlation Coefficient. Two-way scatter graphs 
were plotted to give a visual indication of correlation.  
 
Method-comparison (identification of “cut-off’ threshold)  
ROC curve analysis was used to examine the sensitivity and specificity of the DT scores against the 
cut-off scores already shown to demonstrate clinically significant symptoms (‘caseness’) in the HADS 
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and BDI-II tools. We chose a cut off of 12 for the HADS and a cut off of 13 for the BDI-II; these values 
were obtained from the Loosman study251 which simultaneously validated both the BDI-II and the 
HADS in renal patients, so that the threshold for ‘caseness’ used for both tools were validated 
against the same gold standard (psychological interview). The MSAS-SF and SF-36 tools do not have 
a threshold score for ‘caseness’ so were not included in this part of the analysis.  
 
Intra-respondent reliability 
Sensitivity to change was assessed using multilevel models. First the trajectories of DT scores, HADS 
scores and BDI-II scores over the three visits were graphed. Then linear regression of DT scores by 
visit number was carried out, to assess how DT scores changed between visits. Random intercept 
and random slope models were compared using likelihood-ratio tests, Intra-class Correlation 
Coefficients (ICCs) were calculated. Similar models were produced for HADS and BDI-II scores, in 
order to compare stability over time of the DT with stability over time for the HADS and BDI-II. 
Following this, the relationships between DT and HADs and BDI-II scores over time were examined. 
Random intercept and random slope models of DT by HADS and DT by BDI-II scores were compared 
using likelihood-ratio tests.  
 
Time taken to complete, and acceptability 
Frequencies, medians and inter-quartile ranges were used to describe the time taken for patients to 
complete the DT, the number of participants upset by it and who feel that changes are needed. 
Content analysis was used to identify themes from participants’ qualitative responses, highlighting 
both advantages and disadvantages of the tool. 
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 Withdrawal and Missing Data 
When responses were missing, the entire tool that data was missing from was excluded from the 
analysis but the other completed tools provided by that patient were used. We used pairwise 
deletion during the statistical analysis where data was missing. 
Consent was reconfirmed at each of the three clinic visits that data was to be collected at. If 
participants withdrew consent to continue with the study, data from previous visits was still included 
assuming the participant remained happy for us to do this. If they withdrew consent completely, all 
of their data was removed from the study.  If capacity to consent was lost between study visits, data 
from previous visits (when they were still able to consent) was used, but we did not collect any 
further data. 
 
 Ethical Considerations 
Research Ethics Committee (REC) approval for both this and the following cross-sectional study 
(chapter 4) (which uses the same dataset) was obtained (see Appendix A). Fully informed written 
consent was obtained from all participants in line with Good Clinical Practice (GCP) guidelines, as 
described above. Data was treated confidentially as per the Data Protection Act (1998).  
Patients who expressed suicidal ideation or whose scores on any of the reference tests gave cause 
for concern were discussed with a senior clinician in the research team and appropriate action was 
taken. This included urgent (same day) review by a member of the clinical team, referral on to renal 
clinical psychology services, or hospital admission. 
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6.4 Results 
 Recruitment and participant characteristics 
We recruited 324 patients (158 in the CKD4/5 cohort, 166 in the HD cohort). The median age was 67 
years (IQR 50.25 – 76.48). 69% of participants were male. The mean age was 63 years, ranging from 
19 to 93 years with an interquartile range of 50 to 76 years. These are in keeping with our two 
centres’ renal populations, and also reflect the demographics of the UK renal population as a whole 
(UKRR 17th Annual Report315).  
 
 Study withdrawal/loss to follow up 
We received 324 completed first-visit questionnaires (100% completion rate – this is to be expected 
as the vast majority of the first-visit questionnaires were completed at the same time as consent was 
taken). There was a substantial loss to follow up between first and subsequent visits (see  Table 6.1 
Loss to follow up over three visits, by modality).  
The loss to follow up was greater in the CKD4/5 arm, despite the higher mortality associated with 
haemodialysis. This is likely due to the “captive audience” on haemodialysis; the participants attend 
dialysis sessions three times a week on a predictable schedule, so were easy to locate for follow up. 
In addition, each dialysis session lasts between 3-5 hours, so participants were often happy to pass 
the time by taking part in research.  
In contrast, the CKD 4/5 patients were sometimes missed when clinic appointments were cancelled 
or rearranged at short notice. Some participants completed the research questionnaires in the clinic 
waiting rooms, but others preferred to complete them at home and post them back, with a resulting 
lower completion rate (as expected with postal surveys, which have an average response rate of 
around 17%316,317). 
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Figure 6.1 Recruitment Flowchart 
500 eligible HD patients 1500 eligible CKD 4/5 
patients
166 recruited and 
completed first visit 
questionnaires
158 recruited and 
completed first visit 
questionnaires
117 completed second visit 
questionnaires
69 completed second visit 
questionnaires
75 completed third visit 
questionnaires
24 completed third visit 
questionnaires
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Table 6.1 Loss to follow up over three visits, by modality 
 Visit number 
1 2 3 
CKD 4/5 cohort 158 (100%) 69 (44%) 24 (15%) 
HD cohort 166 (100%) 117 (70%) 75 (45%) 
Total 324 (100%) 186 (57%) 99 (31%) 
 
 
Table 6.2 Characteristics of study population 
 N= 324 
Mean age (years) 63 (IQR 50-76) 
Gender 69% male 
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 Descriptive analysis of questionnaire scores 
Distress Thermometer scores 
Figure 6.2 shows the distribution of Distress Thermometer scores across the whole study cohort. The 
mean DT score was 3.5, with a median of 3 and an interquartile range of 1-5. Figure 6.3 shows the 
distribution of scores stratified by treatment modality (CKD 4/5 or haemodialysis). The 
haemodialysis group have a higher median distress score (median DT score 4 for HD patients 
compared with 2 for CKD patients) – this is analysed in more detail in Chapter 5.  
 
Figure 6.2 Distribution of DT scores (median = 3) 
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Figure 6.3 Graph to show distribution of DT scores by modality (median DT score for CKD 4/5 
patients = 2, median DT score for HD patients = 4) 
 
 
HADS and BDI-II scores 
The median HADS score was 7, with an IQR of 3-13. 97 patients (30%) had a HADS score ≥12 (ie met 
the criteria for ‘caseness’) (  
0
1
0
2
0
3
0
0 5 10 0 5 10
Clinic RRT
P
e
rc
e
n
t
DT
Graphs by Clinic/RRT
Psychosocial Distress in Older Patients with Advanced Chronic Kidney Disease 
 
Page 76 of 277 
 
Figure 6.4). 106 patients (33.5%) had a BDI-II score ≥13 (Figure 6.5). This suggests that between 30-
35% of the participants would have been assessed as possibly being depressed using these two 
established screening tools (25% of participants were ‘cases’ on both screening tools, see Table 6.3). 
This suggests relatively good, but not perfect, agreement between the two questionnaires (the 
differences between the two questionnaires are discussed in Section 4.6.2). 
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Figure 6.4 Distribution of HADS total scores (median score = 7, “Case” ≥ 12) 
 
Figure 6.5 Distribution of BDI scores (median score = 8, “Case” ≥ 13) 
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Table 6.3 Two-way table showing 'cases' of depression using HADS and BDI-II questionnaires 
 
BDI-II 
Total 
Not case Case 
HADS 
Not case 
193 
(60%) 
34 
(10%) 
227 
(70%) 
Case 
17 
(5%) 
80 
(25%) 
97 
(30%) 
Total 
210 
(65%) 
114 
(35%) 
324 
(100%) 
Pearson chi2(1) = 135.7619   P < 0.001 
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MSAS-SF scores 
The mean number of symptoms reported using the MSAS-SF was 1.03 per participant overall, 
however dialysis patients reported almost twice as many symptoms as CKD patients (1.33 
symptoms per dialysis patient versus 0.71 symptoms per CKD patient). The distributio n of 
total MSAS-SF scores (ie number of symptoms weighted by severity) shows a skewed normal 
distribution, with a mean score of 19 and median of 15 (Figure 6.6 Distribution of MSAS scores 
(median = 15)Figure 6.6). This suggests that, while the majority of participants report few 
symptoms, a minority of patients have a large number of severe symptoms.  
 
Figure 6.6 Distribution of MSAS scores (median = 15) 
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SF-36 subscale scores 
Figures 6.7 – 6.14 show the distribution of scores for each of the eight subscales of the SF-36. For 
each, a higher value represents better health.  
Figure 6.7 shows the distribution of scores for the Physical Role subscale. This represents ability to 
carry out daily activities. We found a bimodal distribution, with large numbers of participants 
describing a significant limitation in their ability to carry out daily activities due to physical 
limitations. It is recognised that the SF-36 has a ‘floor’ effect in older participants (when a measure 
possesses a distinct lower limit for potential responses and a large concentration of participants 
score at or near this limit). 
Figure 6.8 shows the distribution of scores for the Emotional Role subscale, representing limitation 
in daily activities due to emotional or psychological problems. Again, a substantial proportion 
reported significant limitations. 
Figure 6.9 shows the distribution of scores for the Energy subscale. There is a fairly normal 
distribution of scores around a mean of 47, suggesting that, while participants’ energy levels show a 
wide variability, the majority feel that their energy levels are impaired to some extent. 
Figure 6.10 shows the distribution of scores for the Emotional Wellbeing subscale. The majority of 
participants reported good emotional wellbeing. 
Figure 6.11 shows the distribution of scores for the Physical Functioning subscale. Like the Energy 
subscale there are a wide range of reported scores, with apparent peaks around 20%, 60% and 90%. 
Figure 6.12 shows the distribution of scores for the Social Functioning subscale. There appear to be 
two peaks – one at 50% and another at 100%. 
Figure 6.13 shows the distribution of scores for the Pain subscale. Although 34% of participants 
score 100% (indicating no impact of pain on their quality of life), a substantial tail of participants 
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have much poorer scores. This is in contrast to the MSAS-SF results, which indicated that these 
patients have few symptoms. 
Figure 6.14 shows the distribution of scores for the General Health subscale. This appears to be 
normally distributed around a mean of 39, suggesting poor overall health in this cohort. 
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Figure 6.7 Distribution of SF 36 Physical Role subscale scores 
  
 
Figure 6.8 Distribution of SF 36 Emotional Role subscale scores 
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Figure 6.9 Distribution of SF 36 Energy subscale scores 
 
 
Figure 6.10 Distribution of SF 36 Emotional Wellbeing subscale scores 
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Figure 6.11 Distribution of SF 36 Physical Functioning subscale scores 
 
 
Figure 6.12 Distribution of SF 36 Social Functioning subscale scores 
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Figure 6.13 Distribution of SF 36 Pain subscale scores 
 
Figure 6.14 Distribution of SF 36 General Health subscale scores 
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 Construct Validity of the DT 
Relationship between Distress and depression – comparison of DT and HADS scores 
Figure 6.15 shows the association between DT scores and total HADS scores. While overall 
correlation is good (Spearman’s rho is 0.450), there are outliers with high DT scores but low HADS 
scores (and vice versa) suggesting that not all highly distressed participants would meet the criteria 
for depression or anxiety on the HADS.  
 
Figure 6.15 Linear regression showing Distress Thermometer scores against HADS scores. 
Spearman’s rho 0.450  
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Relationship between Distress and depression – comparison of DT and BDI-II scores 
Similarly, Error! Not a valid bookmark self-reference. shows good correlation between DT 
scores and the BDI-II.  
 
 
Figure 6.16 Linear regression of Distress Thermometer scores against BDI-II scores 
Spearman’s rho 0.530 
  
 
Relationship between Distress and symptom burden – comparison of DT and MSAS-SF scores 
Figure 6.17 shows a positive correlation between DT scores and increased symptoms on the MSAS-
SF. Spearman’s rho is 0.438, suggesting moderately good correlation, however there are a 
substantial number of participants who score 10 on the DT (maximum levels of distress) but do not 
score highly on the MSAS.  
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Figure 6.17 Linear regression of DT scores against MSAS total scores 
Spearman's rho 0.438 
 
 
Relationship between Distress and Quality of Life – comparison of DT and SF-36 subscales 
Error! Reference source not found.18 shows a negative relationship between DT scores and the SF 3
6 Physical Functioning subscale. This is to be expected, as higher SF 36 scores indicate better physical 
function. Spearman’s rho is only -0.271, suggesting a very loose correlation. The associations 
between DT score and Physical Role (Error! Reference source not found.) and DT and Emotional 
Role (Figure 6.20) are similarly loose.  
There is a much stronger association between DT score and the Energy subscale (Figure 6.21), 
although there are still many participants with low energy who are not distressed, and those with 
good energy levels but high levels of distress. 
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The association between DT score and Emotional Wellbeing subscale (Figure 6.22) is also strong – 
this is to be expected, as Emotional Wellbeing is an extremely similar concept to that of Distress.  
The associations between DT scores and the SF-36 Social Functioning (Figure 6.23), Pain (Figure 6.24) 
and General Health (Figure 6.25) subscales are less strong, with several outliers in both directions 
indicating that distress is due to more than simply poor physical health, and that it is possible to 
have poor general health or high levels of pain without these problems causing distress. 
 
Figure 6.18 Linear regression of Distress Thermometer scores against SF-36 Physical 
Functioning subscale 
Spearman’s rho -0.271 
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Figure 6.19 Linear regression of Distress Thermometer scores against SF-36 Physical Role 
subscale  
Spearman's rho -0.230 
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Figure 6.20 Linear regression of Distress Thermometer scores against SF-36 Emotional Role 
subscale  
Spearman's rho -0.211 
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Figure 6.21 Linear regression of Distress Thermometer scores against SF-36 Energy subscale 
Spearman’s rho -0.409 
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Figure 6.22 Linear regression of Distress Thermometer scores against SF-36 Emotional 
Wellbeing subscale 
Spearman’s rho -0.488 
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Figure 6.23  Linear regression of Distress Thermometer scores against SF-36 Social Functioning 
subscale 
Spearman’s rho -0.381 
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Figure 6.24 Linear regression of Distress Thermometer scores against SF-36 Pain subscale 
Spearman’s rho -0.298 
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Figure 6.25 Linear regression of Distress Thermometer scores against SF-36 General Health 
subscale 
Spearman’s rho -0.384 
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 Identification of “cut-off” threshold for the Distress Thermometer 
ROC curve analysis was performed to examine the sensitivity and specificity of different DT scores 
against the cut-off scores used to identify patients with a high likelihood of depression (‘caseness’) 
on the HADS and BDI-II questionnaires. 
Figure 6.26 shows the ROC curve for DT versus HADS. The area under the curve AUC is 0.76 (95% 
confidence interval 0.70-0.82, p < 0.001). An AUC > 0.70 is accepted as a strong association in studies 
of psychological tests (as there may be many other factors which introduce variation in the results of 
these tests)310. 
 
Figure 6.26 Receiver operator characteristic curve for Distress Thermometer scores plotted 
against HADS cases 
AUC 0.76 (CI 0.70-0.82, p < 0.001)  
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Figure 6.27 Receiver operator characteristic curve for Distress Thermometer scores against 
BDI-II scores 
AUC 0.87 (CI 0.83-0.92, p < 0.001) 
 
 
 
Figure 6.27 shows the ROC curve for DT versus BDI-II. The AUC is 0.86 (95% CI 0.83-0.92, p < 0.001). 
This shows a strong association between BDI cases and DT scores. 
We then tabulated the different sensitivities and specificities of different DT ‘cut-off’ scores in 
detecting ‘caseness’ for the HADS and BDI-II (Table 6.4). The precise cut-off to use would depend on 
whether the DT was being used as a screening tool (in which case a high sensitivity is important, and 
false positives can be excluded at a later date), or whether the aim is to use the DT as a diagnostic 
tool, in which case a balance between false positives and negatives needs to be achieved.  
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Table 6.4 Sensitivity and specificity of different cut-off points to describe ‘caseness’ for 
distress using Distress Thermometer 
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 Sensitivity to change over time  
Change in DT scores over time 
 
Figure 6.28 shows the trajectory of DT scores over the three visits, for each participant. It is clear 
that for some participants, DT scores vary significantly from visit to visit.  
Linear regression of DT by visit number was performed. This showed a co-efficient of -0.33, 
suggesting that DT scores declined by 0.33 points at each subsequent visit. However it is clear from 
the plot of the trajectories that in fact some participants’ scores went up and some went down. 
Indeed, confidence intervals approach 0 (-0.63 - -0.03) and p= 0.033. The full Stata output is shown 
on the next page. 
 
 
Figure 6.28 Trajectories of DT scores of time 
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Linear regression 
. regress dt visitnodate 
 
      Source |       SS           df       MS      Number of obs   =       600 
-------------+----------------------------------   F(1, 598)       =      4.58 
       Model |  36.4116214         1  36.4116214   Prob > F        =    0.0327 
    Residual |  4751.57338       598  7.94577488   R-squared       =    0.0076 
-------------+----------------------------------   Adj R-squared   =    0.0059 
       Total |    4787.985       599  7.99329716   Root MSE        =    2.8188 
 
------------------------------------------------------------------------------ 
          dt |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
 visitnodate |  -.3297855   .1540564    -2.14   0.033    -.6323429   -.0272282 
       _cons |   3.794749   .2771588    13.69   0.000     3.250426    4.339072 
------------------------------------------------------------------------------ 
 
We then carried out a mixed effects regression. First we carried out a random intercept mixed 
effects regression (shown below, Model M1), and compared this with a random slope, random 
intercept model (shown on following pages, Model M2). Likelihood-ratio testing was non-significant 
(p=0.102), suggesting that the random slope, random intercept model was no better than Model 
M1. This is not surprising, as the likelihood statistics are very similar between both models and the 
confidence intervals of the level 1 residuals overlap. Model 2 was therefore discarded.  
The interpretation of this model is that, although different participants have different starting levels 
of distress (random intercept), the trajectories over time are very similar (so the random slope 
model offers no better fit than the fixed slope model). 
Intraclass correlation coefficient was calculated as 0.497 (95% CI 0.410 -  0.585), suggesting that 
49.7% of the variation in DT scores is due to differences between individuals. Cicchetti (1994)318 
suggested that this represented merely “fair” reliability (with ICCs > 0.60 representing “good” 
reliability). 
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Model M1 
. mixed dt visitnodate || hospitalnumber: 
 
Performing EM optimization:  
 
Performing gradient-based optimization:  
 
Iteration 0:   log likelihood = -1427.0521   
Iteration 1:   log likelihood = -1427.0507   
Iteration 2:   log likelihood = -1427.0507   
 
Computing standard errors: 
 
Mixed-effects ML regression                     Number of obs     =        600 
Group variable: hospitalnumber                  Number of groups  =        323 
 
                                                Obs per group: 
                                                              min =          1 
                                                              avg =        1.9 
                                                              max =          3 
 
                                                Wald chi2(1)      =       8.41 
Log likelihood = -1427.0507                     Prob > chi2       =     0.0037 
 
------------------------------------------------------------------------------ 
          dt |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
 visitnodate |  -.3509514   .1210502    -2.90   0.004    -.5882054   -.1136975 
       _cons |   3.817636   .2318943    16.46   0.000     3.363132    4.272141 
------------------------------------------------------------------------------ 
 
------------------------------------------------------------------------------ 
  Random-effects Parameters  |   Estimate   Std. Err.     [95% Conf. Interval] 
-----------------------------+------------------------------------------------ 
hospitalnu~r: Identity       | 
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                  var(_cons) |   3.935316   .5278177      3.025615    5.118535 
-----------------------------+------------------------------------------------ 
               var(Residual) |   3.977309   .3314825      3.377904    4.683078 
------------------------------------------------------------------------------ 
LR test vs. linear model: chibar2(01) = 90.21         Prob >= chibar2 = 0.0000 
 
. estimate store m1 
 
. estat icc 
 
Residual intraclass correlation 
 
------------------------------------------------------------------------------ 
                       Level |        ICC   Std. Err.     [95% Conf. Interval] 
-----------------------------+------------------------------------------------ 
              hospitalnumber |   .4973465   .0452906      .4095815    .5852753 
------------------------------------------------------------------------------ 
 
Model M2 
. mixed dt visitnodate || hospitalnumber: visitnodate, cov(unst) 
 
Performing EM optimization:  
 
Performing gradient-based optimization:  
 
Iteration 0:   log likelihood = -1425.7479   
Iteration 1:   log likelihood =  -1424.766   
Iteration 2:   log likelihood =  -1424.765   
Iteration 3:   log likelihood =  -1424.765   
 
Computing standard errors: 
 
Mixed-effects ML regression                     Number of obs     =        600 
Group variable: hospitalnumber                  Number of groups  =        323 
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                                                Obs per group: 
                                                              min =          1 
                                                              avg =        1.9 
                                                              max =          3 
 
                                                Wald chi2(1)      =       7.66 
Log likelihood =  -1424.765                     Prob > chi2       =     0.0057 
 
------------------------------------------------------------------------------ 
          dt |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
 visitnodate |  -.3546641   .1281737    -2.77   0.006      -.60588   -.1034482 
       _cons |   3.821944   .2440344    15.66   0.000     3.343645    4.300242 
------------------------------------------------------------------------------ 
 
------------------------------------------------------------------------------ 
  Random-effects Parameters  |   Estimate   Std. Err.     [95% Conf. Interval] 
-----------------------------+------------------------------------------------ 
hospitalnu~r: Unstructured   | 
               var(visitn~e) |    .769395    .388454      .2860175    2.069694 
                  var(_cons) |   7.280995   1.751983      4.543298    11.66837 
         cov(visitn~e,_cons) |  -1.578982    .773188     -3.094402   -.0635612 
-----------------------------+------------------------------------------------ 
               var(Residual) |   3.292471   .3934846       2.60492    4.161495 
------------------------------------------------------------------------------ 
LR test vs. linear model: chi2(3) = 94.78                 Prob > chi2 = 0.0000 
 
Note: LR test is conservative and provided only for reference. 
 
. estimate store m2 
 
. estat icc 
 
Conditional intraclass correlation 
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------------------------------------------------------------------------------ 
                       Level |        ICC   Std. Err.     [95% Conf. Interval] 
-----------------------------+------------------------------------------------ 
              hospitalnumber |   .6886101   .0694749      .5395654    .8066933 
------------------------------------------------------------------------------ 
Note: ICC is conditional on zero values of random-effects covariates. 
 
 
 
Likelihood-ratio test of M1 vs M2 
. lrtest m2 m1 
 
Likelihood-ratio test                                 LR chi2(2)  =      4.57 
(Assumption: m1 nested in m2)                         Prob > chi2 =    0.1017 
 
Note: The reported degrees of freedom assumes the null hypothesis is not on the boundary of the 
parameter space.  If this is not true, then the reported test is conservative. 
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Change in HADS scores over time 
 
Figure 6.29 shows how HADS scores changed for each participant across the three visits. Although 
some participants do demonstrate high variability from visit to visit, the overall trend is much less 
erratic. Linear regression suggests that, for each clinic visit, the HADS score declines by 1.026 points 
(95% CI -1.825 - -0.227, p = 0.012).  
We also created a mixed level model (Model 3) in order to compare the ICC with that of the DT (we 
created a fixed slope random intercept model only, in order to directly compare with the best-fitting 
model for the DT). The ICC was 0.717 (95% CI 0.657 - 0.770), suggesting that 71.7% of the variability 
was due to differences between individuals (“good reliability”318). 
 
 
Figure 6.29  Trajectories of HADS scores of time 
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Linear regression 
. regress hadstotal visitnodate 
 
      Source |       SS           df       MS      Number of obs   =       609 
-------------+----------------------------------   F(1, 607)       =      6.35 
       Model |  357.766483         1  357.766483   Prob > F        =    0.0120 
    Residual |  34175.8591       607  56.3028981   R-squared       =    0.0104 
-------------+----------------------------------   Adj R-squared   =    0.0087 
       Total |  34533.6256       608  56.7987263   Root MSE        =    7.5035 
 
------------------------------------------------------------------------------ 
   hadstotal |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
 visitnodate |  -1.025988   .4070125    -2.52   0.012    -1.825311   -.2266641 
       _cons |    10.1409    .729989    13.89   0.000     8.707286    11.57451 
------------------------------------------------------------------------------ 
 
Model M3 
. mixed hadstotal visitnodate || hospitalnumber: 
 
Performing EM optimization:  
 
Performing gradient-based optimization:  
 
Iteration 0:   log likelihood = -1979.5525   
Iteration 1:   log likelihood = -1979.5525   
 
Computing standard errors: 
 
Mixed-effects ML regression                     Number of obs     =        609 
Group variable: hospitalnumber                  Number of groups  =        326 
 
                                                Obs per group: 
                                                              min =          1 
                                                              avg =        1.9 
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                                                              max =          3 
 
                                                Wald chi2(1)      =      20.34 
Log likelihood = -1979.5525                     Prob > chi2       =     0.0000 
 
------------------------------------------------------------------------------ 
   hadstotal |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
 visitnodate |  -1.116413   .2475333    -4.51   0.000     -1.60157    -.631257 
       _cons |   10.22053   .5375679    19.01   0.000     9.166912    11.27414 
------------------------------------------------------------------------------ 
 
------------------------------------------------------------------------------ 
  Random-effects Parameters  |   Estimate   Std. Err.     [95% Conf. Interval] 
-----------------------------+------------------------------------------------ 
hospitalnu~r: Identity       | 
                  var(_cons) |   40.34112   4.022251      33.18013    49.04761 
-----------------------------+------------------------------------------------ 
               var(Residual) |   15.90281   1.330528      13.49761    18.73659 
------------------------------------------------------------------------------ 
LR test vs. linear model: chibar2(01) = 221.88        Prob >= chibar2 = 0.0000 
 
.  
. estat icc 
 
Residual intraclass correlation 
 
------------------------------------------------------------------------------ 
                       Level |        ICC   Std. Err.     [95% Conf. Interval] 
-----------------------------+------------------------------------------------ 
              hospitalnumber |   .7172529   .0289094      .6573443    .7703466 
------------------------------------------------------------------------------ 
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Change in BDI-II scores over time 
Figure 6.30 shows how BDI-II scores changed for each participant across the three visits. Again, 
despite some outliers the overall trend is much less erratic than that of the DT. Linear regression 
suggests that, for each clinic visit, the BDI-II score declines (ie depression improves) by 1.151 points 
(95% CI -2.160 -  -0.141, p = 0.026).  
We created a fixed slope random intercept mixed level model (Model 4) in order to compare the ICC 
for the BDI-II with that of the DT. The ICC was 0.740 (95% CI 0.683 – 0.790), suggesting that 74% of 
the variability was due to differences between individuals (“excellent reliability”318). 
 
 
 
Figure 6.30  Trajectories of BDI-II scores of time 
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Linear regression 
. regress bdi visitnodate 
 
      Source |       SS           df       MS      Number of obs   =       597 
-------------+----------------------------------   F(1, 595)       =      5.01 
       Model |  445.171785         1  445.171785   Prob > F        =    0.0255 
    Residual |  52843.2805       595  88.8122361   R-squared       =    0.0084 
-------------+----------------------------------   Adj R-squared   =    0.0067 
       Total |  53288.4523       596  89.4101548   Root MSE        =     9.424 
 
------------------------------------------------------------------------------ 
         bdi |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
 visitnodate |  -1.150838   .5140279    -2.24   0.026    -2.160367    -.141308 
       _cons |   11.94869   .9254224    12.91   0.000      10.1312    13.76618 
------------------------------------------------------------------------------ 
 
Model M4 
. mixed bdi visitnodate || hospitalnumber: 
 
Performing EM optimization:  
 
Performing gradient-based optimization:  
 
Iteration 0:   log likelihood = -2071.6093   
Iteration 1:   log likelihood = -2071.6093   
 
Computing standard errors: 
 
Mixed-effects ML regression                     Number of obs     =        597 
Group variable: hospitalnumber                  Number of groups  =        320 
 
                                                Obs per group: 
                                                              min =          1 
                                                              avg =        1.9 
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                                                              max =          3 
 
                                                Wald chi2(1)      =      12.23 
Log likelihood = -2071.6093                     Prob > chi2       =     0.0005 
 
------------------------------------------------------------------------------ 
         bdi |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
 visitnodate |  -1.059934   .3030403    -3.50   0.000    -1.653882   -.4659857 
       _cons |   11.84257   .6766535    17.50   0.000     10.51635    13.16878 
------------------------------------------------------------------------------ 
 
------------------------------------------------------------------------------ 
  Random-effects Parameters  |   Estimate   Std. Err.     [95% Conf. Interval] 
-----------------------------+------------------------------------------------ 
hospitalnu~r: Identity       | 
                  var(_cons) |   66.85792   6.618083      55.06742    81.17288 
-----------------------------+------------------------------------------------ 
               var(Residual) |   23.44717   1.996054      19.84393    27.70467 
------------------------------------------------------------------------------ 
LR test vs. linear model: chibar2(01) = 227.45        Prob >= chibar2 = 0.0000 
 
. estat icc 
 
Residual intraclass correlation 
 
------------------------------------------------------------------------------ 
                       Level |        ICC   Std. Err.     [95% Conf. Interval] 
-----------------------------+------------------------------------------------ 
              hospitalnumber |   .7403561   .0274364      .6831051     .790437 
------------------------------------------------------------------------------ 
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Changes in relationship between DT and HADS over time 
We then assessed the stability of the relationship between DT score and HADS score over the three 
visits by fitting a fixed slope random intercept mixed level model (Model 5) and a random slope 
random intercept mixed level model (Model 6). Both models fit the data better than a linear model 
(p < 0.001), however likelihood ratio test suggested that Model 5 was nested within Model 6 (p = 
0.023), so we rejected Model 5. The random slope and random intercept of Model 6 suggest that 
different participants not only have different starting levels of distress, but also that the relationship 
between DT and HADS changes across the three clinic visits. 
Model 6 suggests that, for each one-point increase in HADS score, DT score increases by 0.188 points 
when adjusted for clinic visit (95% CI 0.161 – 0.216, p < 0.001). At each subsequent clinic visit, DT 
score improves by -0.140 adjusted for HADS score (although 95% CI -0.384 – 0.103, p = 0.258).  
ICC was estimated at 0.646 (95% CI 0.476 – 0.785), suggesting that approximately 64.6% of variation 
in the relationship between HADS and DT is due to individual differences between participants.  
 
 
Model 5 
. mixed dt hadstotal visitnodate || hospitalnumber: 
 
Performing EM optimization:  
 
Performing gradient-based optimization:  
 
Iteration 0:   log likelihood = -1357.8252   
Iteration 1:   log likelihood = -1357.7079   
Iteration 2:   log likelihood = -1357.7079   
 
Computing standard errors: 
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Mixed-effects ML regression                     Number of obs     =        600 
Group variable: hospitalnumber                  Number of groups  =        323 
 
                                                Obs per group: 
                                                              min =          1 
                                                              avg =        1.9 
                                                              max =          3 
 
                                                Wald chi2(2)      =     188.42 
Log likelihood = -1357.7079                     Prob > chi2       =     0.0000 
 
------------------------------------------------------------------------------ 
          dt |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
   hadstotal |   .1868887   .0139425    13.40   0.000     .1595619    .2142155 
 visitnodate |  -.1426847   .1186484    -1.20   0.229    -.3752312    .0898619 
       _cons |   1.898811   .2581588     7.36   0.000     1.392829    2.404792 
------------------------------------------------------------------------------ 
 
------------------------------------------------------------------------------ 
  Random-effects Parameters  |   Estimate   Std. Err.     [95% Conf. Interval] 
-----------------------------+------------------------------------------------ 
hospitalnu~r: Identity       | 
                  var(_cons) |   1.594601   .3521285      1.034391     2.45821 
-----------------------------+------------------------------------------------ 
               var(Residual) |   4.067111   .3345184      3.461585     4.77856 
------------------------------------------------------------------------------ 
LR test vs. linear model: chibar2(01) = 27.23         Prob >= chibar2 = 0.0000 
 
. estimate store m5 
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Model M6 
. mixed dt hadstotal visitnodate || hospitalnumber: visitnodate, cov(unst) 
 
Performing EM optimization:  
 
Performing gradient-based optimization:  
 
Iteration 0:   log likelihood =  -1355.058   
Iteration 1:   log likelihood = -1353.9145   
Iteration 2:   log likelihood = -1353.9136   
Iteration 3:   log likelihood = -1353.9136   
 
Computing standard errors: 
 
Mixed-effects ML regression                     Number of obs     =        600 
Group variable: hospitalnumber                  Number of groups  =        323 
 
                                                Obs per group: 
                                                              min =          1 
                                                              avg =        1.9 
                                                              max =          3 
 
                                                Wald chi2(2)      =     192.79 
Log likelihood = -1353.9136                     Prob > chi2       =     0.0000 
 
------------------------------------------------------------------------------ 
          dt |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
   hadstotal |   .1883787   .0138578    13.59   0.000      .161218    .2155394 
 visitnodate |  -.1404105   .1241613    -1.13   0.258    -.3837622    .1029411 
       _cons |   1.883064   .2706124     6.96   0.000     1.352674    2.413455 
------------------------------------------------------------------------------ 
 
------------------------------------------------------------------------------ 
  Random-effects Parameters  |   Estimate   Std. Err.     [95% Conf. Interval] 
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-----------------------------+------------------------------------------------ 
hospitalnu~r: Unstructured   | 
               var(visitn~e) |   .8942682   .3743239      .3937049    2.031257 
                  var(_cons) |   5.881687    1.60509      3.445182    10.04134 
         cov(visitn~e,_cons) |  -1.942568   .7398941     -3.392734    -.492402 
-----------------------------+------------------------------------------------ 
               var(Residual) |   3.226515   .3735847      2.571442    4.048468 
------------------------------------------------------------------------------ 
LR test vs. linear model: chi2(3) = 34.82                 Prob > chi2 = 0.0000 
 
Note: LR test is conservative and provided only for reference. 
 
. estimate store m6 
 
. estat icc 
 
Conditional intraclass correlation 
 
------------------------------------------------------------------------------ 
                       Level |        ICC   Std. Err.     [95% Conf. Interval] 
-----------------------------+------------------------------------------------ 
              hospitalnumber |   .6457572   .0811096      .4763918    .7850572 
------------------------------------------------------------------------------ 
Note: ICC is conditional on zero values of random-effects covariates. 
 
. lrtest m6 m5 
 
Likelihood-ratio test                                 LR chi2(2)  =      7.59 
(Assumption: m5 nested in m6)                         Prob > chi2 =    0.0225 
 
Note: The reported degrees of freedom assumes the null hypothesis is not on the boundary of the 
parameter space.  If this is not true, then the reported test is conservative. 
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Changes in relationship between DT and BDI-II over time 
 
To assess the stability of the relationship between DT score and BDI-II scores over the three visits, 
we fitted a fixed slope random intercept mixed level model (Model 7) and a random slope random 
intercept mixed level model (Model 8). Both models fit the data better than a linear model (p < 
0.001), however the likelihood ratio test hypothesising that Model 7 was nested within Model 8 was 
non-significant (p = 0.072), so we rejected Model 8.  
This implies that, while participants have different starting levels of distress (random intercepts), the 
trajectory of the relationship between DT and BDI-II across the three clinic visits are not significantly 
different (so the random slope model provides no better fit than the fixed slope model). As 
previously established in Section Error! Reference source not found., BDI-II scores are very closely c
orrelated with DT scores (AUC 0.87). We saw on p101 that different participants have similar 
trajectories of distress across the three clinic visits despite different starting levels of distress, so it 
should be no surprise that the relationship between DT and BDI-II scores is also stable over time. 
Model 7 suggests that, for each one-point increase in BDI-II score, DT score increases by 0.165 points 
when adjusted for clinic visit (95% CI 0.145 – 0.186, p < 0.001). At each subsequent clinic visit, DT 
score improves by -0.140 adjusted for BDI-II score (although this was non-significant; 95% CI -0.368 – 
0.088, p = 0.228).  
ICC was estimated at 0.222 (95% CI 0.133 – 0.346), suggesting that only 22.2% of variation in the 
relationship between DT and BDI-II is due to individual differences between participants – this is 
quite a lot lower than the effect of clustering on DT scores and BDI-II scores themselves, and does 
suggest that another unidentified major factor influences the relationship between the DT and BDI-
II.  
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Model M7 
. mixed dt bdi visitnodate || hospitalnumber: 
 
Performing EM optimization:  
 
Performing gradient-based optimization:  
 
Iteration 0:   log likelihood = -1306.7972   
Iteration 1:   log likelihood = -1306.5633   
Iteration 2:   log likelihood = -1306.5633   
 
Computing standard errors: 
 
Mixed-effects ML regression                     Number of obs     =        588 
Group variable: hospitalnumber                  Number of groups  =        317 
 
                                                Obs per group: 
                                                              min =          1 
                                                              avg =        1.9 
                                                              max =          3 
 
                                                Wald chi2(2)      =     253.56 
Log likelihood = -1306.5633                     Prob > chi2       =     0.0000 
 
------------------------------------------------------------------------------ 
          dt |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
         bdi |   .1652745   .0105571    15.66   0.000     .1445831     .185966 
 visitnodate |  -.1402356   .1164005    -1.20   0.228    -.3683764    .0879052 
       _cons |   1.781875   .2464766     7.23   0.000      1.29879     2.26496 
------------------------------------------------------------------------------ 
 
------------------------------------------------------------------------------ 
  Random-effects Parameters  |   Estimate   Std. Err.     [95% Conf. Interval] 
-----------------------------+------------------------------------------------ 
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hospitalnu~r: Identity       | 
                  var(_cons) |   1.137839   .3021018      .6762114    1.914604 
-----------------------------+------------------------------------------------ 
               var(Residual) |   3.990512   .3227552      3.405516    4.675999 
------------------------------------------------------------------------------ 
LR test vs. linear model: chibar2(01) = 17.95         Prob >= chibar2 = 0.0000 
 
. estimate store m7 
 
. estat icc 
 
Residual intraclass correlation 
 
------------------------------------------------------------------------------ 
                       Level |        ICC   Std. Err.     [95% Conf. Interval] 
-----------------------------+------------------------------------------------ 
              hospitalnumber |   .2218722   .0543933      .1332766    .3458605 
------------------------------------------------------------------------------ 
 
 
Model M8 
. mixed dt bdi visitnodate || hospitalnumber: visitnodate, cov(unst) 
 
Performing EM optimization:  
 
Performing gradient-based optimization:  
 
Iteration 0:   log likelihood = -1305.3017   
Iteration 1:   log likelihood = -1303.9384   
Iteration 2:   log likelihood =  -1303.935   
Iteration 3:   log likelihood =  -1303.935   
 
Computing standard errors: 
 
Mixed-effects ML regression                     Number of obs     =        588 
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Group variable: hospitalnumber                  Number of groups  =        317 
 
                                                Obs per group: 
                                                              min =          1 
                                                              avg =        1.9 
                                                              max =          3 
 
                                                Wald chi2(2)      =     253.97 
Log likelihood =  -1303.935                     Prob > chi2       =     0.0000 
 
------------------------------------------------------------------------------ 
          dt |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
         bdi |   .1651177   .0105221    15.69   0.000     .1444948    .1857406 
 visitnodate |  -.1449119   .1240601    -1.17   0.243    -.3880652    .0982413 
       _cons |   1.789329   .2562889     6.98   0.000     1.287012    2.291646 
------------------------------------------------------------------------------ 
 
------------------------------------------------------------------------------ 
  Random-effects Parameters  |   Estimate   Std. Err.     [95% Conf. Interval] 
-----------------------------+------------------------------------------------ 
hospitalnu~r: Unstructured   | 
               var(visitn~e) |   .8160859   .3734534      .3328228    2.001053 
                  var(_cons) |   4.364402    1.51798      2.207339    8.629401 
         cov(visitn~e,_cons) |  -1.565429   .7128478     -2.962585    -.168273 
-----------------------------+------------------------------------------------ 
               var(Residual) |   3.245125    .383907      2.573546    4.091955 
------------------------------------------------------------------------------ 
LR test vs. linear model: chi2(3) = 23.21                 Prob > chi2 = 0.0000 
 
Note: LR test is conservative and provided only for reference. 
 
. estimate store m8 
 
. estat icc 
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Conditional intraclass correlation 
 
------------------------------------------------------------------------------ 
                       Level |        ICC   Std. Err.     [95% Conf. Interval] 
-----------------------------+------------------------------------------------ 
              hospitalnumber |   .5735445   .1060801      .3650027    .7588474 
------------------------------------------------------------------------------ 
Note: ICC is conditional on zero values of random-effects covariates. 
 
. lrtest m8 m7 
 
Likelihood-ratio test                                 LR chi2(2)  =      5.26 
(Assumption: m7 nested in m8)                         Prob > chi2 =    0.0722 
 
Note: The reported degrees of freedom assumes the null hypothesis is not on the boundary of the 
parameter space.  If this is not true, then the reported test is conservative.   
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 Time taken to complete, and acceptability questionnaire 
Median time taken to complete the DT was 4mins (IQR 3-5mins). 285/324 people (88%) completed 
the acceptability questionnaire – of these only 4/285 felt upset by being asked to complete the 
Distress Thermometer, and of the 5/285 who suggested changes, 3 suggested changes to the 
reference questionnaires and not to the DT itself. One patient objected that the term “Distress 
Thermometer” was confusing and implied a physical thermometer.  
The last complaint did suggest that the patient felt upset by being asked to consider their current 
quality of life – they felt that their quality of life was poor, and did not want to dwell on this fact. 
This patient subsequently withdrew from the study. She was offered referral to renal psychology but 
declined this.  
 
6.5 Discussion 
The aims of this study were to assess the construct validity of the Distress Thermometer, to confirm 
reliability over time, to identify a “cut-off” score for use in clinical practice, and to confirm that the 
DT itself was quick and easy to use by renal patients, who are often older or disabled. How far have 
we met these aims? 
 
 Is Distress the same thing as Depression? 
We found a close relationship between the DT and both the HADS and BDI-II, both in terms of a 
general correlation between scores, and between higher DT scores and ‘caseness’ on the HADS and 
BDI-II, which are unlikely to be due to chance alone.  
However there were participants with high levels of distress who did not meet the criteria for 
‘caseness’ on the HADS or BDI-II – for these participants, distress may be due to other issues (pain, 
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other symptoms, poor quality of life) rather than depression. Equally, some depressed participants 
had low distress scores. Anhedonia (lack of enjoyment) and withdrawn mood are frequently present 
in depression but may not be acknowledged as distress by the sufferer. 
There was a closer relationship between DT scores and BDI-II scores (AUC 0.87) than between DT 
scores and HADS scores (AUC 0.76). It is not clear why this should be, however the main difference 
between the BDI-II and the HADS is that the BDI-II includes questions on somatic symptoms (sleep, 
appetite) which the HADS excludes (because these may be due to physical illness rather than 
depression). It is reasonable to suppose that higher DT scores may be related to presence of these 
somatic symptoms in some patients. 
Examining the trajectories of distress it is clear that for some participants, DT scores varied 
significantly from visit to visit, while the BDI-II and HADS scores did not. It is notable that the ICD-10 
diagnostic criteria for depression states that “a duration of at least two weeks is usually required for 
diagnosis [of depression]” (p120, The ICD-10 classification of mental and behavioural disorders: 
clinical descriptions and diagnostic guidelines, World Health Organisation 1992)319. This is not the 
case for distress, which can be transient or prolonged. 
The relationship between HADS and DT scores varied over time. Why might this be? We know that 
HADS scores are fairly stable over time (Figure 6.29) while DT scores vary (Figure 6.28), so perhaps 
another unidentified factor which influences distress is changing between clinic visits. Whatever this 
unidentified factor is, it appears to be related to the participant as 64.5% of the variation between 
DT and HADS scores was due to inter-participant variation.  
In contrast, the relationship between BDI-II scores and distress was stable over time, but little of the 
variation in the relationship (22.2%) was due to differences between participants, which rather begs 
the question what it is due to in that case.  
In terms of choosing a cut-off for ‘caseness’ for the DT (in order to screen for possible 
depression), we plotted sensitivity and specificity tables for a range of DT scores (  
Psychosocial Distress in Older Patients with Advanced Chronic Kidney Disease 
 
Page 123 of 277 
 
Table 6.4). The cut off chosen would depend on the aim of the exercise – if you wish to be 
relatively confident that participants identified really are depressed, ie low false positive rate 
(eg for a research study) we would recommend a relatively high cut -off of 6 (HADS sensitivity 
of 41% and specificity of 75%, BDI-II sensitivity of 63% and specificity of 87%) or 7 (HADS 
sensitivity of 28% and specificity of 90%, BDI-II sensitivity of 47% and specificity of 92%). 
However, as the low sensitivities demonstrate, this will miss a large number of dep ressed 
participants (ie there will be a large false negative rate).  
For screening purposes, a lower cut off of 5 (HADS sensitivity of 60% and specificity of 75%, BDI-II 
sensitivity of 80% and specificity of 75%) would be more useful. There would be false positives, but 
generally as part of a screening programme there would be a secondary assessment of cases to 
confirm the diagnosis.  
An alternative approach, and indeed the approach that we would support in routine practice, is not 
to use a cut off at all, but instead to use the DT as an aid to discussion. This should quickly clarify 
whether DT scores are due to depression or to other factors such as symptoms (ie this would 
provide the second-level screening).  
 
 How does Distress relate to symptoms and quality of life? 
There was a correlation between increasing MSAS total scores (ie increasing symptom number 
and/or severity) and distress. It is not possible to establish causation – do the symptoms cause 
distress, or do distressed patients find their symptoms more burdensome (depressed patients have a 
reduced pain threshold compared with non-depressed patients320,321). 
There was an inverse correlation between all subscales of the SF-36, suggesting that distress 
worsens with worsening quality of life. However, the strongest correlations were between DT score 
and the Energy and Emotional Wellbeing subscales, rather than (for example) the Physical 
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Functioning, Physical Role or Pain subscales. This would suggest a mental health component to 
distress, as opposed to distress being purely a function of physical health limitations. 
 
 Acceptability 
The response to the Distress Thermometer in the acceptability questionnaire was generally positive. 
It does appear to be quick to complete, taking most participants approximately 3-5mins.  
This is in contrast to the reference questionnaires, which elicited quite a few complaints about the 
time taken to complete them, the complexity of the questions, and the irrelevance of some of the 
questions to the participants’ situation (for example, the SF-36 asks about “ability to move furniture” 
and “run for a bus” – there is a clear floor effect here, with very few participants able to do either). 
It seems reasonable to conclude that the DT is a quicker and easier tool to complete than the 
reference questionnaires in this population. 
 
 Limitations of the study 
The main limitation was the very high dropout rate, disproportionally affecting CKD4/5 patients. The 
main factor causing this difference in attrition is likely to be the relative ease of taking part for 
haemodialysis patients, who mostly completed the questionnaires while on dialysis. As they were 
present on the dialysis unit at predictable times of day it was very easy for the research team to 
administer the follow up questionnaires, and as many dialysis patients are bored during their dialysis 
sessions they were quite happy to take part “to pass the time”, as one participant put it. In contrast, 
the CKD4/5 cohort were approached at clinic appointments (which may be rescheduled and may not 
always run to time) or via post (which is known to have lower response rates)317.  
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Efforts were made to approach people for follow up several times, and both stamped-addressed 
envelopes and telephone reminders were used to try to maximise response rates, but it is likely that 
any study comparing dialysis patients and community patients will encounter this problem to some 
extent. 
There were also problems with the reference questionnaires chosen: patients reported 
questionnaire fatigue due to the simultaneous administration of five questionnaires at the same 
visit; there were floor and ceiling effects in this population as previously discussed (although this is 
why we wished to find a short easier tool in the first place), and some patients also had difficulty 
with the complexity of the language used in the reference questionnaires (Americanisms such as 
“walk around the block”, difficulties in categorising frequencies and severities of symptoms in the 
HADS, BDI-II and MSAS, and difficulty in distinguishing between subtle differences in emphasis in 
questions in the SF-36). This is not a “test-wise” population322. 
 
 Unanswered questions 
Although we may conclude that Distress is related to, but distinct from, depression, we need further 
detail on what exactly the DT measures. Further work examining patient definitions of distress will 
be useful in clarifying what patients are experiencing when they describe themselves as “distressed” 
(see Chapter 9). 
It is also not clear whether some subgroups (older patients, frailer patients, those with worse renal 
function) are more distressed than others. Neither do we know what causes distress, and what we 
as clinicians can do about it.  
DT scores were noted to change much more over time than the BDI-II and HADS. It is not clear 
whether this change over time is due to problems with DT, or whether this is intrinsic to 
phenomenon of distress. 
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7 Cross-sectional analysis of distress thermometer scores in haemodialysis and 
CKD patients 
 
7.1 Introduction 
 Aims of this study 
To assess risk factors affecting DT scores in haemodialysis and CKD4/5 patients 
 Hypotheses 
1. Haemodialysis patients experience significantly higher levels of distress than CKD4/5 patients, even 
following adjustment for potential confounders such as age, gender and comorbidity. 
 
 Outcomes and risk factors of interest 
Outcomes: Distress Thermometer score  
Risk factors: Treatment modality (CKD4/5 or HD), age, gender, comorbidity score (Charlson and 
Davies scores), haemoglobin, albumin, eGFR (if CKD4/5), dialysis vintage (if HD), presence of 
diagnosed depression, peripheral vascular disease, diabetes or heart disease, one-year mortality. 
 
 Study design 
This was a prospective cohort study. 
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7.2 Methods 
 Study setting and data collection 
This study used the same dataset as the validation study (ethic committee approval was obtained for 
this further use, see Appendix A). See Chapter 6 for details of study setting, recruitment and data 
collection. 
We did not have access to data regarding co-morbidities or mortality for the Lister participants, so 
limited our analysis to the Royal Free patients, giving a sample size of 287 (139 haemodialysis 
patients, 138 CKD patients). 
 
 Power calculation for cross-sectional study 
As the dataset collected for the validation study was also used in the cross-sectional study (Chapter 
4), a power calculation was performed in Stata to ensure that we had sufficient data available to 
detect a difference between the low clearance and haemodialysis cohorts. Although a pre-study 
sample size calculation would have been preferable, no prior data existed regarding the DT score in 
haemodialysis and low clearance patients and so a post-hoc analysis had to be performed. 
Assuming an alpha of 0.05, and using the means and standard deviations obtained in chapter 4 
(CKD4/5 patients: mean =2.46, st dev= 2.50. haemodialysis patients: mean= 4.13, st dev=2.82), the 
study had a power of 0.9997. Indeed, our study was adequately powered to detect any difference in 
mean DT scores ≥ 1 unit. 
 
 Statistical analysis 
We first described the sample, and the prevalence/distribution of each of the risk factors of interest. 
We calculated whether there was a difference in mean values between the CKD4/5 cohort and the 
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RRT cohort for each risk factor using the unpaired t-test, giving 95% confidence intervals and p-
values.   
We assessed the normalcy of the distribution of the DT, and of each of the other risk factors of 
interest. The DT scores did not follow a normal distribution, so the Wilcoxon Rank-Sum test was used 
to determine whether there was a significant difference between the CKD4/5 patients and the 
haemodialysis patients.  
We plotted scatter graphs of DT scores and the continuous risk factors of interest, and used 
Spearman’s Rank Correlation to assess the strength of the association between them, and whether 
this relationship was statistically significant. We plotted histograms of DT scores stratified by each of 
the possible outcomes for the categorical risk factors of interest, showing the median DT score for 
each category. We used the Wilcoxon Rank-Sum test to test the hypothesis that there was no 
relationship between DT scores and each outcome of the risk factor in question. 
We constructed a model of factors affecting DT scores, fitting models of progressive complexity and 
using Likelihood-ratio tests to assess whether each extra risk factor improved the fit of the model. 
We assessed models which included each of the risk factors which we had found to be significantly 
associated with DT scores in the previous section, discarding those risk factors which did not 
improve the fit of the model, in order to keep the model as simple as possible without sacrificing 
accuracy.  
 
 Missing data 
When questionnaire responses were missing, this was dealt with using pairwise deletion - the 
outcome measure which had data missing was excluded from the statistical analysis, but any other 
completed tools provided by that patient were included in the analysis.  
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7.3 Results 
 Size of cohort and participant characteristics 
We did not have access to data regarding co-morbidities or mortality for the Lister participants, so 
limited our analysis to the Royal Free patients, giving a sample size of 273 (134 CKD4/5 patients, 139 
haemodialysis patients).  
The mean age was 63.2 years in the CKD4/5 cohort, and 65.7 years in the HD cohort. 64% of the 
CKD4/5 and 72% of the HD cohort were male. This is in keeping with our centres’ renal populations, 
and reflects that of the UK as a whole (UKRR 17th Annual Report315). The median eGFR in the CKD 4/5 
cohort was 18mls/min (MDRD equation), and the median dialysis vintage for the HD cohort was 27 
months.  
The prevalence of previously-diagnosed depression was very similar in both cohorts (12.2% in the 
CKD4/5 cohort and 14.6% in the HD cohort). The HD cohort had a slightly higher prevalence of 
ischaemic heart disease, peripheral vascular disease and diabetes, although these differences did 
not reach statistical significance. Despite this, comorbidity scores (both Charlson and Davies 
comorbidity scores) were the same across both cohorts.  
Haemoglobin was higher in the CKD 4/5 cohort (115g/L vs 105g/L in the HD cohort, p<0.001), as was 
serum albumin (41.5g/L in CKD4/5 cohort and 39.2g/L in HD cohort, p<0.001). This may be due to 
higher levels of infection and inflammation in haemodialysis patients. Other characteristics of the 
study population are summarised in Table 4.1.  
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 Table 7.1 Characteristics of study population, by modality 
 CKD 4/5 
(Mean, 95% CI) 
Haemodialysis 
(Mean, 95% CI) 
Unpaired t-test  
p values 
Age 63.2 (60.2 – 66.2) 65.7 (63.2 – 68.2) 0.212 
Male Gender 63.6%  (55.3 – 72.0) 72.3% (64.7 – 79.9) 0.130 
Davies score 1.5 (1.3 – 1.8) 1.7 (1.5 – 2.0) 0.301 
Charlson comorbidity index 6.1 (5.6 – 6.6) 6.3 (5.9 – 6.7) 0.506 
Haemoglobin (g/L) 115 (112 – 118) 109 (107 – 111) <0.001 
Serum Albumin(g/L) 41.5 (40.8 – 42.2) 39.2 (38.5 – 40.8) <0.001 
eGFR (mls/min) 18 n/a  
Months on HD n/a 27  
Diagnosis of depression 12.1% (6.5 – 17.8) 14.6% (8.6 – 20.6) 0.552 
PVD  14.4% (8.3 – 20.5) 24.1% (16.8 – 31.3) 0.044 
IHD 34.8% (26.6 – 43.1) 40.9% (32.5 – 49.2) 0.310 
Diabetes 37.9% (29.5 – 46.3) 46.0% (37.5 – 54.4) 0.179 
One-year mortality 7.5% (3.0 – 12.0) 5.0% (1.4 – 8.7) 0.409 
 
 Assessment of normality for continuous variables 
We saw in Chapter 3 that DT scores are non-normally distributed.  
Age at assessment showed a left-skewed distribution, with a mean age of 64.5 years and a median of 
67.4 years (IQR 52.0 – 77.2) (Figure 7.1).  
Psychosocial Distress in Older Patients with Advanced Chronic Kidney Disease 
 
Page 131 of 277 
 
Haemoglobin (Figure 7.2 and serum albumin results (Figure 7.3) appear to be normally distributed. 
EGFR (Figure 7.4) does appear to be normally distributed, with censoring at both tails – this is due to 
the referral criteria for Low Clearance clinic where these patients were recruited (patients must have 
an eGFR below 20mls/min, or 30mls/min if diabetic, to be referred. Patients with very low eGFRs 
(<5mls/min) are likely to have either started dialysis or to be too ill to attend). 
Dialysis vintage (Figure 7.5) appears to follow a gamma distribution – this is unsurprising as this 
graph essentially represents survival time on dialysis.  
Charlson Comorbidity Index (Figure 7.6) and Davies comorbidity scores (Figure 7.7) appear to be 
fairly normally distributed, despite a “floor” effect (probably due to the age of our cohort) censoring 
the lower end of the CCI distribution, and a little left-skewing of the Davies distribution.  
 
 
 
Figure 7.1 Age distribution across whole cohort (years) 
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Figure 7.2 Distribution of Haemoglobin results 
 
Figure 7.3 Distribution of Serum Albumin results 
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Figure 7.4 Distribution of eGFR results (CKD 4/5 patients only) 
 
 
Figure 7.5 Dialysis vintage (months) (HD patients only) 
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Figure 7.6 Distribution of Charlson Comorbidity Index scores 
 
 
Figure 7.7 Distribution of Davies comorbidity scores 
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 Differences in distribution of DT scores in CKD4/5 patients and HD patients  
Figure 7.8 and  
Figure 7.9 show the distribution in DT scores in CKD 4/5 patients and HD patients respectively. DT 
scores appear to be much more normally distributed in the HD patients following this stratification 
(which suggests that the non-normality may be due to the cohort containing several overlapping 
subpopulations rather than anything intrinsic to the DT itself). DT scores are still non-normally 
distributed in CKD4/5 patients, with a significant floor effect at “0”.  Median DT score was 2 for 
CKD4/5 patients (IQR 0 – 5) and 4 for HD patients (IQR 2 – 6). 
As the DT scores are non-normally distributed, the two-sample Wilcoxon rank-sum test was used to 
test the hypothesis that there was no difference between CKD4/5 and HD patients’ DT scores. P < 
0.001, suggesting this is a significant difference in DT scores between the two groups. 
 
. ranksum dt, by( rrtclinic ) 
 
Two-sample Wilcoxon rank-sum (Mann-Whitney) test 
 
   rrtclinic |      obs    rank sum    expected 
-------------+--------------------------------- 
      Clinic |      131       14651     17619.5 
         RRT |      137       21395     18426.5 
-------------+--------------------------------- 
    combined |      268       36046       36046 
 
unadjusted variance   402311.92 
adjustment for ties    -7656.62 
                     ---------- 
adjusted variance     394655.30 
 
Ho: dt(rrtcli~c==Clinic) = dt(rrtcli~c==RRT) 
             z =  -4.725 
    Prob > |z| =   0.0000  
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Figure 7.8 Distress Thermometer scores (CKD 4/5 patients). Median = 2 
 
 
Figure 7.9 Distress Thermometer scores (HD patients) Median = 4 
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 Association between DT scores and continuous variables 
As the DT scores were non-normally distributed, we used Spearman Rank Correlation to assess the 
relationship between DT scores and the continuous risk factors of interest. 
 
DT score and age 
 
Figure 7.10 Relationship between DT score and increasing age 
 
 
We see from the scatter graph above (Figure 7.10) that DT scores appear to be lower in older 
patients. This is unexpected, as it had been hypothesised that older patients would have poorer 
health and worse quality of life, and thus would be more likely to be distressed. 
. spearman dt ageatassessment, stats(p) 
 
Number of obs =     264 
Spearman's rho =      -0.1463 
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Test of Ho: dt and ageatassessment are independent 
Prob > t =       0.0174 
 
Spearman’s rho was  -0.1463, and p = 0.0174, which suggests that there is a relationship between 
age and DT.  
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DT score and Haemoglobin 
 
Figure 7.11 Relationship between DT score and haemoglobin 
 
The correlation between DT score and haemoglobin appears to be extremely weak. It appears that 
there is a slight reduction in distress as haemoglobin increases, however this is not a statistically 
significant relationship.  
. spearman dt hb, stats(p) 
 
 Number of obs =     264 
Spearman's rho =      -0.0892 
 
Test of Ho: dt and hb are independent 
    Prob > |t| =       0.1484 
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DT score and Serum Albumin 
 
Figure 7.12 Relationship between DT score and Serum Albumin 
 
 
There does not appear to be any correlation between DT score and serum albumin. Spearman’s rho 
is -0.0371, and p = 0.5480. 
. spearman dt alb, stats(p) 
 
 Number of obs =     264 
Spearman's rho =      -0.0371 
 
Test of Ho: dt and alb are independent 
    Prob > |t| =       0.5480 
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DT score and eGFR (CKD4/5 patients only) 
 
Figure 7.13 Relationship between DT score and eGFR 
 
 
There does appear to be a very slight negative correlation between DT score and eGFR in our CKD4/5 
cohort – ie as renal function worsens, distress increases. However, Figure 7.13 shows that the 
distribution of results is very wide with many outliers, and the relationship between DT score and 
eGFR does not reach statistical significance. 
. spearman dt egfrifclinic if modality==0, stats(p) 
 
 Number of obs =     129 
Spearman's rho =      -0.1138 
 
Test of Ho: dt and egfrifclinic are independent 
    Prob > |t| =       0.1991 
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DT score and dialysis vintage (months) (HD patients only) 
 
Figure 7.14 Relationship between DT score and dialysis vintage (months) 
 
There appears to be a very slight negative correlation between time since initiation of dialysis in 
months, and DT scores (ie distress improves as dialysis vintage increases). It is not clear what the 
causal relationship might be here: does distress abate as patients adjust to their new life on dialysis? 
Or do the highly-distress patients have lower survival on dialysis?  
The relationship appears to be extremely weak, and does not reach statistical significance (p = 
0.2845). 
. spearman dt timeonhdmonths if modality==1, stats(p) 
 
 Number of obs =     135 
Spearman's rho =      -0.0928 
 
Test of Ho: dt and timeonhdmonths are independent 
    Prob > |t| =       0.2845 
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DT score and Charlson Comorbidity Index score 
 
Figure 7.15 Relationship between DT score and CCI score 
 
It is interesting to see that the relationship between DT score and Charlson Comorbidity Index 
appears to be negative – as CCI increases, DT score reduces. One might expect the reverse. However 
CCI contains an age component, and Figure 7.10 showed a negative relationship between DT score 
and age – it may be that we are simply seeing the effect of age again.  
The relationship appears to be very weak, and not statistically significant.  
. spearman dt charlson , stats(p) 
 
 Number of obs =     264 
Spearman's rho =      -0.0851 
 
Test of Ho: dt and charlson are independent 
    Prob > |t| =       0.1678 
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DT score and Davies comorbidity score 
 
Figure 7.16 Association between DT score and Davies comorbidity score 
 
In contrast to the CCI, the Davies comorbidity score does not contain an age component, and it is 
interesting to see that the relationship between DT and Davies score is positive (ie increasing 
comorbidity is associated with increasing distress).  
Again this effect is very weak, and not statistically significant in this sample. 
. spearman dt davies , stats(p) 
 
 Number of obs =     264 
Spearman's rho =       0.0153 
 
Test of Ho: dt and davies are independent 
    Prob > |t| =       0.8050  
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 Association between DT scores and categorical variables 
Gender 
Figure 7.17 Difference in DT scores between Male and Female patients 
 
  
Figure 7.17 shows the distribution in DT scores for male and female patients. Median score for male 
patients is 2, and for female patients is 4. This is somewhat significant (p = 0.027) 
. ranksum dt, by( gender ) 
 
Two-sample Wilcoxon rank-sum (Mann-Whitney) test 
 
      gender |      obs    rank sum    expected 
-------------+--------------------------------- 
           0 |       85     12532.5     11262.5 
           1 |      179     22447.5     23717.5 
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-------------+--------------------------------- 
    combined |      264       34980       34980 
 
unadjusted variance   335997.92 
adjustment for ties    -6341.45 
                     ---------- 
adjusted variance     329656.47 
 
Ho: dt(gender==0) = dt(gender==1) 
             z =   2.212 
    Prob > |z| =   0.0270 
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Depression 
Figure 7.18 Differences in DT score between depressed and non-depressed patients 
 
 
 
There were surprisingly few patients (36/264) with a formal diagnosis of depression, given the 
number of “cases” on the HADS and BDI-II. This may account for the very small difference between 
distress in patients who had a formal diagnosis of depression, and those who did not. Median score 
for depressed patients is 4, and for non-depressed patients is 3. P = 0.046. 
 
. ranksum dt, by( depression) 
 
Two-sample Wilcoxon rank-sum (Mann-Whitney) test 
 
  depression |      obs    rank sum    expected 
-------------+--------------------------------- 
           0 |      228     29367.5       30210 
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           1 |       36      5612.5        4770 
-------------+--------------------------------- 
    combined |      264       34980       34980 
 
unadjusted variance   181260.00 
adjustment for ties    -3421.00 
                     ---------- 
adjusted variance     177839.00 
 
Ho: dt(depres~n==0) = dt(depres~n==1) 
             z =  -1.998 
    Prob > |z| =   0.0457 
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DT score and Diabetes 
Figure 7.19 Differences in DT scores between diabetic and non-diabetic patients 
 
 
 
There was no apparent difference in DT scores between diabetic and non-diabetic patients. Although 
the median DT score for diabetic patients was 3 and for non-diabetic was 2, p = 0.902. 
. ranksum dt, by ( diabetesyn ) 
 
Two-sample Wilcoxon rank-sum (Mann-Whitney) test 
 
  diabetesyn |      obs    rank sum    expected 
-------------+--------------------------------- 
           0 |      152     20214.5       20140 
           1 |      112     14765.5       14840 
-------------+--------------------------------- 
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    combined |      264       34980       34980 
 
unadjusted variance   375946.67 
adjustment for ties    -7095.42 
                     ---------- 
adjusted variance     368851.25 
 
Ho: dt(diabet~n==0) = dt(diabet~n==1) 
             z =   0.123 
    Prob > |z| =   0.9024 
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DT score and cardiac disease 
Figure 7.20 Differences in DT scores between patients with and without a diagnosis of cardiac 
disease 
 
 
 
There was no apparent difference in distress scores between patients with a diagnosis of cardiac 
disease (median = 2) and patients with no cardiac disease (median = 3) (p = 0.194). 
 
. ranksum dt, by ( heartdiseaseyn ) 
 
Two-sample Wilcoxon rank-sum (Mann-Whitney) test 
 
heartdisea~n |      obs    rank sum    expected 
-------------+--------------------------------- 
           0 |      163     22373.5     21597.5 
           1 |      101     12606.5     13382.5 
-------------+--------------------------------- 
    combined |      264       34980       34980 
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unadjusted variance   363557.92 
adjustment for ties    -6861.60 
                     ---------- 
adjusted variance     356696.32 
 
Ho: dt(heartd~n==0) = dt(heartd~n==1) 
             z =   1.299 
    Prob > |z| =   0.1938 
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Peripheral Vascular Disease 
 
Figure 7.21 Difference in DT scores between patients with and without PVD 
 
 
 
 
There was no apparent difference in distress scores between patients with a diagnosis of peripheral 
vascular disease (median = 3) and patients with no peripheral vascular disease (median = 3) (p = 
0.377). 
 
. ranksum dt, by (pvd) 
 
Two-sample Wilcoxon rank-sum (Mann-Whitney) test 
 
         pvd |      obs    rank sum    expected 
-------------+--------------------------------- 
           0 |      212       27658       28090 
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           1 |       52        7322        6890 
-------------+--------------------------------- 
    combined |      264       34980       34980 
 
unadjusted variance   243446.67 
adjustment for ties    -4594.68 
                     ---------- 
adjusted variance     238851.98 
 
Ho: dt(pvd==0) = dt(pvd==1) 
             z =  -0.884 
    Prob > |z| =   0.3767 
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One-year mortality 
Figure 7.22 Difference in DT scores between patient who survived for > 1 year, and those who 
did not 
 
 
There was no difference in DT scores in those patients who died with a year of taking part in the 
study, as compared with those patients who survived for more than one year. Median DT score in 
both groups was 2, and two-sample Wilcoxon rank-sum test gave p = 0.695. 
 
. ranksum dt, by ( mortality ) 
 
Two-sample Wilcoxon rank-sum (Mann-Whitney) test 
 
   mortality |      obs    rank sum    expected 
-------------+--------------------------------- 
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           0 |      251     33879.5     33759.5 
           1 |       17      2166.5      2286.5 
-------------+--------------------------------- 
    combined |      268       36046       36046 
 
unadjusted variance    95651.92 
adjustment for ties    -1820.40 
                     ---------- 
adjusted variance      93831.51 
 
Ho: dt(mortal~y==0) = dt(mortal~y==1) 
             z =   0.392 
    Prob > |z| =   0.6952 
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 Model of factors affecting DT scores 
We attempted to model which of the risk factors examined in the previous section affect DT score, 
using multiple regression analysis. 
We first tried to transform the DT scores to produce a normal distribution, in order to make 
regression analysis easier. We tried squaring, inverting, and both logarithmic and natural log 
transformations, but none of these transformations improved the normalcy of the sample. This is 
likely due to the high frequency of “0” scores (which will not change during these transformations – 
for example 02 = 0, 1/0 = 0, etc).  
We therefore decided to continue using the untransformed values in the model, as it was felt that 
the non-normal distribution was due primarily to multiple overlapping subgroups within the sample. 
It was hoped that by stratifying by the various risk factors of interest, we might tease out the 
different normally-distributed subgroups. 
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We transformed “age” by squaring it, as this gave a more normal distribution: 
 
 Figure 7.23  Age (before square transformation) 
 
 
 
Figure 7.24  Age2 (after square transformation) 
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The other risk factors from sections 7.3.3, 7.3.4 and 7.3.5 which reached statistical significance were 
dialysis modality, age, gender and diagnosis of depression. We fit models of progressive complexity, 
using Likelihood-ratio tests to assess whether each extra risk factor improved the fit of the model. 
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Model 1 Dialysis modality 
. regress dt modality 
 
      Source |       SS           df       MS      Number of obs   =       264 
-------------+----------------------------------   F(1, 266)       =     23.72 
       Model |  171.013989         1  171.013989   Prob > F        =    0.0000 
    Residual |  1918.09049       266   7.2108665   R-squared       =    0.0819 
-------------+----------------------------------   Adj R-squared   =    0.0784 
       Total |  2089.10448       267  7.82436134   Root MSE        =    2.6853 
 
------------------------------------------------------------------------------ 
          dt |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
    modality |   1.598039   .3281445     4.87   0.000     .9519475     2.24413 
       _cons |    2.51145   .2346162    10.70   0.000     2.049509    2.973392 
------------------------------------------------------------------------------ 
 
Model 2 Gender  
. regress dt gender 
 
      Source |       SS           df       MS      Number of obs   =       264 
-------------+----------------------------------   F(1, 262)       =      5.25 
       Model |  40.4393155         1  40.4393155   Prob > F        =    0.0228 
    Residual |  2018.46599       262  7.70406865   R-squared       =    0.0196 
-------------+----------------------------------   Adj R-squared   =    0.0159 
       Total |   2058.9053       263  7.82853727   Root MSE        =    2.7756 
 
------------------------------------------------------------------------------ 
          dt |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
      gender |  -.8376602   .3656167    -2.29   0.023    -1.557581    -.117739 
       _cons |   3.882353   .3010583    12.90   0.000     3.289551    4.475155 
------------------------------------------------------------------------------ 
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Model 3 Depression 
. regress dt depression 
 
      Source |       SS           df       MS      Number of obs   =       264 
-------------+----------------------------------   F(1, 262)       =      4.45 
       Model |  34.3541334         1  34.3541334   Prob > F        =    0.0359 
    Residual |  2024.55117       262  7.72729454   R-squared       =    0.0167 
-------------+----------------------------------   Adj R-squared   =    0.0129 
       Total |   2058.9053       263  7.82853727   Root MSE        =    2.7798 
 
------------------------------------------------------------------------------ 
          dt |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
  depression |    1.05117   .4985366     2.11   0.036     .0695213    2.032818 
       _cons |   3.171053   .1840968    17.22   0.000     2.808555     3.53355 
------------------------------------------------------------------------------ 
 
Model 4 Age2 
. regress dt age2 
 
      Source |       SS           df       MS      Number of obs   =       264 
-------------+----------------------------------   F(1, 262)       =      5.91 
       Model |  45.4001505         1  45.4001505   Prob > F        =    0.0157 
    Residual |  2013.50515       262  7.68513417   R-squared       =    0.0221 
-------------+----------------------------------   Adj R-squared   =    0.0183 
       Total |   2058.9053       263  7.82853727   Root MSE        =    2.7722 
 
------------------------------------------------------------------------------ 
          dt |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
        age2 |  -.0002111   .0000868    -2.43   0.016    -.0003821   -.0000401 
       _cons |   4.247997   .4203016    10.11   0.000     3.420398    5.075596 
------------------------------------------------------------------------------ 
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Model 5 Dialysis modality plus gender 
. regress dt modality gender 
 
      Source |       SS           df       MS      Number of obs   =       264 
-------------+----------------------------------   F(2, 261)       =     17.46 
       Model |  242.985705         2  121.492853   Prob > F        =    0.0000 
    Residual |   1815.9196       261  6.95754635   R-squared       =    0.1180 
-------------+----------------------------------   Adj R-squared   =    0.1113 
       Total |   2058.9053       263  7.82853727   Root MSE        =    2.6377 
 
------------------------------------------------------------------------------ 
          dt |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
    modality |   1.759202   .3260479     5.40   0.000     1.117183    2.401221 
      gender |  -1.004504   .3488247    -2.88   0.004    -1.691373   -.3176351 
       _cons |   3.095886   .3210922     9.64   0.000     2.463625    3.728147 
------------------------------------------------------------------------------ 
 
LR test Model 5 (dialysis modality plus gender) vs Model 1 (modality alone) 
 
Likelihood-ratio test                                   LR chi2(1)  =      8.26 
(Assumption: model1 nested in model5)                 Prob > chi2 =    0.0041 
 
LR test Model 5 (dialysis modality plus gender) vs Model 2 (gender alone) 
 
Likelihood-ratio test                                   LR chi2(1)  =     27.92 
(Assumption: model2 nested in model5)                 Prob > chi2 =    0.0000 
 
So the model adjusting for dialysis modality plus gender is a better fit than the models adjusting for 
either modality or gender alone. Models 1 and 2 were therefore discarded. 
 
Psychosocial Distress in Older Patients with Advanced Chronic Kidney Disease 
 
Page 163 of 277 
 
Model 6 Dialysis modality plus gender plus depression 
. regress dt modality gender depression 
 
      Source |       SS           df       MS      Number of obs   =       264 
-------------+----------------------------------   F(3, 260)       =     12.84 
       Model |  265.690396         3  88.5634652   Prob > F        =    0.0000 
    Residual |  1793.21491       260  6.89698041   R-squared       =    0.1290 
-------------+----------------------------------   Adj R-squared   =    0.1190 
       Total |   2058.9053       263  7.82853727   Root MSE        =    2.6262 
 
------------------------------------------------------------------------------ 
          dt |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
    modality |   1.734103   .3249203     5.34   0.000     1.094293    2.373914 
      gender |   -.951364   .3485359    -2.73   0.007    -1.637676   -.2650516 
  depression |     .85812   .4729549     1.81   0.071    -.0731897     1.78943 
       _cons |   2.955674   .3288992     8.99   0.000     2.308029    3.603319 
 
LR test Model 6 (dialysis modality plus gender plus depression) vs Model 3 
(depression alone) 
Likelihood-ratio test                                   LR chi2(2)  =     32.03 
(Assumption: model3 nested in model6)                 Prob > chi2 =    0.0000 
 
LR test Model 6 (dialysis modality plus gender plus depression) vs Model 5 
(dialysis modality plus gender) 
Likelihood-ratio test                                   LR chi2(1)  =      3.32 
(Assumption: model5 nested in model6)                 Prob > chi2 =    0.0684 
 
So the model adjusting for dialysis modality plus gender plus depression is a better fit than the 
model adjusting for depression alone, but not significantly better than the model adjusting for 
dialysis modality plus gender. Model 6 was therefore discarded.  
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Model 7 Dialysis modality plus gender plus age2 
. regress dt modality gender age2 
 
      Source |       SS           df       MS      Number of obs   =       264 
-------------+----------------------------------   F(3, 260)       =     13.99 
       Model |  286.074638         3  95.3582128   Prob > F        =    0.0000 
    Residual |  1772.83066       260  6.81857948   R-squared       =    0.1389 
-------------+----------------------------------   Adj R-squared   =    0.1290 
       Total |   2058.9053       263  7.82853727   Root MSE        =    2.6112 
 
------------------------------------------------------------------------------ 
          dt |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
    modality |    1.79353   .3230641     5.55   0.000     1.157375    2.429685 
      gender |  -.8934869    .348136    -2.57   0.011    -1.579012   -.2079619 
        age2 |  -.0002076   .0000826    -2.51   0.013    -.0003702    -.000045 
       _cons |   3.921303   .4570064     8.58   0.000     3.021398    4.821208 
------------------------------------------------------------------------------ 
 
LR test Model 7 vs Model 4 
Likelihood-ratio test                                 LR chi2(2)  =     33.61 
(Assumption: model4 nested in model7)                 Prob > chi2 =    0.0000 
 
LR test Model 7 vs Model 5 
Likelihood-ratio test                                 LR chi2(1)  =      6.34 
(Assumption: model5 nested in model7)                 Prob > chi2 =    0.0118 
 
So the model adjusting for dialysis modality plus gender plus age2 is a better fit than the model 
adjusting for age2 alone, and also somewhat better than the model adjusting for dialysis modality 
plus gender. Models 4 and 5 were therefore discarded in favour of model 7. 
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7.4 Discussion 
 Is there a difference in DT scores between CKD4/5 patients and haemodialysis patients? 
We found that haemodialysis patients had significantly higher DT scores than CKD4/5 patients 
(median DT score 4 for haemodialysis patients and 2 for CKD4/5 patients, p < 0.001). This is in 
keeping with previous studies; Da Silva Gane17 found that quality of life worsens after dialysis 
initiation, particularly in haemodialysis patients. In contrast, patients managed conservatively 
maintained their quality of life. There are many reasons why this should be the case. Kurella Tamura 
found that functional status declined following initiation of dialysis101, while Carson18 found that 
dialysis patients spent significantly more time in hospital compared with conservatively managed 
patients. There may also be an element of self-selection: patients with severe symptoms may be 
more likely to choose what they perceive to be an “active management” modality in the hope that 
their health may improve, where as those who feel well may be reluctant to “rock the boat” by 
starting dialysis. 
 
 What other factors affect DT scores? 
Increasing age was associated with lower DT scores. This was unexpected – one might imagine that 
older patients would have more comorbidities and poorer functional status, and thus higher levels of 
distress. It may be that younger patients with CKD experience a greater dissonance between their 
own poor health and the good health of the majority of their peers (who may be travelling, having 
successful careers, and starting families – all of which are out of reach for young haemodialysis 
patients). In contrast, older CKD patients may “expect” poor health in old age, seeing this as a 
normal part of ageing.  
Looking at the literature on distress in other diseases, Blank et al323 and Cassileth et al324 both report 
lower levels of distress in older cancer patients compared with younger ones, and Nelson et al284 
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specifically noted that DT scores were lower with increasing age in prostate cancer patients. They 
explained that “older adults, as compared with younger adults, demonstrate better emotion 
regulation, a more generative perspective, and a shifting of goals” (p897). 
Female gender was also associated with increased distress (median DT score 4 compared with 2 for 
male patients, p = 0.027). It is not clear why this should be: are women more distressed in the 
general population, or is there something specific to CKD which affects women more than men? Or 
do women experience negative emotion as “distress” and men experience it as something else (such 
as anger, frustration)? Perhaps women are more willing to express their negative emotions – it must 
be remembered that this sample had a median age of 67 years old, and men of this generation were 
frequently encouraged to have a “stiff upper lip”.  
There was no association between DT scores and haemoglobin. This may be explained by the fact 
that patients in both cohorts will have their haemoglobin managed with erythropoietin therapy 
(either on dialysis or self-administered in the community), and this treatment should maintain 
haemoglobin within fairly tight limits. Indeed it is surprising that there was a difference in 
haemoglobin values between the two cohorts at all as both groups have the same treatment targets. 
The very low haemoglobin results seen in the study (Hb < 80g/L) may represent recent acute blood 
loss (such as from a bleeding fistula or duodenal ulcer) rather than chronic renal anaemia. 
Alternatively, the patients with very low haemoglobin results may not have engaged with Epo 
therapy, have contraindications to Epo therapy (such as uncontrolled hypertension), or may have 
inflammatory conditions (such as recent infection) which have made them Epo-resistant. 
Low serum albumin is often a marker of poor overall physical health, and is associated with 
increased six-month mortality in CKD patients44. One might therefore hypothesise that patients with 
poor physical health would experience higher levels of distress. It is therefore rather surprising that 
low serum albumin does not appear to have a significant association with increased distress. 
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There was also no significant association between DT scores and either of the comorbidity indices 
(CCI and Davies score). Again this was an unexpected finding: we had hypothesised that patients 
with more comorbidities would be more distressed.  
There was a weak negative association between eGFR and DT scores, which did not reach 
significance. There was also a weak negative association between distress and dialysis vintage – are 
patients with higher levels of distress more likely to die, or do patients get less distressed the longer 
they are on HD? It appears to be the latter, as there was no association between higher DT scores 
and one-year mortality.  
Depression appears to be under-diagnosed in our cohort. Only 36 patients had a formal diagnosis of 
depression, compared with 97 patients who were “cases” on the HADS and 114 who were “cases” 
on the BDI-II. Under-diagnosis is well-recognised as a problem in the literature on depression in CKD 
patients248,253,325, and screening for depression is often recommended for prevalent dialysis patients. 
Diagnosed depression does appear to be a risk factor for distress, whereas the other specific physical 
comorbidities that we looked at (diabetes, cardiovascular disease and peripheral vascular disease) 
were not.  
In summary, the only significant risk factors for distress which we identified were: haemodialysis vs 
CKD4/5, younger age, female gender, and existing diagnosis of depression. It is notable that none of 
the physical risk factors examined were associated with increased DT scores. This points towards 
distress as a psychological phenomenon, although we demonstrated in Chapter 4 that distress is 
distinct from depression. 
We then modelled the risk factors affecting DT score. The model which best fit our data was the 
model adjusting for age2, gender and dialysis modality. Interestingly, the effect of an existing 
diagnosis of depression was attenuated once these other risk factors were accounted for, suggesting 
a degree of confounding (ie the differences in diagnosis of depression could be explained by 
differences in age, gender and dialysis modality).  
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One can easily imagine how age and gender might affect likelihood of diagnosis with depression 
(which, it must be remembered, is not the same as likelihood of having depression). It is interesting 
that dialysis is associated with higher rates of diagnosed depression, when (as discussed above) our 
data suggests that depression is under-diagnosed in this group. It is possible for both statements to 
be true: it seems that depression is diagnosed more frequently in dialysis patients than in CKD4/5 
patients, but that this is still an under-representation of true rates of depression in this group. 
 
 Limitations of the study 
There are potential issues regarding the timing of the administration of the questionnaires for 
dialysis patients. As previously discussed, most dialysis patients completed the questionnaires during 
dialysis sessions. It is known that patients’ cognitive abilities are affected by dialysis (“brain 
stunning”)312. It is also highly likely that patients experience heightened distress during dialysis 
sessions – they may experience pain (needling of fistulas, cramps), frustration (waiting for transport, 
machines not being ready), and anxiety (machines alarming). Further work needs to be done to 
examine whether distress does indeed change from baseline during dialysis sessions, as the higher 
rate of distress experienced by haemodialysis patients may be caused by dialysis itself, and may not 
be present on non-dialysis days. 
Our sample size was well-powered to detect a difference in DT scores between CKD4/5 patients and 
HD patients, but may not have been sufficient to assess the effects of the less commonly-occurring 
risk factors (such as one-year mortality).  
It appears that there was significant under-diagnosis of depression, which may have affected our 
estimation of the association between DT scores and depression. For example, if only the most 
severely-depressed patients are being diagnosed, this would tend to lead to an over-estimation of 
the relationship between distress and depression. This also raises the possibly of other co-
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morbidities such as PVD and cardiac disease also being under-diagnosed, or at least under-recorded 
on the electronic patient record (EPR), again biasing our findings with respect to the association 
between DT scores and these comorbidities. 
 
 Unanswered questions 
Some of the risk factors we examined, in particular eGFR and dialysis vintage, would be best 
assessed longitudinally. By following the trajectory of distress in the same patient, as eGFR declined 
or as they spent more time on dialysis, we would get a clearer picture of the effect of these risk 
factors on DT scores, controlled for individual confounders and inter-rater variability. We did not 
have enough repeated measures in this study to examine these risk factors longitudinally (due to 
high attrition rates), and our follow up period of two months was too short to see significant 
changes in eGFR in the CKD4/5 cohort, but we examine trajectories of distress in more detail in 
Chapter 8.  
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8 Distress Trajectory study 
 
8.1 Introduction 
8.2 Aim of this study 
The first part of the study aims to examine change in DT scores in CKD4/5 patients, over a period of 
up to three years, and to assess whether change in DT scores is due to change in functional status or 
change in eGFR.  
The second part of the study examines the six months before and after initiation of dialysis in more 
depth, and explores the trajectories of distress and functional status at this transitional time. 
 
8.3 Part 1 Hypothesis  
1. Higher DT scores are strongly associated with worse KPS scores and lower eGFRs. 
2. Greater rise in DT scores over time (ie worse distress) is strongly associated with greater rate of 
decline in KPS scores and faster rate of decline in eGFR. 
8.4 Part 2 Hypothesis:  
1. DT scores worsen following initiation of haemodialysis, and do not return to baseline in the following 
six months 
 
8.5 Methods 
 Research Ethics Committee approval 
Research ethics committee approval was obtained from Health and Social Care 2 Research Ethics 
Committee of Northern Ireland (REC reference 13/NI/0075, see appendix A for approval letter). 
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 Study group 
 Study Setting 
The first part of this study was carried out at UCL Centre for Nephrology (CFN) Low Clearance Clinics 
(LCC) at the Royal Free Hospital (RFH), and its five satellite units. These clinics have approximately 
1300 patients, and care is delivered by two nephrology consultants (0.5 WTE) and eight clinical nurse 
specialists (CNS). CFN policy is to transfer all renal patients to LCC clinic for management of their CKD 
symptoms and for dialysis modality planning when eGFR< 20mls/min (<30mls/min for diabetic 
patients). Conservatively managed (palliative) patients are also followed up in this clinic. 
The second part of this study was carried out across the five satellite dialysis units managed by the 
Royal Free Hospital (RFH): Mary Rankin; Barnet; Edgware, St John and St Elizabeth, and Tottenham 
Hale (the Royal Free does not have any in-centre outpatient dialysis, only satellite outpatient units). 
Following the standard UK outpatient dialysis model, patients attend three times per week, for 
between 3-4.5hrs each, in one of six regular “slots” (either on Monday, Wednesday and Friday or 
Tuesday, Thursday and Saturday, in the morning, afternoon or evening). 
 
 Population 
This study had two parts: the first used existing clinical data from the electronic patient record to 
assess change in distress scores over time in prevalent CKD patients. All patients aged 70 years or 
older, who attend CFN Low Clearance Clinics (LCC) at the Royal Free Hospital (RFH) or one of its five 
satellite units, were screened for eligibility for the study (approx. 900 patients).  
Patients from within this cohort who started haemodialysis within the study recruitment period 
were approached for consent to participate in the second part of the study (change in distress 
around time of initiation of haemodialysis). Unfortunately due to the small size of the CFN’s 
peritoneal dialysis cohort, a separate PD arm would not have been able to recruit enough patients to 
be adequately powered, and there is evidence that PD patients and HD patients are sufficiently 
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heterogenous17 that a combined RRT arm would have been methodologically unsound. Patients who 
chose peritoneal dialysis were therefore excluded from the second part of the study. 
 
 Inclusion and Exclusion Criteria  
8.5.5.1 Inclusion criteria for 1st part (prevalent CKD patients) 
Attending CFN LCC clinics  
Aged 70 years or older 
At least three DT scores recorded on the electronic patient record (EPR) 
 
8.5.5.2 Inclusion Criteria for 2nd part (change in distress around initiation of haemodialysis) 
Took part in 1st part of study 
Started haemodialysis within the last month 
 
8.5.5.3 Exclusion Criteria (both parts) 
Inability to consent 
Unable to understand or complete Distress Thermometer (DT) 
 
 Sample size calculation 
There were 921 patients >70yrs attending LCC on 01/10/2011. We assumed that, since the Distress 
Thermometer had been in routine use in LCC for over a year at that point, 50% of these patients 
would have at least three DT scores recorded in the EPR, and would thus be eligible for the first part 
of the study (giving a sample size of 460). 
Psychosocial Distress in Older Patients with Advanced Chronic Kidney Disease 
 
Page 173 of 277 
 
50-60 LCC patients >70yrs commence haemodialysis (HD) annually. We anticipated that at least 50 
patients from the first part of the study would commence HD during the recruitment period (two 
years). Based on recruitment to previous studies, we felt that recruitment of 80% of eligible patients 
to part two of the study was realistic (based on the fact that the patient’s regular team would be 
recruiting and consenting them, and that the study was not particularly burdensome). 
 
 Recruitment  
8.5.7.1 Research team 
The research team at the Royal Free comprised Helen Alston (HA); Aine Burns (AB), my supervisor 
and lead consultant for Low Clearance, who was study Primary Investigator (PI); and the Royal Free’s 
Renal Systems and Clinical Data Manager (DW), who extracted the data for the 1st part of the study 
from the electronic patient record. 
 
8.5.7.2 1st part: CKD 
As only existing data from the electronic patient record (EPR) was used, and as this data was 
accessed only by HA (a member of the LCC clinical team) consent was not required. A list of 
potentially eligible patients was obtained from the EPR, and this was manually searched to produce 
a list of eligible patients. A database query was then run by our Renal Systems and Clinical Data 
Manager to extract the data needed for analysis from the EPR. 
 
8.5.7.3 2nd part: Initiation of haemodialysis 
Eligible patients were identified by HA by cross-referencing the monthly renal modality report (this is 
a routinely generated database query which lists patients who have changed from “low clearance” 
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to “haemodialysis” on our renal database) with the EPR to confirm that they met the other inclusion 
criteria. Eligible patients were then approached in the dialysis unit on arrival for their routine dialysis 
session, and asked if they were interested in taking part. If they expressed interest, they were 
provided with a written patient information leaflet, and given time to consider the study and to ask 
questions. Those who were happy to proceed were asked to provide written consent. Patients who 
refused were not approached again. 
 
 Data 
Outcomes of interest: Change in distress thermometer scores over time  
Risk factors of interest: Residual renal function measured by eGFR (MDRD), planned treatment 
modality (low clearance, dialysis, conservative care), biochemical and haematological parameters, 
co-morbidities, functional status (routinely recorded by KPS scoring at each visit) and demographic 
data (age, sex, ethnicity, etc). 
 
8.5.8.1 Data Collection 
Data for part one of the study was collected retrospectively from the electronic patient record. 
The distress thermometer is not routinely used in our dialysis units, so for part two of the study, HA 
administered the DT monthly (on the same day of the week each time, to minimise the potential for 
fluctuations in distress scores caused by changes in biochemical/fluid status related to dialysis). If 
the patient did not attend their regular session, HA attended the next session that they were 
expected at or, where this was not possible, the corresponding session the following week. The data 
for other risk factors was obtained from the electronic patient record.  
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8.5.8.2 Data handling and record keeping 
Names, hospital numbers, dates of birth and genders of patients, along with data relating to the 
outcomes of interest listed above, was collected from the electronic patient record in accordance 
with the patient consent form, patient information sheet and the study protocol. This data was 
manually inputted into a spreadsheet using Excel 2010 (Microsoft) and sent electronically to HA for 
statistical analysis using the statistical package STATA/IC 12.1 (StataCorp LP). University College 
London acted as the data controller for the study. 
HA processed, stored and disposed of the patient demographic information and in accordance with 
all applicable legal and regulatory requirements, including the Data Protection Act 1998. Patient data 
was stored centrally at the Centre for Nephrology as follows: the hard copies of questionnaires were 
stored in a locked filing cabinet controlled by HA, and the database was stored on password-
protected UCL computers in a secure office (requiring swipecard access), and on an NHS-issued 
encrypted USB stick (for transfer between NHS sites only). 
 
 Statistical Methods 
8.5.9.1 Part 1 
Data was analysed using STATA/IC 12.1 (StataCorp LP). Linear regression was used to analyse distress 
and KPS at baseline. Multi-level regression was used to look at changes of distress and KPS score 
over time, adjusted for eGFR and the factors previously shown in our model to be significantly 
associated with higher DT scores (age and gender – all patients in Part One were CKD4/5 so their 
modality was the same) (see Chapter 6 for further information on multi-level models).  
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8.5.9.2 Part 2 
We originally intended to model the change in trajectory in DT scores following initiation of dialysis 
using multiple regression analysis. However, in the event of low recruitment we instead used a 
technique previously used by Murtagh et al326 to assess trajectories of illness in CKD5: Visual Graphic 
Analysis. Described by Brown et al327, Visual Graphic Analysis (VGA) is a qualitative method of 
assessing trajectories by visual inspection. 
Individual trajectories were plotted using Stata. Time was centred around date of first dialysis 
session. Graphs were plotted using the same scales, and also using the same colours and layout to 
avoid any inadvertent visual biases. The graphs were compared, and common patterns identified. 
These patterns were then verified by a second researcher. Where there was any disagreement this 
was discussed until agreement was reached.  
 
 Missing data 
If data was missing we treated this as “data missing completely at random”, as this was felt likely to 
be due to factors such as nursing staff forgetting to enter the data, distress thermometers being 
taken home instead of being handed in, etc. Maximum likelihood estimations were used in 
imputation. Refusal to complete DTs is documented as a separate category in the EPR (this would be 
data missing not at random), and this data was therefore not imputed. 
 
 Withdrawal from study  
As part one of the study was a retrospective review of anonymised, routinely-collected clinical data, 
patient consent was not required and therefore patient withdrawal was not an issue. 
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If patients in part two withdrew their consent to take part in the study, they were asked if they gave 
consent for continued use of the data already collected. If they said yes, we continued to use this 
data. If they said no, all of their data was removed from the study.  Consent and capacity were 
confirmed with the patient monthly while the patient remained in the study, immediately prior to 
the administration of the DT.  
 
 Ethical Considerations 
Ethics committee approval was obtained from Research Ethics Committee as previously discussed 
(see Appendix A). There were few ethical considerations for part one of the study, as this was 
retrospective analysis of routinely-recorded data. For part two, if any patients expressed high levels 
of distress or suicidal ideation, this was immediately communicated to the patients named nurse and 
dialysis consultant for further action. 
 
8.6 Part 1 Results 
 
 Sample size  
We obtained records for 316 CKD4/5 patients aged over 70 who had three or more completed DTs 
recorded on the electronic patient record. Baseline characteristics are shown in table. 
 
 Statistical analysis 
We carried out a simple linear regression to confirm that our previous findings were also valid in this 
new cohort (ie that age and gender affected DT scores while eGFR did not), and to assess the impact 
of low functional status using the Karnofsky Performance Scale on DT scores. 
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We then carried out a multi-level regression to assess how DT score changed over time with eGFR 
and KPS scores. 
 Baseline characteristics of the sample (n=318) 
The mean age was 85, and 64% of the participants were male. On average there were 5 recorded DT 
scores on the EPR, however some patients had up to 16 DT scores recorded. eGFRs ranged from 
54mls/min down to 7mls/min (mean not calculated, as different participants have multiple 
measurements of renal function included in the study data).  
 
Table 8.1 Baseline characteristics of CKD4/5 cohort 
 Mean (min/max values) 
Age 85.2 years ( min 72.78 -  max 104.54) 
Gender  64% male 
Number of DTs recorded 5 (3 – 16) 
eGFR range 7 – 54 mls/min 
 
 Linear regression 
We next carried out linear regression to confirm that the variable previously found to be associated 
with DT scores in the cross-sectional study (Chapter 7) were also significant in this cohort.  
8.6.4.1 Age 
. regress distressscore age 
 
      Source |       SS       df       MS              Number of obs =    1547 
-------------+------------------------------           F(  1,  1545) =    2.58 
       Model |  21.9059849     1  21.9059849           Prob > F      =  0.1085 
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    Residual |  13125.5497  1545  8.49550145           R-squared     =  0.0017 
-------------+------------------------------           Adj R-squared =  0.0010 
       Total |  13147.4557  1546  8.50417576           Root MSE      =  2.9147 
 
------------------------------------------------------------------------------ 
distresssc~e |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
         age |   .0179742   .0111934     1.61   0.109    -.0039817    .0399301 
       _cons |   .9844541   .9103949     1.08   0.280     -.801286    2.770194 
------------------------------------------------------------------------------ 
 
Interestingly, increasing age is associated with increasing DT scores in this cohort (not statistically 
significant, p=0.109). It must be noted that this cohort only includes patients older than 70 years, 
while the cohort in Chapter 7 included all age groups. 
 
8.6.4.2 Sex 
. regress distressscore Sex 
 
      Source |       SS       df       MS              Number of obs =    1547 
-------------+------------------------------           F(  1,  1545) =    5.04 
       Model |  42.7174505     1  42.7174505           Prob > F      =  0.0250 
    Residual |  13104.7383  1545  8.48203124           R-squared     =  0.0032 
-------------+------------------------------           Adj R-squared =  0.0026 
       Total |  13147.4557  1546  8.50417576           Root MSE      =  2.9124 
------------------------------------------------------------------------------ 
distresssc~e |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
         Sex |   .3504643   .1561676     2.24   0.025     .0441414    .6567872 
       _cons |   2.321884   .0912353    25.45   0.000     2.142926    2.500842 
------------------------------------------------------------------------------ 
 
Female gender remains associated with higher DT scores in this cohort (p=0.25) 
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8.6.4.3 Karnofsky Performance Scale 
 
. regress distressscore karnscore 
 
      Source |       SS       df       MS              Number of obs =     778 
-------------+------------------------------           F(  1,   776) =   89.25 
       Model |  703.768357     1  703.768357           Prob > F      =  0.0000 
    Residual |  6118.98357   776  7.88528811           R-squared     =  0.1032 
-------------+------------------------------           Adj R-squared =  0.1020 
       Total |  6822.75193   777  8.78089051           Root MSE      =  2.8081 
 
------------------------------------------------------------------------------ 
distresssc~e |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
   karnscore |  -.0570595   .0060398    -9.45   0.000    -.0689157   -.0452032 
       _cons |   6.731523   .4519192    14.90   0.000     5.844394    7.618652 
------------------------------------------------------------------------------ 
 
There is a significant negative association between KPS scores and DT scores – ie the lower the KPS 
(worse functional status), the higher the level of distress is likely to be (p<0.001). 
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8.6.4.4 eGFR 
 
. regress distressscore eGFR 
 
      Source |       SS       df       MS              Number of obs =    1534 
-------------+------------------------------           F(  1,  1532) =    0.08 
       Model |  .661553143     1  .661553143           Prob > F      =  0.7803 
    Residual |  13024.1885  1532  8.50142853           R-squared     =  0.0001 
-------------+------------------------------           Adj R-squared = -0.0006 
       Total |  13024.8501  1533  8.49631446           Root MSE      =  2.9157 
 
------------------------------------------------------------------------------ 
distresssc~e |      Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
        eGFR |   .0025448   .0091226     0.28   0.780    -.0153492    .0204388 
       _cons |   2.383222   .1971893    12.09   0.000     1.996433    2.770012 
------------------------------------------------------------------------------ 
 
There is no association between eGFR and DT score in this linear model (p=0.780) 
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 Multi-level modelling 
 
We then fitted a multi-level model to assess how DT scores were affected by KPS scores over time: 
 
8.6.5.1 Model 1 - KPS 
. xtmixed distressscore karnscore || patHospNo1 : 
 
Performing EM optimization:  
 
Performing gradient-based optimization:  
 
Iteration 0:   log likelihood = -1816.5378   
Iteration 1:   log likelihood = -1816.5378   
 
Computing standard errors: 
 
Mixed-effects ML regression                     Number of obs      =       778 
Group variable: patHospNo1                      Number of groups   =       259 
 
                                                Obs per group: min =         1 
                                                               avg =       3.0 
                                                               max =         9 
 
 
                                                Wald chi2(1)       =     43.48 
Log likelihood = -1816.5378                     Prob > chi2        =    0.0000 
 
------------------------------------------------------------------------------- 
distressscore |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
--------------+---------------------------------------------------------------- 
    karnscore |  -.0478348   .0072543    -6.59   0.000    -.0620529   -.0336167 
        _cons |   6.066753   .5499417    11.03   0.000     4.988887    7.144619 
------------------------------------------------------------------------------- 
 
------------------------------------------------------------------------------ 
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  Random-effects Parameters  |   Estimate   Std. Err.     [95% Conf. Interval] 
-----------------------------+------------------------------------------------ 
patHospNo1: Identity         | 
                   sd(_cons) |   1.942827   .1243983      1.713689    2.202602 
-----------------------------+------------------------------------------------ 
                sd(Residual) |   2.030001   .0626223        1.9109    2.156525 
------------------------------------------------------------------------------ 
LR test vs. linear regression: chibar2(01) =   179.36 Prob >= chibar2 = 0.0000 
 
. estat icc 
 
Residual intraclass correlation 
 
------------------------------------------------------------------------------ 
                       Level |        ICC   Std. Err.     [95% Conf. Interval] 
-----------------------------+------------------------------------------------ 
                  patHospNo1 |   .4780679   .0381136      .4043998    .5527026 
------------------------------------------------------------------------------ 
 
This confirmed that KPS is strongly associated with DT scores (p<0.001). ICC was estimated at 0.478 
(95% CI 0.404 – 0.553), suggesting that 47.8% of variation in the relationship between DT and KPS is 
actually due to individual differences between participants. 
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8.6.5.2 Model 2 – KPS and age 
 
. xtmixed distressscore karnscore age || patHospNo1 : 
 
Performing EM optimization:  
 
Performing gradient-based optimization:  
 
Iteration 0:   log likelihood = -1816.1284   
Iteration 1:   log likelihood = -1816.1284   
 
Computing standard errors: 
 
Mixed-effects ML regression                     Number of obs      =       778 
Group variable: patHospNo1                      Number of groups   =       259 
 
                                                Obs per group: min =         1 
                                                               avg =       3.0 
                                                               max =         9 
 
 
                                                Wald chi2(2)       =     44.40 
Log likelihood = -1816.1284                     Prob > chi2        =    0.0000 
 
------------------------------------------------------------------------------- 
distressscore |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
--------------+---------------------------------------------------------------- 
    karnscore |  -.0497178   .0075366    -6.60   0.000    -.0644892   -.0349464 
          age |  -.0198916    .021968    -0.91   0.365    -.0629482    .0231649 
        _cons |   7.820604   2.012497     3.89   0.000     3.876182    11.76503 
------------------------------------------------------------------------------- 
 
------------------------------------------------------------------------------ 
  Random-effects Parameters  |   Estimate   Std. Err.     [95% Conf. Interval] 
-----------------------------+------------------------------------------------ 
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patHospNo1: Identity         | 
                   sd(_cons) |   1.938808   .1242011       1.71004     2.19818 
-----------------------------+------------------------------------------------ 
                sd(Residual) |   2.029869   .0625994      1.910811    2.156346 
------------------------------------------------------------------------------ 
LR test vs. linear regression: chibar2(01) =   178.53 Prob >= chibar2 = 0.0000 
 
 
. lrtest M2 M1 
 
Likelihood-ratio test                                 LR chi2(1)  =      0.82 
(Assumption: M1 nested in M2)                         Prob > chi2 =    0.3655 
 
As might have been expected from the linear regression, the addition of age to the model does not 
improve its fit (LR test p=0.3655). We therefore discarded Model 2.  
 
8.6.5.3 Model 3 – KPS and Sex 
 
. xtmixed distressscore karnscore Sex || patHospNo1 : 
 
Performing EM optimization:  
 
Performing gradient-based optimization:  
 
Iteration 0:   log likelihood = -1814.6427   
Iteration 1:   log likelihood = -1814.6427   
 
Computing standard errors: 
 
Mixed-effects ML regression                     Number of obs      =       778 
Group variable: patHospNo1                      Number of groups   =       259 
 
                                                Obs per group: min =         1 
                                                               avg =       3.0 
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                                                               max =         9 
 
 
                                                Wald chi2(2)       =     47.68 
Log likelihood = -1814.6427                     Prob > chi2        =    0.0000 
 
------------------------------------------------------------------------------- 
distressscore |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
--------------+---------------------------------------------------------------- 
    karnscore |  -.0461927   .0072782    -6.35   0.000    -.0604577   -.0319277 
          Sex |   .5941945   .3045475     1.95   0.051    -.0027076    1.191097 
        _cons |   5.737702   .5735642    10.00   0.000     4.613537    6.861867 
------------------------------------------------------------------------------- 
 
------------------------------------------------------------------------------ 
  Random-effects Parameters  |   Estimate   Std. Err.     [95% Conf. Interval] 
-----------------------------+------------------------------------------------ 
patHospNo1: Identity         | 
                   sd(_cons) |   1.928413   .1235771      1.700799    2.186487 
-----------------------------+------------------------------------------------ 
                sd(Residual) |   2.028091   .0624842      1.909248    2.154331 
------------------------------------------------------------------------------ 
LR test vs. linear regression: chibar2(01) =   178.51 Prob >= chibar2 = 0.0000 
 
. estimate store M3 
 
. lrtest M3 M1 
 
Likelihood-ratio test                                 LR chi2(1)  =      3.79 
(Assumption: M1 nested in M3)                         Prob > chi2 =    0.0516 
 
Again, the addition of Sex to the model did not improve the fit (LR test p=0.0516). Model 3 was 
therefore discarded. 
 
Psychosocial Distress in Older Patients with Advanced Chronic Kidney Disease 
 
Page 187 of 277 
 
8.6.5.4 Model 4 – KPS and eGFR 
 
. xtmixed distressscore karnscore eGFR || patHospNo1 : 
 
Performing EM optimization:  
 
Performing gradient-based optimization:  
 
Iteration 0:   log likelihood =  -1797.624   
Iteration 1:   log likelihood =  -1797.624   
 
Computing standard errors: 
 
Mixed-effects ML regression                     Number of obs      =       771 
Group variable: patHospNo1                      Number of groups   =       257 
 
                                                Obs per group: min =         1 
                                                               avg =       3.0 
                                                               max =         9 
 
 
                                                Wald chi2(2)       =     41.31 
Log likelihood =  -1797.624                     Prob > chi2        =    0.0000 
 
------------------------------------------------------------------------------- 
distressscore |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
--------------+---------------------------------------------------------------- 
    karnscore |  -.0465006   .0072781    -6.39   0.000    -.0607654   -.0322359 
         eGFR |   -.008406   .0147109    -0.57   0.568    -.0372388    .0204268 
        _cons |   6.154651   .6231799     9.88   0.000      4.93324    7.376061 
------------------------------------------------------------------------------- 
 
------------------------------------------------------------------------------ 
  Random-effects Parameters  |   Estimate   Std. Err.     [95% Conf. Interval] 
-----------------------------+------------------------------------------------ 
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patHospNo1: Identity         | 
                   sd(_cons) |   1.959657   .1259351      1.727741    2.222703 
-----------------------------+------------------------------------------------ 
                sd(Residual) |    2.01546   .0627113      1.896221    2.142198 
------------------------------------------------------------------------------ 
LR test vs. linear regression: chibar2(01) =   179.79 Prob >= chibar2 = 0.0000 
 
. estimate store M4 
. lrtest M4 M1 
 
Likelihood-ratio test                                 LR chi2(1)  =      0.33 
(Assumption: M1 nested in M4)                         Prob > chi2 =    0.5684 
 
The addition of eGFR to the model did not improve the fit (LR test p=0.5684). Model 4 was also 
discarded. 
 
Model 1, adjusting simply for KPS scores and for clustering at the individual level, provides the best 
fit for the data. There was a moderately large amount of variability at the level of the individual 
(47.8%). 
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8.7 Part 2 Results 
 Visual Graphical Analysis 
Figure 8.8.1 DT trajectories around start of dialysis 
 
0510 0510 0510 0510 0510
-2
0
.0
0
-1
0
.0
0
0
.0
0
1
0
.0
0
-2
0
.0
0
-1
0
.0
0
0
.0
0
1
0
.0
0
-2
0
.0
0
-1
0
.0
0
0
.0
0
1
0
.0
0
-2
0
.0
0
-1
0
.0
0
0
.0
0
1
0
.0
0
-2
0
.0
0
-1
0
.0
0
0
.0
0
1
0
.0
0
1
2
3
4
5
6
7
8
9
1
0
1
1
1
2
1
3
1
4
1
5
1
6
1
7
1
8
1
9
2
0
2
1
2
2
2
3
DT score
T
im
e
 (
m
o
n
th
s
)
Psychosocial Distress in Older Patients with Advanced Chronic Kidney Disease 
 
Page 190 of 277 
 
We identified five categories of trajectory of DT scores: flat trajectory (divided into flat low and flat 
high), rising at start of dialysis but returning to baseline, rising at start of dialysis but not returning to 
baseline, and other rises in DT score. 
 
 Category 1: Flat trajectory, low distress 
 
Figure 8.8.2 DT trajectories - flat progression 
 
 
 
Figure 8.8.2 shows the four participants with a flat, low distress trajectory. Their pre-dialysis DT 
scores were low, and there is no rise around the time of start of dialysis.  
These participants may genuinely not be upset by the transition onto dialysis, or they may simply not 
identify with the concept of distress or wish to discuss this with their healthcare providers. 
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 Category 2: Flat trajectory, high distress 
 
Figure 8.8.3 DT trajectories - always high 
 
 
These two participants had high levels of distress (DT score >6) in the pre-dialysis stage. There is no 
noticeable change in their DT scores around the time of starting dialysis, but their scores do not 
improve either. It is possible that the cause of their distress is unrelated to their medical situation. 
  
0
5
1
0
0
5
1
0
-20.00 -10.00 0.00 10.00
6
12
D
T
 s
c
o
re
Time (months)
Psychosocial Distress in Older Patients with Advanced Chronic Kidney Disease 
 
Page 192 of 277 
 
 Category 3: Rising but resolving 
Figure 8.8.4 DT trajectories - rising then resolving 
 
 
In this category, participants had an obvious rise in their DT score around the time of starting 
dialysis, but this returned to baseline within a few months. Some of these participants had other 
rises in their DT score at other times (for example, participant 5 had a substantial rise in his DT score 
approximately 10 months before starting dialysis) – it is unknown what caused this rise.  
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 Category 4: Rising but not resolving 
 
Figure 8.8.5  DT trajectories - rising but not resolving 
 
 
These participants also had a substantial rise in their DT scores around the time of start of dialysis, 
but unlike those in category 3, there was no return to baseline observed.  
In some cases, such as participant 20, this may be because follow up was curtailed (by patient death, 
in that particular case). In others, such as participants 7 and 17, there is a slight improvement 
followed by another rise. It may be that the second rise is unrelated to dialysis, as in both instances 
it occurred over six months after starting dialysis. 
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 Category 5: Other patterns  
 
Figure 8.8.6  DT trajectories - other patterns 
 
 
These participants did not fit into any of the previous patters. Participants 8 and 23 have large rises 
six months prior to starting dialysis, but then a flat trajectory around the initiation of dialysis and in 
the time after that. It would be interesting to know whether this coincided with a hospital 
admission, bereavement, or other major life event.  
Participant 9 has several smaller rises in DT score, but neither seems to be temporally related to 
starting dialysis.  
0
5
1
0
0
5
1
0
-10.00 -5.00 0.00 5.00 10.00
-10.00 -5.00 0.00 5.00 10.00
8 9
23
D
T
 s
c
o
re
Time (months)
Psychosocial Distress in Older Patients with Advanced Chronic Kidney Disease 
 
Page 195 of 277 
 
Figure 8.8.7 DT and KPS trajectories around start of dialysis 
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 Comparing trajectories of KPS and DT 
 
Figure 8.8.7 plots the trajectories of DT and KPS for the year before and after starting dialysis (time is 
centred on date of first dialysis session).  
It is apparent that high KPS scores are associated with lower DT scores, and vice versa. However the 
DT appears to be much more variable than the KPS – KPS scores change gradually and slowly, while 
the DT can go up and down fairly rapidly.  
Equally, DT scores often worsen but then improve again quite rapidly. In contrast, a decline in KPS of 
more than 10% (which may be due to inter-reporter variability) does not seem to improve. 
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8.8 Discussion 
 
 Part One 
The relationship between the DT and KPS is strong. For each 10% loss of functional independence on 
the KPS, DT score falls by 0.47 (p<0.001). This relationship is moderately stable over time – up to 
47.8% of the variability in this relationship is due to variation at the level of the individual. 
Interestingly in Chapter 6 we did not find a particularly strong association between the SF-36 
Physical Functioning subscale and DT scores – this may because the SF-36 does not discriminate well 
between lower levels of physical functioning (there is a “floor” effect) and so almost all of our 
patients had low scores on that particular subscale. 
The relationship between DT scores and other factors, such as gender, eGFR and age, is much less 
strong. We have an age-restricted sample, which may explain why age is not a significant risk factor 
for increased distress. However it is surprising that falling eGFR does not have an impact on distress. 
The participants were followed for up to three years, and in that time we recorded eGFRs as low as 
7mls/min, which is certainly low enough to expect participants to have experienced some uraemic 
symptoms. 
 
 Part Two 
We identified five categories of DT trajectory. The majority of participants showed an increase in 
distress around the time of starting dialysis, however while some returned to baseline (adapted) 
after a couple of months, not everybody did.  
A minority were unaffected by the start of dialysis – either because they reported no distress at all 
(category 1), which might suggest that they would use a different word to describe their negative 
emotions, or because they were so distressed all the time that dialysis made no difference to their 
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DT scores (category 2). Both of these categories of participants should be probed gently by the 
clinical team to ensure that they are receiving all the help that they wish to receive.  
A final category did not experience a rise in distress around the time of start of dialysis but did 
experience a rise in distress at other times. The causes of these non-dialysis rises are not known. 
 Clinical implications 
How do we reconcile the findings of Part One and Part Two? Low eGFR is not associated with higher 
levels of distress, however in Part Two we found that the majority of participants experience a rise in 
DT scores around the time of start of dialysis, and for some participants this rise does not return to 
baseline even after six months. The distressing aspects of dialysis appear to be unrelated to prosaic 
changes in eGFR – this aspect needs to be explored in more detail, but from a clinical perspective, 
the exhortation to “treat the patient, not the figures” should be born in mind.  
On the other hand, poor functional status (low KPS scores) do seem to be associated with higher 
levels of distress. Kurella Tamura101 noted a functional decline around time of initiation of dialysis, 
and this did not recover to baseline even after several months. There are a number of studies 
examining the efficacy of physical rehabilitation for renal patients115,119,328 – functional decline is 
however very difficult to reverse, even with very motivated patients. Patients suffering from distress 
may be in no position to engage with physiotherapy. 
 
 Limitations of this study 
The very small numbers recruited to Part Two meant that we were unable to carry out a regression 
analysis to assess which factors are associated with more unfavourable trajectories. We were able to 
carry out a Visual Graphical Analysis, but this is an exploratory technique without the ability to 
assess risk factors of interest.  
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 Unanswered questions 
 
We need to do further work to investigate which patients’ DT scores do not return to baseline 
following initiation of dialysis, and why that might be. It would also be extremely interesting to know 
what causes the rises in DT scores which are not associated with starting dialysis (category 5) – are 
the causes related to other health matters, or not related to health at all? 
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9 Qualitative Study 
9.1 Introduction 
9.2 Aims 
To explore factors affecting distress in an older UK adult renal population (CKD 4/5, aged over 70 
years). 
 
9.3 Specific research questions 
1. How do patients define distress? 
2. What are the causes of distress in CKD4/5 and dialysis patients? 
3. What do we as healthcare professionals currently do, and what could we do differently, to mitigate 
this distress? 
9.4 Research Ethics Committee Approval 
Research Ethic Committee approval was obtained from West of Scotland Research Ethics Committee 
5 (ref 14/WS/0120, see Appendix A for approval letter). 
 
9.5 Methodology 
I have chosen to use an interpretative (hermeneutic) phenomenological approach. I believe that the 
appropriate object of study for this project is the global phenomenon of distress, rather than the 
conscious attitudes of patients towards their own distress. Spiegelberg described hermeneutics as 
“the attempt to grasp the essential structures of the phenomena, and the essential relationships 
within and among them” p62 329. 
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The phenomenon of distress is likely to be different for patients who have not yet started dialysis 
(who may be apprehensive about dialysis in the future) compared with patients who are already on 
dialysis (who have direct lived experience of dialysis). For this reason I will interview participants 
from both of these different stakeholder groups. 
I have chosen an interpretative rather than descriptive phenomenological approach because, as a 
nephrologist myself, I recognise the limitations of my own subjectivity. The interpretative approach 
effectively utilises my pre-existing expert knowledge and facilitates a co-constitution between 
researcher and participant.  
In contrast, a descriptive approach would require a “bracketing”, or examination and conscious 
rejection, of my prior personal knowledge in order to truly understand the participants’ perspective 
330,331. In this particular context, I would find this inauthentic; my position as a nephrologist is 
precisely what has driven my interest in this research topic, an aspect which Koch acknowledges 331. 
It is also unlikely that participants, who already know that I am a healthcare professional, would be 
able to set this knowledge aside. This power imbalance is something that I was very aware of during 
the interviews, and although I took steps to mitigate it (by encouraging frank opinions from the 
participants, mirroring them when they expressed their opinions of other healthcare professionals, 
and stressing the confidential nature of the interview), it is likely that it still influenced the interviews 
overall. 
The concept of the “Hermeneutic Circle”, from theologian Schleiermacher 332, describes the process 
by which, in interpretative phenomenology, the researcher’s position in the world affects their 
interpretation of the data, which then prompts reflection and synthesis, and the generation of new 
knowledge. This process may be facilitated by the use of a reflexive journal (or contemporaneous 
notes on the interview process), which I have used in the past to good effect.  
In terms of evaluation of the study, Heideggerian scholars would reject the concept of external 
validity, since knowledge is viewed through the lens of a person’s previous experience, and is never 
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independent of interpretation333,334. Instead, Koch suggests that a piece of interpretative 
phenomenological research should be judged on the criteria of philosophy (the research should 
demonstrate a clear understanding of the philosophical underpinnings of the methodology), 
representation (a clear process of reflection on the part of the researcher, and co-constitution 
between researcher and participant) and rigor (which Koch describes as a clear explication of the 
way in which the research was carried out, with justification for research decisions made)333. 
In broader terms, Merriam and Patton have both produced useful frameworks for evaluating 
qualitative research in general 299,335, which I have referred to when preparing this chapter. 
 
9.6 Methods 
 Study Design 
Semi-structured interviews with older renal patients: patients were purposively selected to include a 
broad range of gender, socio-economic class, ethnic group and experience of nephrology services.  
 Study group 
9.6.2.1 Population 
All patients aged 70 years or older attending UCL Centre for Nephrology (CFN) Low Clearance Clinics 
(LCC) at the Royal Free Hospital (RFH) and its 5 satellite units (approx. 1300 patients). CFN policy is to 
transfer all renal patients to LCC clinic when eGFR< 20 for non-diabetic and <30 for diabetic patients. 
Care is delivered by 2 consultants (0.5 WTE) and 8 clinical nurse specialists (CNS). 
9.6.2.2 Inclusion Criteria 
1. Attending CFN low clearance clinics or dialysis units 
2. Aged 70 years or older 
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9.6.2.3 Exclusion Criteria 
1. Inability to consent 
2. Unable to comprehend spoken english (as we were carrying out a content analysis, validity would be 
affected if translation services were used). 
3. Change in modality in last three months (likely to lead to confusion about whether sources of 
distress relate to old or current modality, hard for patient to assess new modality accurately) 
 
 Recruitment  
Eligible patients from each of four treatment modalities (LCC, HD, PD, CM) were identified by the 
research team from the renal patient database, in discussion with the renal multidisciplinary team 
(who have personal knowledge of the patients and can therefore assess suitability for the study).  
Patients were purposively selected to represent our elderly LCC population (age, sex, ethnicity, 
social, functional and carer status), enriched by inclusion of patients with particularly high or low DT 
scores in the past. 
The patient information sheet and a covering letter were sent to all eligible patients. Patients were 
then asked by a member of the team at their next routine appointment whether they were 
interested in taking part in the study. If they expressed interest, a member of the research team 
provided them with written information about the study, and they were given time to consider the 
study and to ask questions.  
Those who were happy to proceed were asked to provide written consent, and an appointment was 
made for the researcher to carry out the interview. A phone call was made to the patient the day 
before this appointment to confirm that they were still happy to proceed. Patients who refused 
were not approached again. 
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 Data 
 Sample size 
We chose a sample size of 20 patients, 10 from each treatment modality. Based on the literature, we 
expect to reach a saturation of themes by this point ("the experience of most qualitative researchers 
(emphasis added) is that in interview studies little that is 'new' comes out of transcripts after you 
have interviewed 20 or so people" (Green and Thorogood, 2013, p.120)336). Previous experience 
within the department suggested that a saturation of themes usually occurred much earlier than 20 
interviews (closer to 12). If new themes had still been emerging after 20 interviews, further patients 
would have been recruited until a saturation of themes was reached. 
 
9.6.5.1 Data Collection 
We conducted semi-structured interviews with patients in a place of their choice (subject to risk 
assessment). The interview schedule is included in Appendix. 
Each interview lasted 30-60 minutes, or longer if the participant had further issues to discuss and 
was keen to proceed (a second interview was arranged if the patient so wished).  
 
9.6.5.2 Data handling and record keeping 
Names, hospital numbers, dates of birth and genders of patients, along with data relating to the 
outcomes of interest listed above, were collected from patients in accordance with the patient 
consent form, patient information sheet and the study protocol. We generated aliases for all 
patients which were stored with their real names and other data mentioned above in a password-
protected database which was stored on an NHS machine. 
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Taking of consent and provision of information about the interview took place before recording 
started, to maintain anonymity. The interview was recorded as a WAV file using ClearRecord on a 
password-protected iPad in aeroplane mode (to prevent inadvertent copies uploading to the cloud). 
The files were transferred to a password-protected UCL machine via usb immediately following the 
interview, and were then deleted from the iPad. The files were labelled with the time and date of 
the recording, but no identifiable data was associated with the recording. Aliases were used for 
contemporaneous notes, and no names were used by the researcher during the recording. If 
patients did refer to themselves in a way which might be identifiable, this section of the recording 
was edited on return to UCL to remove the identifiable data prior to transcription. 
The anonymised data was transcribed by an outside transcription service which is regularly used by 
Dr Low and has experience in transcribing sensitive interviews. The transcribed interviews were 
returned to Dr Alston for analysis using NVivo 10. Dr Alston also transcribed several of the interviews 
in parallel both to confirm accuracy of transcription and as a training exercise. University College 
London acted as the data controller for the study. 
Dr Alston processed, stored and disposed of the patient information in accordance with all 
applicable legal and regulatory requirements, including the Data Protection Act 1998 and any 
amendments thereto. Patient data was stored centrally at the Centre for Nephrology as follows: the 
anonymised interview WAV files, the electronic copies of transcripts, and the NVivo database were 
stored in a password-protected folder on a UCL machine, and the database containing the aliases 
and real patient names was stored in a different password protected folder on an NHS machine. 
Consent forms, any hard copies of interviews or other paperwork were stored in a locked filing 
cabinet controlled by Dr Alston in the Centre for Nephrology offices (access requires both swipecard 
and keycode). There was nothing to link individual consent forms with hard copies of the interviews 
(they were filed separately). 
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The patient data was not transferred to any party except those identified in this protocol and was 
not processed and/or transferred other than in accordance with the patients’ consent.   
 
 Data Analysis 
Each interview was transcribed verbatim. The transcripts were transferred onto NVivo9, a software 
programme for analysis of qualitative data. The data was analysed using thematic content analysis. 
We identified key themes in the transcript and counted the frequency of these themes in the text. 
We undertook a thematic analysis of the transcripts to explore patients’ understanding and 
experience of “distress” and factors contributing to it. Texts were re-read in their entirety to confirm 
key themes and place individual accounts in the context of information about each participant.  
 
 Withdrawal from study 
If patients withdrew from the study at any point before or during the interview, or up until two 
weeks after the date of the interview, we removed all of their data from the study.  After this stage 
the interview would have been transcribed and analysis would have started, and it would have been 
very difficult to remove the information at this stage. 
 
 Ethical Considerations 
Ethics committee approval was obtained. Fully informed written consent was obtained from each 
participant in line with good clinical practice (GCP) as described above, including consent for audio 
recording. Data was treated confidentially as per the Data Protection Act (1998).  
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9.7 Results 
 Conduct of interviews 
We recruited 19 participants, of which 7 were CKD4/5 and 12 were dialysis patients. 12 were men. 
There was a range of socio-economic classes, from professionals such as lawyers to retired barmaids. 
The mix of ethnic backgrounds was more limited, reflecting the area of north London from which 
these participants were recruited, but it included Jamaican, Irish, Jewish and mixed-race participants 
as well as white British.  
There was a good rapport between interviewer and participant and I did not feel that my status as a 
healthcare professional prevented participants from speaking freely. Several did ask for medical 
advice, and needed to be redirected to their own medical team. Others asked me for clarification of 
medical decisions made by their team (“why might they have said that?”), and in those instances I 
asked the participant what they had understood at the time. 
Although participants were very happy to talk, they were less able to introspect. Male respondents 
in particular had great difficulty in reflecting on the emotional impact that previous events had had 
on them. These respondents were from the generation of the “stiff upper lip”, and are likely 
unaccustomed to interrogating their emotions. The female respondents, although of the same 
generation, were much more emotionally literate and could explain their thoughts and feelings 
much more readily. 
 
 What is distress? 
The participants gave a wide range of definitions of distress. They described feelings of frustration 
and helplessness, concerns around change in self-image, grief, shock, empathy for others’ suffering 
and physical discomfort. Constructing a coherent definition of distress is challenging; although each 
participant had a clear idea of what they meant by distress, individual definitions were often in 
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conflict. Definitions appeared to be informed by individuals’ biographical narrative rather than being 
embedded in a shared social understanding. 
Many participants described frustration and feelings of helplessness or powerlessness. For some this 
was provoked by physical limitations (“when you find that simple things, putting your socks on and 
things like that, you get very angry” – Michael, dialysis patient). Other found their reliance on others 
frustrating (“sometimes you know they’ll be chatting and you think oh stop chatting and put me on” 
– June, dialysis patient). Others described physical pain (“No, the only distress that you get is if they 
take too much fluid off, where you get cramps” – Wilbur, dialysis patient). 
Miles, a retired accountant with CKD5, found his diagnosis of CKD distressing (“Nobody likes to be 
told that they are not 100% healthy”). He described distress as a sense of disorder caused by the 
change in self-perception from “healthy” to “ill” (“Suddenly along the way you are suddenly told that 
there is something not quite right with you and you’ve got to eat certain foods or anything. That in 
itself is distressing. Because you are not the same person you were”). He distinguished between 
severe distress which “keeps you awake all night”, and mild distress which he described as “being 
upset”. 
Many participants experienced distress related to worries about their families, and Miles explicitly 
related this to his sense of helplessness when his wife was ill (“I can’t help her. I could help myself by 
overcoming the distress myself, but I can’t help her”). Clive, a solicitor still working in his late 70s 
despite his CKD5, felt that distress was a more public phenomenon, which he experienced upon 
hearing about cases of child cruelty (“Makes your blood run cold”). 
Several described distress as “grief”, and related their own bereavements as examples of distressing 
situations. In comparison, their own ill health was perceived as less distressing (perhaps because, as 
Miles explained above, their own health felt more within their control). 
There was disagreement on how distress presents. One participant felt that distress “comes out of 
the blue without apparent reason”. Another felt that distress “can come and go”. Yet another 
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described it as very transient: “Little things. You get a bit under the weather for it, but not for the 
whole day. It’s just a few minutes”.  
Others felt that distress was a personal failing: 
“I'm of the opinion that people these days have this huge feeling of entitlement, which is bloody 
rubbish. You've got to help yourself if you can” - Michael.  
“There’s no way you can stop her being unhappy, she’s not one of these people who will make an 
effort to be happy” – Clive 
Some participants did not associate their own negative emotional states with the term “distress”: 
“I'm not distressed, the question that's missing off there is, frustration, huge” - Michael 
“I don't know if the word is distressed, worry I always say worry, I'm worried about this and I'm 
worried about that. Maybe I am distressed” - Jeanette 
“I think distressed is not a word I would use” - Alan 
This raises the possibility that the Distress Thermometer is not identifying participants who 
experience high levels of negative emotion but do not associate such emotions with their own 
definition of distress. 
“If this was a frustration thermometer? I’d be right at the top” – Michael 
The participants who did not identify with the word “distress” felt that distress was a very severe 
emotion (“I think if you were distressed yes, you would be at your wits’ end, you wouldn't know 
where to turn sort of thing” – Jeanette).  
Our explanations of the Distress Thermometer may need to reflect this to encourage patients to 
report milder symptoms, in order to allow HCPs to intervene before the symptoms become more 
troublesome. On the other hand, the original Distress Thermometer studies only intended the DT to 
detect “patients in significant distress” (Roth et al p1904)278, so perhaps detection of milder distress 
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would simply lead to the pathologisation of self-limiting symptoms for which the patient has no 
need of our help. 
There was recognition from some participants that distress was a broad concept: 
“I mean I know distress can mean pain, it can mean all sorts of different things, but yeah that’s what 
that would mean to me” – George.  
“You’ve got something wrong with you you’re distressed about it. You can also be distressed about 
other people’s conditions, you can be distressed about world conditions!” –Clive 
 
 Depression v Distress 
There was a fairly even split between those who felt that distress was the same thing as depression, 
and those who felt it was not. Interestingly, those who felt it was different to depression were 
divided on whether distress was more or less severe than depression – Samuel described distress as 
“a calamity”, whereas Jasmine said that “to me, distress is when something is not right and it’s 
bugging you. Depression is when you see no way of surviving”.  
Miles differentiated between depression which “can come upon a person out of the blue without 
apparent reason” and distress where “something has caused it, yes. I don’t think you get distressed 
for no reason. You get distressed because something has actually caused it”. This echoes the concept 
of “secondary depression” affecting dialysis patients, described by Mimi Israel337. There is extensive 
debate within the psychiatric community about the differences and demarcations between 
depression as a psychiatric illness and normal grief response to traumatic or upsetting events 
(reflected in the controversy over the removal of the Bereavement Exemption in the DSM-V338,339), 
and it is interesting that, colloquially, participants seemed to understand this distinction. 
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 Causes of distress in CKD4/5 patients 
As we had hypothesised, the causes of distress were different for participants who had CKD4/5 and 
those who had already started dialysis.  
For those participants with CKD4/5, there was a division between those who felt distressed by their 
diagnosis of CKD, and those who tried not to think about it. Those who felt distressed by their 
diagnosis reported a change in self-perception as a result of the diagnosis:  
“I never ever went to the doctor until I was at least 70 and I was always very fit” – Michael  
“No. I don’t think of myself as a patient particularly” – Clive  
“All my life I have been fairly healthy. Suddenly along the way you are suddenly told that there is 
something not quite right with you and you’ve got to eat certain foods or anything. That in itself is 
distressing…because you are not the same person you were. That is distressing” – Miles  
“This one kind of floored me because I just got it into my head that I was going to die and that's it” – 
Mary 
Some mentioned the sense of unfairness they felt on diagnosis despite being a “good patient” (Alan) 
by following medical advice. Hazel specifically mentioned the outrage she felt when other patients 
“cheated” (“I thought, that’s not on your diet!”). Diets in general were felt to have an almost 
talismanic ability to protect against dialysis (“I kept a diet and everything so I should be okay” – 
Miles; “I asked what I could do for myself and the answer was nothing really. I said I’m not having 
that so I did change a few things in my life” – Hazel). This may be because diet is seen as an area 
within patients’ own control. 
Others reported that they had initially been disturbed by their diagnosis, but as time had passed and 
nothing had happened, they had been reassured by the fact they were not receiving active 
treatment: 
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“After a few months when it was found that it was more or less like stale mate, it hadn’t got worse 
thank god, so they stopped worrying” – Miles 
“The fact that I had no symptoms, and if I hadn’t been told, wouldn’t have known and didn’t think it 
was getting any worse until as I say I was told I’d progressed from 3 to 4, I won’t say it lulls you into a 
sense of false security but it prevents you being alarmed doesn’t it” – George 
“I said to him in some alarm [laughs] oh what do I do about it? And he said nothing!” - Clive 
The participants with CKD4/5 all found the idea of dialysis distressing. Some compared dialysis with 
death (“it’s more or less a death sentence isn’t it. I called it a death sentence but I suppose a life 
sentence is more accurate” – Clive). Others simply refused to discuss it or consider it at all, preferring 
to put off any decisions till the future. The implication was that, by putting off dialysis decisions, they 
may also put off dialysis itself.  
It was widely assumed that healthcare professionals were motivated to initiate dialysis, and there 
were several comments about not “letting” doctors start them on dialysis, and “playing along” with 
doctors in order to avoid further discussion: “I took the leaflets and I read them and I thought no 
way am I doing this. But he said we have got to have a plan what you want. So I agreed I would 
probably look at home dialysis if it was appropriate and left it at that. No way.” - Hazel. 
 
 Causes of distress in haemodialysis patients 
Some of the dialysis patients reported that they had been “pushed” into dialysis unwillingly, rather 
than it being a treatment decision that they had made themselves. However nobody wished to 
withdraw from dialysis. The ambivalence appears to represent sadness about the necessity of 
starting dialysis, rather than regret that they had not chosen the Supportive Care pathway instead.   
Many participants described an intense period of distress around the time of start of dialysis. 
Beatrice described dialysis “it's terrible. I'm losing all my life because I'm either here or I'm asleep”. 
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Aidan commented “Well, I was told that it wouldn’t be a pleasant experience, and it hasn’t been 
pleasant”. 
Mary “cried for two weeks. When they told me I got to have dialysis I was devastated, devastated”.  
None felt any better since starting dialysis. On the contrary, Aidan felt that he “seemed to 
deteriorate”, and Alan complained of “Pains. Energy. Tiredness. Ability to run up and down stairs. It’s 
all different. My life is very different now”.  
 
  Association between dialysis and death 
As well as the idea mentioned previously that dialysis was “a death sentence”, some participants 
associated dialysis with death in a more literal sense.  
Jeanette described observing other inpatients who were already on dialysis, and wondering whether 
the same fate awaited her: “She'd come back upstairs, they'd leave her in bed and she seemed to 
sleep for a while and I would watch her to see if she was all right because I thought I wonder if she's 
going to die. That was my thought, everybody's going to die, me too.”  
Samuel also reported a frightening discussion he had with a neighbour who was already on dialysis 
(who was unaware that Samuel had CKD too): “Well I will tell you. My neighbour upstairs right at the 
stairs, he was on dialysis and he recently died about a year ago. Yeah. He was a bit older than me. I 
met him one day out in the car. He said to me… he didn’t know anything about me. He said to me it’s 
a death sentence. That is what frightened me. I don’t feel I want to die”. He went on to explain that 
another acquaintance on dialysis had also died: “So all the people you have known with kidney 
disease, it has not been very positive?” “Well yeah, yes. It’s only two we’ve known. They both died.” 
Interestingly, Albert described several extremely traumatic events – witnessing the deaths of two of 
his cohort in the bay in front of him during dialysis sessions, and the experience of his own cardiac 
arrest on dialysis – but denied feeling any distress about these events, and seemed puzzled at the 
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suggestion that he might have found them upsetting. His method of dealing with things was not to 
think about them “Well … you know, I just feel a bit … it could happen to me … but, you know 
[laughs], what can you do about it?  You could be walking along – you could be getting on the bus, 
and drop down dead.  So … that’s it”.  
And although Jasmine claimed to have “taken it all in stride”, she still remembered the exact date of 
her first dialysis session fifteen years ago, suggesting that she saw that date as a significant one. 
 
 Intrusiveness of dialysis treatment 
The main reason that participants with CKD4/5 wished to avoid starting dialysis, and the main 
complaint from those participants who were already on dialysis, was the intrusion into and impact 
on the rest of their day to day lives (“it interferes with your life to such an extent that whether or not 
you’re doing much [laughs] you you you you shrink, you shrink very much in thought” – Clive). 
On this background, delays (such as delays due to problems with patient transport, or delays being 
put onto machines) were a major source of distress. Participants reported that these delays 
increased their sense of constraint and lack of control. There was a strong feeling that delays were 
avoidable and due to inefficiencies in the service – participants did not blame the individual staff for 
this (they generally praised the dialysis nurses and individual drivers for being hardworking, although 
this may have been partly because they were aware that I am a HCP, or because they did not want 
criticism to get back to the staff). Instead they blamed underfunding of the service, and 
incompetence of the transport managers.  
Participants reported that being on dialysis was bad enough, and that delays made this worse than it 
needed to be. Delays were interpreted as a lack of concern for them as patients, a lack of courtesy 
and respect, and left participants feeling disempowered and “like a cog in a machine” rather than 
being treated as an individual. 
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Patients who organised their own transport felt more empowered and happier than those on 
hospital transport. However, they were distressed by delays waiting for machines to be ready, 
because this made them keep other people (their taxi drivers) waiting.  
June expressed distress that her carers arrived at unpredictable times, and this meant that she often 
was not ready for the transport driver.  To manage this, she had started getting up at 4am on dialysis 
days in order to get herself ready on her own (“I can’t bear unpunctuality, I’m always fifteen minutes 
early, been like that all my life”). She would rather inconvenience herself than keep others waiting, 
as this allowed her to retain some control of the situation (“you know, to have to rely on other 
people for things, eh it does get a bit annoying”). 
 
 Managing distress 
Following the initial grief/trauma response that many participants reported upon starting dialysis, 
most participants described a process of adaptation to dialysis (“I wasn’t very happy to start with. Of 
course I’ve gotten so used to it now” – June). This was not always done willingly! (“I adjusted to my 
illness. Because it can’t adjust to me. I made up my mind on that bit, that I have to adjust to my 
illness” - Hester).  
Jasmine explained how one of the ward nurses had helped her to adjust: “You know you read a book 
and starting reading, it’s so interesting. Then you suddenly come to a page and you can’t come off 
that page because the whole thing is gone, funny enough. You read that line and you leave it and you 
come back and you read the line but you’re not reading it like how you were reading it before. And I 
said to her ‘After you left I was thinking about it. So when I got up in the morning I felt much better.’ 
So I said to her ‘I have turned the page and moved on’.” 
Other methods used to manage distressing situations included practicing acceptance, and having a 
sense of fatalism (“I wish I didn’t have to, but I know I have to. So there is no fight, you know” – 
Psychosocial Distress in Older Patients with Advanced Chronic Kidney Disease 
 
Page 216 of 277 
 
Hester; “Having to take enforced retirement through health wasn’t something I either had planned 
for or wanted. But it happened. I had no choice” - Alan). 
In particular, participants accepted that ill health was a normal part of ageing (“Well I’m elderly. 
People’s health does deteriorate as they get older” – George; “You're getting old, things are bound to 
stop working” – Michael). Some accepted death as part of this (“all these ailments – you know, so I’m 
… I’m quite reconciled to the end, when it does come” – Aidan). Others felt quite the opposite, and 
fought against their mortality (“I said you’ve got the wrong person, I don’t behave like that [Laughs] 
To me life is very precious. And having got it I intend to hang on to it as long as I can” – Alan). 
Some participants compared themselves to other patients around them, and felt that instead of 
being distressed about their own situation they should be grateful for what they had (“I think yes, 
some of them are probably worse than me so I shouldn’t be feeling sorry for myself” – Jasmine). 
Several participants had made a conscious decision to be positive about their situation – these 
participants could point to a specific moment when they decided to accept things (“Then I decided 
just to bear it, I'm not letting it get the better of me, I'm just not, I'm going to get up and do what I've 
got to do, even going for this” – Jeanette; “So you know a lot of thought went into it and what I do is 
I adjust. I adjusted myself because I realize… I didn’t fool myself. I adjusted myself and didn’t fool 
myself and come to the expectations that my life would become any different” – Hester). 
Many mentioned their “placid” personality as a protection against distress. They also mentioned 
their relationship with other patients, and the sense that the dialysis staff cared for them and 
treated them with respect.  
Dialysis was not discussed between the other patients; instead they distracted each other from their 
situation (“We didn't really talk about the dialysis, we talked about everything else. It's funny, 
sometimes, you want to hear the laughter that comes out of here at times, it really cheers you up” – 
Beatrice). Other patients who broke the social contract of positivity were viewed with disdain (“This 
woman said to me one day ‘I can’t see why you’re laughing. This is nothing to laugh about.’ So I said 
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to her ‘Look, if you cry you cry alone but if you laugh the world laughs with you.’ She said ‘Well I’m 
not laughing because it’s not funny’.” – Jasmine). 
 
 Maintaining sense of self 
Participants did not wish to be defined by their renal disease. Instead they made great efforts to 
maintain their previous sense of self despite the limitations imposed by their illness. There were 
differences between the genders: men often talked about past career successes (“I ended up with 
over a million visitors in a year. I think we made thirty thousand quid in turnover in our first year or 
something” – Alan). Others explicitly defined themselves by their previous career (“Looking at me 
you see the result of being a lawyer for all that time” – Clive).  
Geoff used his previous experience in management to analyse the problems in the dialysis unit 
(“There is no doubt that the staffing is not adequate, and I’ve spent a lifetime career looking at 
staffing levels. There’s a formula that you have to apply to any staffing levels.  You add 13 percent on 
for sickness and holidays”). By asserting his authority as a professional, Geoff rejected his status as a 
patient. He had also befriended his GP and went on holidays with him, again subverting the 
doctor/patient power dynamic.  
In contrast, the women talked about their families. They explained long-running family feuds, 
proudly told of their children’s successes, and positioned themselves within a framework of 
interlocking relationships. They were keen to protect their families from anxiety (“Yeah, I couldn’t 
talk [to my children] about it in the beginning” – Jasmine), but also described the feeling of security 
they derived when their families took over caring commitments (“She did everything, she looked 
after me like nobody's business” – Mary).  
Participants also made strenuous efforts to maintain their physical independence – as previously 
mentioned, many organised their own transport to and from the dialysis unit. Others sadly described 
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the limitations on their freedom now that their mobility was impaired (“All these things that you 
took for granted that you could do, you now find that they are difficult” – Michael; “I used to go out 
and do my shopping. I used to take a taxi and go to places. You know, you just did normal things. But 
I can’t do it so much now” – June). Beatrice described the indignity of needing her son in law to help 
with her personal care (“It is embarrassing and upsetting, very upsetting actually. But what can you 
do, it's got to be done, there's nothing you can do about it”). 
 
 Information about dialysis 
Participants with CKD4/5 were generally quite reluctant to receive information about dialysis, or to 
make future plans (“I'm the type of person, I don't like to ask questions, I think ignorance is bliss” – 
Jeanette). They wished to maintain the status quo, and seemed to view dialysis as an event far in the 
future which might never happen (“I’m just hoping I won’t need it… 90% of the time the thing that 
worries you doesn’t happen, it doesn’t come to fruition” – Miles). Receiving information about it 
ahead of time was seen as pointless, as Hester stated “Wait until that time comes. I don’t know what 
is going to happen in two years’ time. That is too far ahead for me”. 
Clive was unwilling to make any kind of preparations for dialysis at all (“I’m very much a bury-your-
head-in-the-sand man, I am”). Miles did not feel that he could make a decision on whether he would 
want dialysis or not until he was “at that point [of needing dialysis]”. He felt that this dislike of 
change was part of getting old: “It’s only when you are old and you get set in your ways that you 
can’t get used to things. I wouldn’t like to change now, I wouldn’t like any sort of change now. I 
wouldn’t like any sort of change”. 
Many CKD4/5 patients were reassured by fact that no "active" treatment was require for CKD 
(“Because it has got no physical alteration in my life, no, I don’t think about it” – Miles). Several 
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participants explained that the doctors were "just monitoring" them, so they did not think that their 
kidney disease was all that serious.  
Those on dialysis did not want to consider withdrawal from HD or to imagine health worsening, even 
when they reported that their health was much worse than it had been prior to starting dialysis. 
They had unrealistic expectations of life expectancy on dialysis (“I’ve reached 74 and a bit, I don’t 
want to go yet. If I get to eighty something I think no, no. I don’t want more fiddling about” – Hazel). 
There was no sense of planning for end of life, even though some patients were clearly aware that 
their life expectancy was limited (“I expect that I won’t live much longer – you know, with all these … 
cos of … a, a dicey heart” – Aidan). 
We discussed whether participants would like to meet (or if they were on dialysis, would they have 
liked to have met) other people who had been in their position to learn about their experience of 
starting dialysis – nobody thought that that would be helpful (“Something like that you are far better 
off finding out for yourself. Because the way it affects one person doesn't necessarily affect another 
one the same” – Beatrice; “I don’t think so, because it was the experience that one would have to go 
through oneself” – Aidan; “No, I don’t think so. I mean, I’ve got the leaflets, I can read those” - 
George).  
Indeed, Hazel felt it would have been actively unhelpful: “I don’t think it would have done me much 
good to talk to people about it. They might have said the wrong thing and if they had been upset 
with it I really wouldn’t want to know that”.  
 
 Living with uncertainty 
Attitudes towards the uncertainty of living with CKD were split – as previously discussed, some clung 
to the fact that “it [dialysis] might never happen”, while others found the uncertainty to be a source 
of distress. 
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George explained that “In a way it was good news in that it is not immediately. But in other senses it 
is not good news because it is sort of deferring it. It’s the sword of Damocles”. In particular, he was 
disconcerted that the lack of symptoms gave him no indication of whether his CKD was better or 
worse “because you got no idea where you are. At least with the arthritis you know where it is 
because you can feel it all the time”.   
Interestingly, several participants who had started dialysis reported that it was not actually as bad as 
they had feared (“Frightened of the unknown, I was scared” – Jeanette;  “I was all a bit scared but 
now I'm used to it I don't even think about it really. It's like everything once you get used to it” – 
Beatrice). 
 
9.8 Discussion 
 The Meaning of Distress 
When asked to define distress, participants provided a wide variety of responses, which while 
thematically interconnected, are nevertheless broad enough to include critical ambiguity and 
contradiction. What, for example, is the experience of distress? For some participants, it was self-
described as a negative emotional state (as per the NCCN definition277), for others a rational 
concern, and for others again a bodily discomfort.  
Similarly, where the locus of distress? For some, distress emerged from within the self, in particular 
around negative changes in self-image or sense of control. For others it came from without, 
generated by reflecting on the suffering of others, be they immediate family members or victims of 
war on the news. Most commonly, distress is understood to reside in an interdependency of self and 
world, described as a response to negative events in that participant's life and characterised as 
frustration, anxiety, worry, and so on. 
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Such is this interdependency that participants often struggled to distinguish the experience of 
distress from the causes of distress, describing a distressing situation when asked to describe 
distress itself. The concept of distress, then, is caught in a tautological circularity – distressing events 
are distressing because they cause distress, but equally distress as an experience is defined as the 
state which is caused by distressing events. Is this circularity problematic? Not if we posit that 
distress as a phenomenon is intrinsically socio-spatial, as it appears to be, being tied into patients' 
immediate experience of the world, their conceptual models of the world, their cultural background, 
their personal biography, and their sense of place in society.  
Given the range of opinions on offer, can we pin down a single definition of distress that covers all 
participants' definitions? To do so means mobilising a suitably wide definition so as not to exclude 
any of the perspectives discussed. Hence the utility of the proposal that distress is the “negative 
emotional experience of the individual” (National Comprehensive Cancer Network277 ) which 
effectively encompasses the variety of participant viewpoints, being broad by design.  
That said, while we as researchers we can come to some consensus around a technical definition, 
amongst the population as a whole, in the breadth and fluidity of possible definitions, distress as a 
term should be understood as a floating signifier340. That is to say, in use, the word “distress” does 
not unambiguously refer to any one concept, experience, or phenomenon, but rather is a cluster of 
related terms, with meaning generated idiosyncratically by each individual. To understand any 
individual's notion of distress, one must interrogate how the term is shaped by the lens of their 
history, attitude to life, memories, associations, and values.  
The question is, then, what impact this definitional fluidity has on the Distress Thermometer as a 
diagnostic device. Firstly we must acknowledge that asking patients to define distress is somewhat 
of an artificial exercise – in practice, the Distress Thermometer is designed to work with whatever 
definition of distress each patient deploys, without challenging them on that definition. Secondly, we 
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should note that while definitions of distress may vary across a population, for any individual, 
distress is a stable, common sense term that presents little difficulty in comprehension.  
In fact, far from problematic, it is the nature of the distress as a term that makes it so useful for this 
task. In being productively ambiguous, it is capable of embodying multiplicitous nuance, and so can 
map onto each individual's own personal understanding of distress. While patients may disagree 
amongst themselves as to what distress truly is, for each individual, distress provides a single 
intuitive metric that is quantifiable, can track change over time, and easily facilitates conversation 
with practitioners.  
If there is a concern to be had with regards to how patients define distress, it is around those 
participants who distanced themselves from the notion of distress itself. Although we might still say 
that these patients experience some degree of distress, they would not agree, perhaps because they 
associate distress with a degree of severity that they don't feel they experience, or because it is 
related to an inability to cope when they feel like they are coping well. For these patients, it would 
be useful to provide an alternative definition that allowed them to express their distress without 
appeal to the word itself.  
 
 Clinical implications 
9.8.2.1 Distress around initiation of dialysis 
Distress appeared in this study to be a near-universal response to the transition onto dialysis. Both 
the threat of impending dialysis and the upheaval caused by the initiation of dialysis were described 
as distressing. However, the majority of participants who had been on dialysis for some time 
reported an acceptance, or resignation, to their new circumstances, with an according reduction in 
their distress levels. 
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It is important to avoid pathologising a normal transition onto dialysis. The impact of haemodialysis 
on a patient’s life is immense, and it is understandable that many experience a sense of loss for their 
old life, approaching a grief reaction. Parker et al found that “serious medical problems” (which must 
surely encompass initiation of dialysis) were equivalent to bereavement in terms of psychological 
impact341. It may not be possible, or even desirable, to prevent patients from being upset by this 
unlooked-for change. 
However, the Hedonic Treadmill Model342 would suggest that the majority of patients return to their 
baseline level of happiness given time to adapt psychologically (this level of baseline happiness 
would of course vary from individual to individual343). This study appears to support that 
supposition. So should we intervene only on those patients in whom the adaptive process is 
maladaptive, prolonged or severe? These patients would likely meet the criteria for Prolonged Grief 
Disorder, now included in the DSM V344, and thus may benefit from medication or renal psychology 
input. The Distress Thermometer may be used to detect these patients, or alternatively renal 
services could ensure close attention from the named dialysis nurse for the first few months on 
dialysis, and rapid referral if there are concerns about adjustment. 
 
9.8.2.2 Reducing distress 
In terms of mitigating the wider causes of distress, Morse345 discusses the common responses and 
coping mechanisms to threats to sense of self, and this framework provides a useful framework for 
interpreting many of the themes reported by our participants.  
She describes the “salvaged self”, or maintenance of a previous identity despite a current inability to 
function in that role. We saw this in the way participants used their previous careers as a lens 
through which to interact with the dialysis unit. We also saw the disproportionate impact that delays 
had on a participant’s distress levels. Interestingly, this was not due to the intrusion of the delays 
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themselves into the rest of the patient’s life (most participants went straight home after dialysis 
anyway), but was due to the perception that these delays created that the participant was seen as “a 
cog” rather than an individual.  
Small initiatives from staff to recognise patients’ individuality and existing skills (for example patient 
consultation groups) are likely to have a disproportional impact on patient satisfaction. Substantially 
more effort is needed to avoid delays in transport and in having machines ready for patients – this 
could include split dialysis shifts, or an increase in dialysis self-care (so they can put themselves onto 
dialysis when they arrive without needing to wait for a nurse to become free). 
The desire to maintain the status quo has been previously described by Llewellyn et al346 in patients 
with CKD4/5 who elected not to have dialysis. We found a similar picture in our study. This wish to 
maintain the status quo included a wish to avoid hearing about dialysis and to “stick your head in the 
sand” instead. Giving information at a time when patient does not wish to receive it is likely to be 
counterproductive – the patient will find this distressing and the information is unlikely to be 
retained. Of course the clinical situation may supersede the patient’s wish to defer discussions! 
However the use of a Buddy or peer-support system may be better accepted if it is offered once on 
dialysis (ie as a “dialysis mentor” scheme for new starters, rather than as part of the pre-dialysis 
education programme). 
 
 Limitations and Unanswered Questions 
The major limitation to this study is the small number of black and minority ethnic participants 
recruited. Several BAME patients were approached, but many older South Asian participants were 
non-fluent in English, and others declined to take part. Religious and cultural beliefs may also play a 
role in the attitudes of some patients to distress and suffering. 
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The association between dialysis and death suggests a potential link between the distress 
experienced around dialysis initiation and the phenomenon of grief. It would be interesting to 
explore how far participants agree with this position, and whether interventions for prolonged grief 
reactions or trauma are helpful in easing the transition onto dialysis.  
Some of the participants were quite unable to reflect on prior distressing events in their lives, which 
may be a protective response (“burying one’s head in the sand”) or may be due to an upbringing in 
which emotions were not discussed or displayed. This resulted in the situation where Albert insisted 
to me that his own cardiac arrest had not distressed him as he never thought about it. 
We also spoke little about dialysis withdrawal, and I suspect that the wish to maintain the status quo 
and to avoid engaging with upsetting future events (which emerged strongly from my interviews, 
and which was also described by Llewellyn et al346), would play a large part in influencing attitudes 
towards palliation and cessation of dialysis. 
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10 Conclusion 
10.1 Use of mixed methods in this project 
From the initial planning stage of this thesis, it was clear that my research question mandated a 
mixed method approach. Questions such as “what do patients mean when they say they are 
distressed?” could not be answered using a quantitative approach, and “what are the risk factors 
associated with increased DT scores?” is clearly best answered with a quantitative approach.  
The gaps in the existing distress literature, such as lack of clarity about the definition of distress 
within individual papers, and lack of consensus between researchers, suggested that my thesis 
would benefit from a multi-paradigm approach. This approach provided two benefits301: both 
complementarity (allowing me to explore different aspects of the phenomenon of distress), and 
triangulation (providing confirmation of my findings from multiple sources, for example both the 
Cross-sectional and Trajectory studies found similar risk factors for high DT scores, despite using 
data from different cohorts). 
I initially conceived of this thesis as a quantitative-focused mixed methods study. However as my 
work developed, I discovered that the insights into distress which I gained from the qualitative work 
was the key to understanding the experience of distress. The quantitative studies left me with many 
questions – who do some people with high depression scores say that they are not distressed? Why 
do some participants’ DT scores go up when they start dialysis, when others do not? The qualitative 
study allowed me to understand my quantitative data better, and made sense of the sometimes 
confusing results.  
The use of mixed methods sits well within the paradigm of interpretative phenomenology. In my 
interviews I examined the phenomenon of distress through the lens of multiple different patients. In 
the wider thesis, I examined it through the lens of both qualitative and quantitative paradigms, and 
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from the “snapshot” perspective of the cross-sectional study and the longitudinal perspective of the 
trajectory study. In this way I was able to construct a theory of distress from many different angles. 
This is fitting; I found that distress itself extends across the physical, discursive and clinical domains, 
so it is unsurprising that multiple approaches were needed to give a complete picture.  I have 
synthesised the results of the four studies into the six overall research questions below. 
 
 
10.2 Summary of Key Findings 
 Is the DT an acceptable tool for use in CKD4/5 and dialysis populations, and what is it measuring? 
It appears to be both quick and acceptable, taking 3-5mins to complete. We found a close 
relationship between the DT and both the HADS and BDI-II, in terms of both a general correlation 
between scores, and between higher DT scores and ‘caseness’ on the HADS and BDI-II (AUC 0.87 and 
0.76 respectively).  
The relationship between HADS and DT scores did vary over time, for unknown reasons. This 
variation appears to be related to the participant. In contrast, the relationship between BDI-II scores 
and distress was stable over time, but little of the variation in the relationship (22.2%) was due to 
differences between participants.  
There was a correlation between increasing MSAS total scores (ie increasing symptom number 
and/or severity) and distress, and an inverse correlation between all subscales of the SF-36, 
suggesting that distress worsens with worsening quality of life. The strongest correlations were 
between DT score and the Energy and Emotional Wellbeing subscales. 
The DT has been validated in many different diseases, but to our knowledge this is the first time it 
has been used in renal patients.  
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 Is Distress the same as Depression? 
Findings from both the validation study and the interview study support the conclusion that, while 
distress is closely associated with depression, it is not the same thing.  
Despite the good agreement between DT scores and “caseness” on the HADS and BDI-II, there were 
plenty of participants who scores highly on the DT but did not meet the criteria for depression on 
the other tools, and those who appeared meet the criteria for “caseness” on the HADS or DT but 
who did not report high levels of distress. 
Participants in the interview study differentiated between distress (which could come and go, and 
had an identifiable cause) and depression (which was there constantly and for no reason). Opinions 
on the relative severity of depression and distress varied, but a distinction was made between the 
two things in most cases. 
The originator of the DT, Roth278, did not intend distress to be thought of as the same thing as clinical 
depression. Neither do the DT copyright holders, the NCCN277, who use the term “negative 
emotional experience of the individual”. The whole advantage of the DT is its flexibility and ability to 
encompass a wide range of negative emotions. It is productively ambiguous. While patients (and 
staff) may disagree amongst themselves as to what distress truly is, for each individual, distress 
provides a single intuitive metric that is quantifiable, can track change over time, and easily 
facilitates conversation with practitioners. 
 
 How can we define Distress? 
As mentioned above, the NCCN defines distress as “the negative emotional experience of the 
individual”. This broad term is difficult to improve on, given the broad range of emotions and 
experiences described by our participants.  
Psychosocial Distress in Older Patients with Advanced Chronic Kidney Disease 
 
Page 229 of 277 
 
Participants in the interview study often struggled to distinguish the experience of distress from the 
causes of distress, describing a distressing situation when asked to describe distress itself. Distress 
behaves as a “floating signifier”340; to understand any individual's notion of distress, one must 
interrogate how the term is shaped by the lens of their history, attitude to life, memories, 
associations, and values.  
 
 Which patients are more likely to be distressed? 
The cross-sectional study found that younger patients, female patients, those with a pre-existing 
diagnosis of depression, and those on haemodialysis had significantly higher rates of distress.  
Previous studies have reported that younger patients are generally more distressed than older 
patients284,323,324, and the fact that those with a pre-existing diagnosis of depression were more likely 
to be distressed should come as no surprise. However, to my knowledge no previous studies have 
made an association between distress and gender (many studies on distress have been carried out in 
cancers which generally affect one gender only, such as prostate cancer). The finding that 
haemodialysis patients are significantly more distressed than patients with CKD4/5 is also novel, and 
complements existing work showing high levels of depression156 and poorer quality of life in HD 
patients17. 
The longitudinal study also demonstrated high levels of distress in patients with poor functional 
status – this may be due to sadness at not being able to do the things that they enjoy, frustration at 
being dependent on others, or even due to physical pain or high symptoms burden from underlying 
medical problems. Again, this is a novel finding. 
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 How does distress change around the start of dialysis? 
The DT trajectory study found that, for the majority of participants, there is a rise in DT scores 
around the time of initiation of dialysis. For some of these participants, distress levels returned to 
baseline after a couple of months. However for a substantial minority, distress levels remained 
elevated up to one year post-initiation of dialysis.  
In the interview study, Distress appeared to be a near-universal response to the transition onto 
dialysis. However, participants who had been on dialysis for some time reported an acceptance, or 
resignation, to their new circumstances, with an according reduction in their distress levels. 
Although they did not enjoy dialysis, it no longer caused them distress. The concept of psychological 
adaptation, described in chapter 10, is likely to be in effect here.  
I am not aware of any other published studies assessing change in distress over time before and 
after a traumatic event (for cancer patients, it would be difficult to recruit participants prior to their 
diagnosis). Da Silva Gane et al17 assessed change in self-reported quality of life before and after 
starting dialysis and found that quality of life did decline in haemodialysis patients, but there was no 
evidence of return to baseline in this study.  
 
 What are the causes of distress and what can be done to mitigate this? 
In the interview study, both the threat of impending dialysis and the upheaval caused by the 
initiation of dialysis were described as distressing. This was attributed by patients to a fear of the 
unknown, a desire to avoid change and disruption, and concerns about the impact that dialysis 
would have on the rest of their lives. 
Other sources of distress were functional decline and increased reliance on others, family problems, 
and wider societal problems.  
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Techniques that participants used to mitigate distress included denial, avoiding information about 
dialysis, and putting off decisions until the future. There was a sense that life was short and 
unpredictable, and that there was no point in worrying yourself about something that was in the 
future.  
In terms of HCP interventions, the main point of contention for patients was the delays associated 
with dialysis and hospital transport. Some patients had addressed these problems themselves by 
organising private taxis, but efforts from the healthcare team should also be made to improve this. 
 
10.3 Implications for practice 
How does this affect how we use the Distress Thermometer? In the first instance, we should 
recognise that the Distress Thermometer is a discussion aid, rather than a diagnostic tool. 
Participants who score highly on the Distress Thermometer may be depressed, but they may also 
have high symptom burden, be worried about their daughter, or be anxious about starting dialysis. 
The only way to truly understand the significance of a high DT score is to discuss that score with the 
patient themselves, in order to contextualise the score within their wider experience.  
We should take high scores seriously – DT scores greater than 5 have a specificity of 75% for 
depression on the HADS or BDI-II. We should be particularly vigilant for signs of distress in younger 
patients, women, and those with existing mental health problems.  
We should also target our dialysis education slightly differently – currently we reassure patients that 
“they might never need dialysis”, which they interpret as meaning that they can put it out of their 
mind. However many of our participants found the uncertainty difficult to cope with, echoing the 
finding of Gilbar et al296 that denial as a coping mechanism was, contrary to expectation, not 
associated with lower distress. From a clinical perspective, dialysis modality decisions are best made 
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in the calm environment of an outpatient clinic, rather than as an emergency in A&E in the middle of 
the night. Some decisions cannot be put off till the future.  
A change in focus from peer educators in Low Clearance Clinic to “Dialysis Buddies” after initiation of 
dialysis may encourage greater uptake of this resource among older patients. Certainly new starters 
on haemodialysis are at a vulnerable stage, and need close monitoring to ensure that they are 
adapting to their changed circumstances. There is no need to pathologise the normal process of 
adaptation, but a significant minority will not adapt after six months on dialysis, and those patients 
may benefit from increased psychological support.  
 
10.4 Implications for future research 
Researchers who wish to use the DT as a marker of overall negative emotional experience need to 
be aware of its limitations. In particular, as distress is self-defined, there will be a subset of 
participants who do not share the researchers’ concept of distress which may lead to information 
bias (as the DT may not be measuring what the researchers think it is measuring).  
Furthermore, the fluctuating nature of distress (see Figure 6.28) means that any longitudinal studies 
which use the DT will need to be appropriately powered to avoid spurious results due to background 
variability. In particular, in light of the multiple trajectories of distress which we identified around 
the time of dialysis initiation, any future studies which use the DT to monitor response to an 
intervention (such as referral to psychology) will need to avoid misclassifying the improvement in 
distress that many patients achieve without intervention (as part of normal psychological 
adjustment), as an effect of the intervention. A good control group will be key here. 
The next logical step is a larger scale longitudinal study, following participants for a year before and 
after starting dialysis but with a large enough cohort to investigate the factors affecting trajectory of 
distress using quantitative methods.  
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It would also be extremely interesting to investigate the relationship between distress and frailty. As 
there is an association between DT score and functional status (as measured by the KPS) there is a 
good chance that frailty will indeed be associated with DT scores. Frailty is extremely common in 
dialysis patients (much more common than in the general population), and the frailty phenotype is 
defined as worsening functional status and strength, weight loss and exhaustion. 
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